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Several jurisdictions around the world have passed medical aid-in-dying laws that 
allow a physician, or, in some areas, a nurse practitioner to legally prescribe life- 
ending medications to individuals faced with a serious illness. There are some 
individuals receiving hospice services that also die by suicide without legal lethal 
means.   Little is known, however, about deaths that are identified as suicide by 
professionals working with hospice patients in home settings in areas where medical 
aid in dying is allowed. This qualitative study undertaken in Washington State, where 
the Death with Dignity Act was implemented in 2009, investigates suicide and 
hastened death through the experiences of hospice professionals working with 
patients in their homes. Data were collected through in-depth, semi-structured 
interviews with seven nurses, seven social workers, four physicians, and three 
chaplains. Analysis of these data indicates participants’ interpretation of suicide is 
often blurry, but there are some patients receiving home hospice services who take 
power into their own hands and die by suicide because they are not eligible for, have 
no knowledge of, or lack access to legalised medical aid in dying.  Power is a factor 
shaping roles and beliefs among hospice professionals and those they serve. 
Participants in this study work with patients who utilise medical aid in dying despite 
personal or organisational challenges and conflicts. Many deaths by suicide may be 
interpreted as rational but a perceived taboo about suicide limits open conversations 
among professionals and within organisations. Culture, location, socioeconomic 
disparities, and organisational policy impact how patients perceive, accept, or afford 
legal options.  Palliative care professionals need open communication with patients 
and each other about suicide and hastened death in homecare.   
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The documentary film, How to Die in Oregon, features individuals who have died 
using legal life-ending medications in Oregon, the first state to pass the Death with 
Dignity Act (DWDA) in the United States.  The first person featured on the film, 
Roger, thanks the people of the state of Oregon for the “honour of doing myself in of 
my own volition, to solve my own problems” (Richardson, 2011). Prior to ingesting 
the medication, the film shows an unidentified person stirring the medication into a 
glass of liquid and handing the glass to Roger to drink. Within moments of drinking 
the liquid he lies dying, says goodbye to several people surrounding him and thanks 
the team for preparing the medication. The scene raises many questions including 
who might have been responsible for assisting Roger. Was it the initial physician who 
signed the prescription, the person who stirred the medication, or was the patient 
completely independent?   Did the patient kill himself and, if so, was this ‘suicide’ or 
a medically assisted death?  
 
The impetus for this research came from over 20 years of experience as a hospice 
social worker working with several patients who later died by suicide. The deaths of 
patients who died by suicide using a gun or suffered severe consequences from self-
induced medication overdoses were issues that did not disappear with the 
implementation of the Washington State Death with Dignity Act in 2009. Rather, 
these experiences provoked questions about professionals’ experiences in a climate 
of changing regulations and organisational policy.  Colleagues often shared with me 
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their personal reflections about encounters with hospice patients who intentionally 
hastened death, suggesting that they died by suicide, but these deaths were not 
reported as suicide to authorities, including the local coroner. This led me to 
question what experiences are considered suicide among hospice professionals, 
including deaths utilising the Death with Dignity Act (DWDA). The experience 
described in the film is only one of many that can lead to uncertainty about the 
definition of suicide or hastened death, particularly in a location where there is a law 
allowing a physician to prescribe a lethal dose of medications for a patient to self-
administer. I include the term ‘hastened death’ because in the film, Roger’s death 
would not legally be called a suicide or an assisted suicide. The term hastened death 
is broadly defined in this study as a death that is anticipated due to an advanced 
illness but intentionally accelerated with or without the assistance of a healthcare 
professional.  Hastened death may include death by an individual who intentionally 
overdoses on medication, stops eating and drinking, or receives assistance from 
another to die sooner than might be anticipated.  An intentionally hastened death 
might be seen as a suicide by some individuals and not by others and may also 
include deaths through medical aid in dying, where legally allowed.  
 
1.1 Question, aim, and objectives 
The research question was: What are professionals’ experiences of suicide and 
hastened death with hospice patients in Washington State? The aim of this study is 
to understand hospice professionals’ experiences with patients who have died by 
suicide or hastened death in Washington State, where medical aid in dying is 
permitted by law.   To achieve this aim, I have three objectives. The first is to 
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determine what experiences are considered to be suicide by participants who have 
patients who have either died utilising the DWDA or intentionally hastened death by 
other means.  The term hastened death is used because some participants may 
consider an experience with a patient who died using the DWDA as a suicide and 
others may not because, by law, the deaths are not identified as a suicide.  Using the 
term ‘hastened death‘ in the research question enables a broader understanding of 
experiences that may include deaths that are not considered to be suicide.   
 
The second objective is to determine how medical aid in dying might impact 
experiences of suicide in home hospice care. This objective is included to understand 
how professionals working with home hospice patients experience their patients 
dying utilising the DWDA, whether the law has influenced patients’ deaths by suicide, 
and whether there are any differences in experiences depending on location or 
where the professional is employed.  
 
The third objective is to determine how professionals discern between patients at 
risk for suicide and patients utilising medical aid in dying laws. This objective is 
included to understand how suicide assessment and training is implemented in an 
area where medical aid in dying is allowed.  
 
1.2 Research design 
This study seeks to capture the interpretations, experiences, and perceptions of 
suicide and hastened death by enabling health professionals to provide detailed 
descriptions of their experiences with patients who hastened their death or died by 
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suicide. When researching such a complex and sensitive area, interpretations and 
experiences are best captured through a qualitative research approach employing in-
depth, semi-structured interviews with participants with the most knowledge of the 
research topic (Sandelowski, 2004). Thematic analysis influenced by a social 
constructionist theoretical framework was used to analyse the data. In addition, 
theories of power were applied post hoc as a theoretical framework because it 
helped to make sense of the stories and the political context in which they are 
shared. The thesis then examined and applied Lukes’ three-dimensional view of 
power to the data to understand how power influences the experiences of 
participants (Lukes, 2005).  This approach analyses terms used, and how hidden and 
invisible dimensions of power apply to suicide and hastened death in hospice care 
and is understood in relation to sociopolitical, personal, professional, and cultural 
influences.  
 
1.3 Contribution to knowledge 
The results of this study may be used to inform private organisations’ policies, 
improve professionals’ communication with patients receiving hospice care, and 
contribute to the development of suicide assessment training for hospice 
professionals. In addition, this thesis contributes to the evidence on how suicide is 
interpreted by professionals working with patients facing a life-threatening illness.   
 
1.4 Thesis structure 
This thesis is comprised of eight chapters. This first chapter contains a brief overview 
of the research topic and the design. Chapter Two presents essential background 
information to better understand the context from a global perspective before 
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focusing on hospice care and medical aid in dying in the United States, and, more 
specifically, in Washington State, the research location.  
 
Chapter Three is a literature review integrating qualitative and quantitative studies 
about professionals’ experiences with suicide and hastened death in locations where 
medical aid in dying is allowed around the world. This review includes studies 
completed about professionals’ experiences with patients who may have died by 
what is interpreted as suicide or an intentional hastened death, including 
experiences with medical aid in dying. The review’s approach was mainly 
interpretive, aimed to explore the concept and language of suicide used by the 
authors of the studies and the experiences of the professionals in the studies. A 
thematic analysis was completed, the results of which supported the need for more 
research. 
 
Chapter Four describes the chosen methodology, which is influenced by a social 
constructionist philosophy. It is followed by a description of methods used to 
conduct interviews and analyse the data, describe how rigour was applied, and how 
the research adhered to ethical standards.  
 
Chapters Five and Six feature analysis of the findings. The findings are separated in 
two chapters; first, to distinguish the results identified by each professional group, 
and second, to identify results from across professional groups. Chapter Five 
recognises that there is a relationship of hospice with medical aid in dying because 
professionals continue to work with patients regardless of their choice to utilise 
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medical aid in dying, but this relationship differs by professional group. Participants 
had varied experiences, sense of responsibility, and power over decisions depending 
on their specific professional role. Chapter Six looks at the findings from across 
professional groups, in two parts. In the first part, issues of social justice are 
examined due to barriers and challenges to access medical aid in dying and how 
culture and environment impact these experiences. The second part of Chapter Six 
examines professional experiences with patients who died by suicide, and the 
interpretation of suicide in hospice care.  
 
Chapter Seven discusses the key conclusions of this research, applying Lukes’ theory 
of the three dimensions of power to the findings (Lukes, 2005). Application of Luke’s 
theory was developed in the discussion and was not the initial theoretical focus of 
the research. Power is found in the relationship between the professional and the 
patient who hastens death or by the individual who takes power into their own 
hands and dies by suicide. The effect of the invisible and hidden dimensions of power 
on suicide and medical aid in dying in hospice care are examined. In addition, this 
chapter explores the uncertain, blurry boundaries of suicide in hospice that are rarely 
discussed or understood. Chapter Eight concludes with a summary and suggestions 





Medical aid in dying, also known as ‘assisted dying’, ‘death with dignity’, ‘assisted 
suicide’, or ‘aid in dying’ is allowed in seven jurisdictions of the United States, 
including the states of California, Colorado, Montana, Oregon, Vermont, Washington, 
and the District of Columbia (California Legislative Information, 2015; Colorado 
Revised Statute, 2016; Council of the District of Columbia, 2016; Montana Supreme 
Court, 2009; Oregon Legislature, 1994; Vermont General Assembly, 2013; 
Washington State Legislature, 2009). Medical aid in dying offers capable adults 
diagnosed with an advanced illness the option of requesting a prescription for a self-
administered lethal dose of medications from their physician with the intent to 
hasten death (Death With Dignity National Center, 2017; Tucker, 2009, 2012). 
Individuals requesting medical aid in dying must have the ability to make and 
communicate healthcare decisions to their physician and consulting physician, and 
they may be referred to a psychologist or psychiatrist if there is concern about 
mental health or decision-making capacity (California Legislative Information, 2015; 
Colorado Revised Statute, 2016; Montana Supreme Court, 2009; Oregon Legislature, 
1994; Vermont General Assembly, 2013; Washington State Legislature, 2009). Deaths 
in locations where medical aid in dying is authorised in the United States are not 
considered suicide (Death With Dignity National Center, 2017; Oregon Legislature, 
1994; Washington State Legislature, 2009). The implementation of medical aid in 
dying laws, however, are interpreted by many—including healthcare professionals—
as a form of suicide that in some cases is considered rational for a terminally ill 
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capable person who seeks assistance to die if life becomes unbearable (Battin, 
2015a; Macleod, Wilson, & Malpas, 2012; Richards, 2017; Tierney, 2010; Vamos, 
2012; Werth & Holdwick, 2000). Some studies on hastened death indicate a 
‘euthanasia underground’ but were completed in locations where medical aid in 
dying was not authorised at the time of the research (Back et al., 2002; Cohen, Fihn, 
Boyko, Jonsen, & Wood, 1994; Emanuel, Daniels, Fairclough, & Clarridge, 1998; 
Magnusson, 2002; Starks et al., 2005; Stevens & Hassan, 1994; Tamayo-Velázquez, 
Simón-Lorda, & Cruz-Piqueras, 2012; Warren & Zinn, 2010). Despite these accounts, 
very little is known about professionals’ experiences with hospice patients who 
intentionally hasten death, particularly in a state that legally permits medical aid in 
dying. If patients are dying by suicide other than with medical aid in dying, it is 
important to ask what factors are involved in these decisions to hasten death so as to 




To understand the context for this study it is important to clarify global terms used 
when discussing medical aid in dying, and how hospice services are implemented in 
the research location. First, a brief overview of terms is provided to describe medical 
aid in dying in global jurisdictions and in locations allowed in the United States. 
Second, there is a brief explanation of hospice care in the United States and how 
patients access hospice as an option to understand how and where services are 
provided. Third, there is a description of hospice service locations in Washington 
State where patients are served. The chapter concludes with a description of the 
 18 
issue of suicide as examined in the literature and how this applies in a home hospice 
context in Washington State.  
 
2.1 Overview of global terms used to describe medical aid in dying  
Many terms have been used around the world to describe medical aid in dying. They 
include assisted suicide, physician-assisted suicide, medical assistance in dying, 
assisted dying, physician assisted dying, and voluntary euthanasia (Diehl-Schmid et 
al., 2017; Richards, 2016; Steck, Egger, Maessen, Reisch, & Zwahlen, 2013). Terms 
vary depending on the law, legal terms utilised in a particular jurisdiction, the 
researchers, or the background of the authors. For example, Tucker, an attorney and 
advocate, reports the term ‘aid in dying’ is value neutral (Tucker, 2012). Documents 
available from the Government of Canada cite ‘medical assistance in dying’, or MAiD, 
as the primary term used, but several other formulations are cited including ‘medical 
aid in dying’ or ‘physician assisted dying’ (Nicol & Tiedemann, 2016).  
 
In the process of writing this thesis, I considered several phrases reflecting the 
complexities of terms used in this research. I began by using the name of the statutes 
in Oregon and Washington State—the Death with Dignity Act (DWDA)—because they 
were the only states to have adopted death with dignity laws at the time this 
research was initiated. I ultimately decided to use the term ‘medical aid in dying’, 
which is a term adopted by Canada and some areas of the United States (Colorado 
Revised Statute, 2016; Government of Canada, 2016). This term suggests that the 
laws are a patient-initiated process that requires approval by a physician and are 
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regulated by a governing authority. In these jurisdictions, the patient is not acting 
alone and requires the consent of a medical provider.  As Salem suggests, medical aid 
in dying “medicalises suicide ... transforming the private act of suicide into a medical 
event ... an extension of medical power over life and death” (Salem, 1999, p. 30). 
However, the name of the law in Washington State, the Death with Dignity Act 
(DWDA) and the term ‘Death with Dignity‘ (DWD) are also used since they are the 
most common terms participants in the study location used. Table 2.1 provides 
definitions of the terms used and is an example of how definitions vary depending on 
location: 
Table 2.1. Definitions and terms 
 Term Country Definition 






A physician or nurse 
practitioner2 directly 
administers a substance that 
causes the death of the 
mentally competent person 
who has requested it 




Assisted Suicide (AS) 
 
Medical aid in dying 
Aid in Dying (AiD) 
Assisted Dying (AD)  
Death with Dignity Act 
(DWDA) 












A physician or nurse 
practitioner prescribes a 
substance that the requesting 
mentally capable individual can 










                                                     
1 Quebec National Assembly. (2014). An Act respecting end-of-life care. Québec Official Publisher Retrieved from 
http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php?type=5&file=2014C2A.PDF  
2 Government of Canada is currently the only country that allows a nurse practitioner to prescribe or administer 
lethal medications to a patient who requests it. 
 20 
Medical Assistance in Dying 
(MAiD) 
Assisted dying 
Medical aid in dying 
Europe 
Canada 
Term used to describe both the 
direct administration of a lethal 
medication by a physician or 
nurse practitioner, and a 
prescribed substance that a 
mentally capable individual 
self-administers 
 
As medical aid in dying laws are enacted and implemented globally, terminology 
appears to be shifting. For example, the Termination of Life on Request and Assisted 
Suicide Act in the Netherlands uses the term ‘assisted suicide’ to describe a lethal 
dose of medication that is prescribed by a physician but self-administered by an 
individual requesting it (Netherlands Ministry of Foreign Affairs, 2017). ‘Euthanasia’, 
the term used to describe the direct administration of medication by a physician to 
end life is allowed in Belgium, Canada, Columbia, Luxembourg, and the Netherlands 
(Emanuel, Onwuteaka-Philipsen, Urwin, & Cohen, 2016; Steck et al., 2013). The 
Canadian law passed in 2015, however, uses the term ‘medical assistance in dying’, 
(or the acronym ‘MAiD’) that suggests ‘assisted suicide’ as a prescribed dose of 
medication that is self-administered and allows ‘euthanasia’ as the direct 
administration of a lethal dose of medications by a nurse practitioner or physician 
(Government of Canada, 2016).  
 
The United States is positioned alone in avoiding the term ‘suicide’ in the content of 
medical aid in dying laws or court rulings that permit ‘assisted suicide’. Laws in 
Canada and Europe do not omit the word suicide in the legislative provisions 
(Dembosky, 2016; Leonard, 2015).  Canada, Luxembourg, Netherlands, and 
Switzerland predominantly use ‘assisted suicide’ as a term to describe a self-
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administered dose of medications prescribed by a physician (Emanuel et al., 2016; 
Government of Canada, 2016; Steck et al., 2013). However, assisted dying is also a 
term used to describe both euthanasia and assisted suicide (Lewis & Black, 2013; 
Voorhees, Rietjens, van der Heide, & Drickamer, 2014).  Regulation and allowable 
practices vary globally and cannot be easily compared (Steck et al., 2013). For 
example, Belgium permits ‘euthanasia’, and Switzerland only permits ‘assisted 
suicide’ (Belgian Act on Euthanasia of May, 2002; Dierickx, Deliens, Cohen, & 
Chambaere, 2016; Fischer et al., 2008). Switzerland, however, does not have a 
specific named law, but rather an article in the penal code that suggests if certain 
conditions are met physicians will not be prosecuted if they are involved with deaths 
resulting from the self-administration of lethal medications (Gamondi, Oliver, 
Borasio, Preston, & Payne, 2016). Physicians in Switzerland, like areas that allow 
medical aid in dying in the United States, are not required to be present when the 
patient is ingesting the medication (Steck et al., 2013). Table 2.2 includes information 
about terms used in legislation around the world. Terms written in languages other 
than English have been translated. 
Table 2.2. Global legislative terms3 









Belgium The Belgian Act on Euthanasia of May 28th 2002  No Yes 2002 
Luxembourg Euthanasia and Assisted Suicide Law of 16th March 2009   Yes Yes 2009 
Netherlands Termination of Life on Request and Assisted Suicide Act Yes  Yes 2002 
Switzerland Assisted Suicide (article in penal code) Yes No 1942 
Canada —   
All provinces 
Medical Assistance in Dying  
Euthanasia and Assisted Suicide 
Each province/territory to 
decide  
2016 
Quebec Medical Aid to Die No Yes 2015 
California End of Life Option Act Yes No 2016 
Colorado End of Life Option Act Yes No 2016 
D.C. Death with Dignity Act  Yes No 2017 
Montana Rights of the Terminally Ill Act (court ruling)                    Yes No 2009 
Oregon Death with Dignity Yes No 1997 
Vermont Patient Choice and Control at End of Life Yes No 2013 
Washington Death with Dignity Yes No 2009 
Colombia Statutory Bill on Ending Life in a Decent and Human Way and 
Assistance to Suicide                                     
No Yes 2015 
                                                     
3 Adapted from:  Lewis, D., Gerson, S. M., Gamondi, C. (in press) Assisted Dying: A Global Overview. In Walshe, C., Preston, N., Johnston, B. (eds.) 
Palliative Care Nursing. Principles and Evidence for Practice. 3rd edit. Open University Press/McGraw-Hill Education, Maidenhead 
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Belgium is the only country with no minimum age limit for euthanasia, but The 
Netherlands allows eligible minors ages 12 to 18 to utilise euthanasia or assisted 
suicide (Watson, 2014). The United States and Colombia are the only countries that 
require the patient to have a life-threatening disease to be eligible for medical aid in 
dying (Emanuel et al., 2016). The omission of the term ‘suicide‘ in the content of laws 
or court rulings in the United States compared to the codes or laws of other nations 
suggests differences in legislative processes (Emanuel et al., 2016).  In addition, this 
variation may be reflective of cultural differences and attitudes toward suicide 
(Battin, 2015b). 
 
2.2 Medication and cost of medical aid in dying  
The cost for medication and medical aid in dying is included in this chapter to further 
demonstrate global variations.  A study of costs for medical assistance in dying in 
Canada suggests total costs, including physician visits, medication, and pharmacist, 
vary from CA$268.75 to $751.85 (Trachtenberg & Manns, 2017). To be eligible for 
medical assistance in dying in Canada, individuals are required to be covered under 
the national insurance health program and there would not likely be direct costs for 
the patient (2002; Government of Canada, 2016; Li et al., 2017). Switzerland allows 
non-Swiss nationals the option of ‘assisted suicide’ through Right to Die associations 
that have costs varying from £7500 to £10,000 (Dignitas, 2017; Irwin, 2016). One 
study from Washington State estimated that due to the rising cost of secobarbitol, 
drug costs alone vary from US$500 to $5000 (Shankaran, LaFrance, & Ramsey, 2017).  
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The United States federal government prohibits federal funds to be used for medical 
aid in dying, leaving it to individual states to allocate funds for this purpose (Death 
with Dignity National Center, 2017; Assisted Suicide Funding Restriction Act of 1997, 
1997). Patients who receive Medicaid, the state-allocated healthcare benefit for low-
income residents, receive benefits for only physician visits and medications in the 
states of California and Oregon (West, 2017).  
 
There is also variation in the type of medication used for medical aid in dying, 
particularly in the United States. There is a shortage of the medication Nembutal 
(pentobarbital) in the United States because of a ban enacted by the European Union 
to limit its use in capital punishment (Leonard, 2015).  Due to the lack of availability 
of pentobarbital, and the increased cost of secobarbitol, different alternative 
medications are increasingly being used where medical aid in dying is allowed in the 
United States (Oregon Public Health Division, 2016; Shankaran et al., 2017; 
Washington State Department of Health, 2016a; West, 2017). Alternative 
medication—such as a phenobarbital/chloral hydrate/morphine sulfate mix or a mix 
of morphine sulfate, Propranolol (Inderal), Diazepam (Valium), Digoxin, and a buffer 
suspension—costs from US$450 to $600. (Death with Dignity National Center, 2017).  
 
2.3 Medical aid in dying in the United States 
As of May 2017, medical aid in dying has been authorised in California, Colorado, the 
District of Columbia (D.C.), Montana, Oregon, Vermont, and Washington. The term 
‘medical aid in dying’ encompasses the statutes and court rulings passed in all states 
but is also known as Death with Dignity (DWD), or, if referring to the legislative act, 
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the Death with Dignity Act (DWDA) (Death With Dignity National Center, 2017).  
There is an anticipated increase in medical aid and dying as an option in the future as 
more US states propose laws (Death With Dignity National Center, 2017). 
 
The laws of California, Colorado, District of Columbia (D.C.), Vermont, and 
Washington follow similar regulations as in the state of Oregon but there are some 
differences across states. For example, except for Colorado, the physician must wait 
at least 48 hours after receiving a written request from the patient before writing the 
prescription. California requires an attestation form to be submitted by the patient 
48 hours prior to taking the medication and not all states collect data on individuals 
using medical aid in dying (Death With Dignity National Center, 2017).   
 
Montana is governed by a state high-court ruling that does not prohibit a physician 
from writing a legal lethal prescription for their terminally ill patient and follows 
guidelines similar to states with medical aid in dying laws (Montana Supreme Court, 
2009).  In general, for an individual to be eligible for medical aid in dying in California, 
Colorado, D.C., Montana, Oregon, Vermont, and Washington they must:  
 Be 18 years of age or older 
 Be a resident of the state where they are making the request  
 Have a life-threatening illness with a prognosis of 6 months or less confirmed 
by attending physician and consulting physician 
 Make two verbal requests to attending physician a minimum of 15 days apart 
 Provide a written request to attending physician 
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 Have mental capacity to make health-care decisions in the opinion of both 
attending and consulting physician 
  Be referred by attending or consulting physician for psychological or 
psychiatric evaluation if concerned about decisional capacity 
The patient may ask the physician most familiar with them for medical aid in dying 
medications but the physician, and all healthcare professionals, may refuse to 
participate for personal reasons, or if they are employed by a healthcare system that 
does not allow them to participate (Chin, Hedberg, Higginson, & Fleming, 1999; 
Dunn, Reagan, Tolle, & Foreman, 2008; Ganzini et al., 2000). There is limited 
evidence of how often hospice medical directors prescribe legal life-ending 
medications, but there is evidence that some organisations view the values of 
medical aid in dying as incompatible with hospice values thus preventing some 
hospice physicians from participating in the process (Campbell & Cox, 2010). The 
patient may seek out and make the request from another physician who may not be 
familiar with them (Chin et al., 1999). Patients may also get referrals for a physician 
from a medical aid in dying advocacy organisation (Compassion & Choices, 2017; End 
of Life Washington, 2017).  Physicians may choose to be present but are not required 
to do so when a patient is ingesting the life-ending medications and the place of 
death cannot be in a public location (Dunn et al., 2008).  
 
2.4 Medical aid in dying in Washington State  
The DWDA in Washington State, a modified version of a law adopted in Oregon, was 
passed by popular vote in 2008 and implemented in March 2009 (Washington State 
Legislature, 2009). Figure 2.1 illustrates the numbers of individuals from 2010 to 
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2015 reported to have received a prescription to hasten death and numbers 
reported to have died from the medication utilising the DWDA. There is, though, 
little information indicating how many individuals begin the process of medical aid in 
dying but do not ultimately obtain the prescription. 
 





Data collected by the Washington State Department of Health demonstrates that the 
primary reasons most patients choose life-ending medications are loss of autonomy, 
inability to engage in activities making life enjoyable, loss of dignity, and concerns 
about being a burden to family members and caregivers (Washington State 
Department of Health, 2016a).  These data support research highlighting that the 
impact of loss of independence, loss of dignity, feelings of burden, depression, 
anxiety, physical discomfort, and spiritual distress are some of the factors that may 
contribute to a patient's desire to hasten death (Hendry et al., 2013; Hudson et al., 
2006; Loggers et al., 2013; Pearlman et al., 2005; Starks et al., 2007; Starks et al., 
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2005; Thulesius, Scott, Helgesson, & Lynoe, 2013).  In addition, the Washington 
health data show that individuals seeking medical aid in dying are 95 to 98% white, 
74% have some college education, 95% live in the western, more populated part of 
the state, and over 80% were receiving hospice services, suggesting that vulnerable 
and disenfranchised individuals are not at risk of being coerced to hasten death 
(Hendin & Foley 2008; Washington State Department of Health, 2016a).   
 
2.5 Hospice care in the United States 
Palliative care, which includes hospice care, offers a specialised patient-centred 
approach that integrates the comfort of the whole person, including physical, 
emotional, and spiritual symptoms (Center To Advance Palliative Care, 2017). 
However, these symptoms cannot always be relieved for patients facing advanced 
disease (Quill, Lo, & Brock, 2008; WHO, 2012). Most hospice programs in the United 
States are certified and follow guidelines established by the federally administered 
Center for Medicare and Medicaid Services to receive financial reimbursement for 
services provided to patients (Carlson, Schlesinger, Holford, Morrison, & Bradley, 
2008). Medicare is a federal health insurance program for people over 65 years old 
with a work history, and for those who have been deemed to be disabled or 
diagnosed with end-stage renal disease (Centers for Medicare & Medicaid Services, 
2017). Medicare and most other insurances, including private insurances and 
employee health plans, include a benefit to pay for hospice services to assist patients 
facing a life-threatening illness who choose to forgo curative life-prolonging 
measures in favour of palliative treatment to relieve symptoms (Mor & Teno, 2016). 
This benefit is often called the ‘hospice benefit’ (Centers for Medicare & Medicaid 
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Services, 2017). Over 85% of individuals in the United States receiving hospice 
services in 2014 were served by Medicare, the primary source of the hospice benefit 
(National Hospice and Palliative Care Organization, 2015).  Private insurance, 
Medicaid (a joint federal and state program providing health coverage for primarily 
low-income individuals), self-pay, and charity care account for most of the remaining 
15% of the population served by hospice (Medicaid.gov, 2017; National Hospice and 
Palliative Care Organization, 2015).  
 
The National Hospice and Palliative Care Organization (NHPCO), the primary network 
of hospice and palliative organizations in the United States, publishes an annual 
report of recent facts and figures (National Hospice and Palliative Care Organization, 
2015). This report, which describes the interdisciplinary team members required for 
hospice, indicates that the numbers of patients in the United States choosing to have 
hospice service is steadily increasing from 1,380,680 in 2010 to over 1,656,353 in 
2014 (National Hospice and Palliative Care Organization, 2015).   
 
Figure 2.2 illustrates an example of the process for individuals to be admitted for 
hospice care in the United States. The patient is seen at the centre of the family circle 
on the left.  In general, individuals need to be diagnosed with a terminal illness with a 
prognosis of 6 months or less and be referred by a physician, but they must also 
meet other specific criteria to receive services. (National Hospice and Palliative Care 
Organization, 2015). These clinical criteria help to establish a patient’s six-month 
prognosis based on their illness and are used as a guideline to assess a patient’s 
eligibility for hospice services (Centers for Medicare & Medicaid Services, 2017; Dunn 
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et al., 2008). Once a patient consents to hospice services, most must “waive 
coverage for other treatment related to the terminal diagnosis” (Dunn et al., 2008, p. 
20). ‘Waiving coverage’ means that the hospice is responsible for the management of 
the patients’ comfort care related to the disease.  
 
 
Figure 2.2. Hospice admission process 
 
After the patient is admitted to hospice, which is mostly in the home setting (see 
Table 2.3), team members assess and provide support to caregivers but, in general, 
do not provide 24-hour care (Oliver et al., 2013). Patients who live at home might 
have hired caregivers, who are separate from hospice staff, if they need more care 
than family, friends, or community are able to provide.  In addition, hospice provides 
equipment and medications for comfort, but do not pay for or provide medical aid in 
dying medications (Centers for Medicare & Medicaid Services, 2017). Federal funds, 
including Medicare and Medicaid, cannot be used for medical aid in dying because of 
a 1997 law enacted in response to the Oregon DWD law (Assisted Suicide Funding 
 31 
Restriction Act of 1997, 1997; Centers for Medicare & Medicaid Services, 2017; West, 
2017). As of May 2017, Oregon and California are the only states to have chosen to 
segregate state funding of Medicaid to pay for doctors’ visits and medications for 
low-income eligible individuals seeking medical aid in dying (Grube & Cardenas, 
2017; West, 2017). 
 
Approximately 1 in 5 patients admitted to hospice are discharged because they are 
stable and determined to no longer be terminally ill (according to disease-specific 
Medicare criteria), or because they move or transfer to another hospice program. 
Patients may also choose to revoke services to pursue other treatment options, or, in 
rare circumstances, they are discharged for cause (Teno, Plotzke, Gozalo, & Mor, 
2014).  Discharge for cause, or ‘live discharge’ might mean that their condition has 
improved or stabilised, or in some cases they may be discharged improperly because 
of the high cost of hospitalisation (Dolin et al., 2017; Teno et al., 2014).  
 
Most patients receiving hospice services are referred when their disease is advanced, 
causing the average length of stay to be a median of less than 18 days (National 
Hospice and Palliative Care Organization, 2015). For patients who live beyond six 
months, physicians or nurse practitioners are required to make what are called ‘face-
to-face’ visits every 60 days with the roughly 10% of patients to determine if they 
continue to meet the criteria and six-month prognosis (Harrold, Harris, Green, Craig, 
& Casarett, 2013; National Hospice and Palliative Care Organization, 2015; 
Rothenberg, Doberman, Simon, Gryczynski, & Cordts, 2014).  
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2.6 Location of hospice services in Washington State 
Hospice in the United States is primarily provided in the patient’s home setting but 
family, informal unpaid, or paid carers commonly aid patients requiring 24-hour care. 
Hospice team members are then available to consult to address pain and symptom 
management, counsel, and support the patient and carers (Oliver et al., 2013; Ong, 
Brennsteiner, Chow, & Hebert, 2016). There are variations in location of hospice 
services nationwide compared to Washington State. Centers for Medicare and 
Medicaid Services (2017) report that in 2015 the site of service for hospice 
nationwide is nearly 52% in a home setting. In contrast, data collected from 
Washington State indicates that in 2015, 56.8% received care in a home setting. 
Differences in site of services nationwide compared to Washington State is described 
in Error! Reference source not found. below: 
Table 2.3 Site of Services 
Adapted from Centers for Medicare & Medicaid Services (2017) Hospice Provider 
Data 2015 
 
2.7 Suicide, hastened death, and medical aid in dying in home hospice 
Few studies have examined the impact of how medical aid in dying laws have 
affected hospice professionals’ experiences with patients hastening death, and 
Site of Hospice Services Washington State 2015   
34 Medicare Certified Programs 
United States 2015  












Hospice inpatient  7.9% 8.8% 
Acute care hospital 2.6% 5.3% 
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whether this impact has shaped communication and assessment of patients at risk of 
suicide. Studies examining suicide as an important topic with hospice patients in the 
United States have been carried out, though not specifically in locations where 
medical aid in dying was allowed, including two unidentified south-eastern states, 
California, and a nationwide survey of social workers (Arnold, 2004; Fairman, 
Montross Thomas, Whitmore, Meier, & Irwin, 2014; Washington et al., 2016). 
Schoonman, et al, explored attitudes of the public in The Netherlands regarding non-
physician assisted suicide with patients who did not qualify for legalised euthanasia. 
They found that in certain cases most people were supportive, but they could not 
find research about experiences with hospice or palliative care patients in 
jurisdictions where medical aid in dying is allowed and who may have hastened 
death through other means (Schoonman, van Thiel, & van Delden, 2014). The limited 
depth of understanding of the organisational and societal impact on experiences of 
clinicians in the United States, either before or since the passing of legislation is 
reported in various qualitative studies (Back et al., 2002; Bharucha et al., 2003; 
Blondeau, Dumont, Roy, & Martineau, 2009; Dobscha, Heintz, Press, & Ganzini, 2004; 
Harvath, Miller, Ganzini, Smith, & Clark, 2005; Nissim, Gagliese, & Rodin, 2009; 
Pearlman et al., 2005; Starks et al., 2007; Starks et al., 2005).  
 
Suicide risk is often associated with a person’s “history of self-harm; a diagnosed 
mental health problem; personality disorder; addiction problems and gender” 
(Robson, Scrutton, Wilkinson, & MacLeod, 2010, p. 1250). However, patients with 
advanced disease may consider ending their own lives due to physical suffering, 
paralysis, or emotional pain, including hopelessness that may be treated with 
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pharmacological and/or non-pharmacological methods (Monforte-Royo, 
Villavicencio-Chavez, Tomas-Sabado, & Balaguer, 2011). There is limited 
understanding about how professionals, including physicians, nurses, and social 
workers conduct conversations with patients about desire for hastened death and 
discern the difference with suicidal intent, particularly in the home setting (Kelly, 
Burnett, Badger, et al., 2003; Kelly, Burnett, Pelusi, et al., 2003; Monforte-Royo et al., 
2011; Monforte-Royo, Villavicencio-Chavez, Tomas-Sabado, Mahtani-Chugani, & 
Balaguer, 2012; Robson et al., 2010).   
 
There are several cross-sectional studies, surveys, and qualitative research exploring 
hospice clinicians’ attitudes and experiences of working with patients who 
considered hastening death (Arnold, 2004; Arnold, Artin, Person, & Griffith, 2004; 
Back et al., 2002; Carlson, Simopolous, Goy, Jackson, & Ganzini, 2005; Dobscha et al., 
2004; Fenn & Ganzini, 1999a; Ganzini, E. R. Goy, et al., 2003; Ganzini et al., 2002; 
Ganzini, Nelson, Lee, et al., 2001; Kohlwes, Koepsell, Rhodes, & Pearlman, 2001). A 
comprehensive investigation of the research is examined in the next chapter. 
Significant gaps in knowledge remain about the influence that external factors such 
as use of terminology and organisational, cultural, and professional ethical issues 
within the patient/healer relationship have on professionals’ experiences and 
communication about patients’ concerns. Such concerns require the hospice 
professional to identify and discern the difference between a patient’s risk for suicide 
due to depression or mental illness associated with impaired decision-making 
capacity, and those patients with decision-making capacity who might want to 
hasten death or are seeking medical aid in dying.   
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Campbell and Black (2014), in their study examining the policies of Washington State 
hospice organisations, suggest important organisational differences regarding 
language, values, and approach to dilemmas around issues of hastened death.  They 
argue that hospice philosophy is geared to support an individual’s desire for 
autonomy, yet the policies of some organisations providing hospice services have 
missions in opposition to medical aid in dying that pose restrictions on staff.  
Campbell and Black use the term ‘physician assisted death’ and say that it “presents 
a defining question that requires reflection and discussion on the meanings and 
purposes of ... hospice values” (p. 151). However, they do not discuss how staff 
interpret and carry out the policy in their work with patients. Understanding how 
policy is applied or affects professional clinical practice with hospice patients may 
help to make sense of the ‘defining question’ alluded to by Campbell and Black. A 
belief may be that there is limited or no relationship between medical aid in dying 
and hospice care if restrictions are imposed on staff when the organisational policy is 
in opposition to participation with the DWDA.  This leads one to question how 
professionals are working with patients who utilise the DWDA in different 
organisations and if there is a difference depending on the policy of the 
professionals’ employer.    
 
Although this research is focused in Washington State, how policy affects practice 
pertains to other areas where medical aid in dying is allowed, particularly where 
there is debate about the need for euthanasia and assisted suicide to be distinct 
from palliative care (Materstvedt, 2013). A white paper from the European 
Association of Palliative Care (EAPC) on euthanasia and physician-assisted suicide 
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suggests that because the focus of palliative care is not to hasten death, it is not 
“compatible” with medical assistance in dying (Radbruch, L. et al, 2016). Other 
professional palliative care organisational statements such as the International 
Association for Hospice & Palliative Care (IAHPC) and the Australian and New Zealand 
Society of Palliative Medicine (ANZSPM), indicate that all forms of assistance in dying 
including euthanasia, physician assisted suicide, and assisted suicide are in 
opposition to the palliative care goal not to hasten death (Materstvedt & Bosshard, 
2015). The American Association of Hospice and Palliative Medicine (AAHPM) 
position statement emphasises that physicians working where Physician Assisted 
Dying (PAD) is allowed should not have to participate nor should they be prohibited 
from working with patients requesting assistance (AAHPM, 2016). Organisational 
policies and statements from professional medical organisations, however, do not 
necessarily indicate what is actually occurring in practice.  
 
Overall, there are a few cultural differences in the population of Washington State 
that are unique, and some results of this research may be context specific.  For 
example, Washington State had an overall higher rate of suicide at 14.7 per 100,000, 
than the national average of 13.2 deaths per 100,000 in 2013 (Washington State 
Department of Health, 2016b). Suicide rates appear to be increasing, however, as 
Center for Disease Control data from 2016 reports that the Pacific Northwest region 
including Washington, Oregon, and Idaho had suicide rates of 17.8 per 100,000 
(American Association of Suicidology, 2017).  Some reasons for this higher suicide 
rate are suggested to be due to lack of access to healthcare, rural and social isolation, 
and access to firearms (US Department of Health and Human Services, Health 
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Resources and Services Administration, 2015). The suicide rate rises to 25 per 
100,000 in rural counties of Washington (Washington State Department of Health, 
2016b).  For comparison, California has a suicide rate of 10.8 overall, but the rate 
increases to 19 per 100,000   in rural counties (United Health Foundation, 2015). 
Across the United States, evidence indicates there is increased suicide in rural areas 
compared to urban locations, and firearms are a major cause of these deaths (Miller, 
Azrael, & Barber, 2012).   Since deaths from DWD medications are not considered 
suicide, they are not included in the any of the United States suicide reports. Suicide 
rates, rural population, and access to care resources are some of the differences that 
may be more context specific but relevant in other areas.  
 
The research question in this study was: What are professionals’ experiences with 
suicide and hastened death with hospice patients in Washington State?   It is the aim 
of this study to examine these issues about suicide and hastened death that includes 
medical aid in dying from the experiences of the professionals working with patients 
in Washington State.  Understanding how power is related to the results of the study 
may help to make sense of the extent to which individuals do or do not have power 
in their lives and deaths and provide information to overcome barriers impacting 
patient safety and quality of life.  The objectives of this study are to determine what 
experiences of patient deaths are considered to be suicide, how medical aid in dying 
might impact experiences of suicide in home hospice care and understand how 
professionals discern between patients at risk of suicide from those utilising the 
DWDA.   
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Palliative care requires that the clinician listens to patient concerns, and that they 
work collaboratively with the patient and interdisciplinary team members to provide 
relief from suffering. Yet hospice professionals’ ability to respond to what is 
important to the patient may depend on several factors including personal, 
organisational, and cultural issues, particularly in the home setting, which may differ 
from a clinical environment. A professional’s ability to provide assessment may be 
limited depending on their clinical training, where they work, use of terminology, 
experience, and personal and cultural views. The knowledge gained from this 
research will help to inform private organisations’ policies to address concerns about 
hastened death and the impact of medical aid in dying laws on professional 
experiences with patients dying by suicide  
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Literature review: Professionals’ experiences of suicide and hastened death with 
hospice patients where medical aid in dying is allowed 
The purpose of this literature review was to provide a comprehensive understanding 
of professionals’ experiences with hospice patients who die by suicide or hasten their 
death in areas where medical aid in dying is legally allowed. To date, no published 
review could be found that identified studies concerning both unassisted and 
assisted suicide among hospice or palliative care patients where there is legal 
medical aid in dying. 
 
This review follows what Dixon-Woods, et al (2005) suggest largely as an interpretive 
approach to include both qualitative and quantitative evidence to gain a 
comprehensive understanding of the literature examining professionals’ experiences 
of suicide in a hospice or palliative care context. The aim of an interpretive approach 
is conceptual development summarising the findings rather than specifically an 
integration of clearly defined data (Dixon-Woods et al., 2005). The guiding 
epistemology of this research is inductive, seeking to explore experiences identified 
as suicide and language used when describing experiences about assisted suicide, 
euthanasia, or hastened death used by the authors of the studies.  
 
3.1 Method 
This review is approached systematically and in a rigorous manner containing six 
essential elements identified by Popay et al, (2006): identifying the review focus, 
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specifying the review questions, identifying studies to include, data extraction and 
quality appraisal, synthesis, and dissemination. The analysis is primarily an inductive 
approach, meaning there is not a “complete set of a priori themes” but reflects the 
“main ideas and conclusions across the studies” (Popay et al., 2006 p 18). Thematic 
analysis is used because of the flexibility integrating diverse forms of evidence to gain 
a comprehensive understanding of the topic in a single review (Boland et al., 2014; 
Hawker, Payne, Kerr, Hardey, & Powell, 2002; Popay et al., 2006).   
 
The results follow Popay et al’s (2006) recommended guidelines for a narrative 
synthesis: preliminary analysis, exploration of relationships, and assessing the 
robustness of the synthesis (Popay et al., 2006). Popay et al (2006) suggests narrative 
synthesis is a way of telling the story of research evidence that is also flexible when 
combining studies from diverse methodologies.  
 
3.2 Review focus 
In this chapter, the term ‘medical aid in dying’ will include both euthanasia, where a 
medical professional administers a lethal dose of medication to an individual who 
requests it, and physician assisted suicide or assisted suicide, where an individual 
self-administers a prescribed lethal dose of medication.  
 
As previously discussed in the introduction, medical aid in dying is a general name 
applying to various laws or court rulings currently in effect in several countries 
around the world including Belgium, Canada, Columbia, Luxembourg, Netherlands, 
Switzerland, and areas of the United States, including California, Colorado, Montana, 
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Oregon, Vermont, Washington, and the District of Columbia (D.C).  A list of terms 
used in literature is included in Appendix 1.  
 
Many patients requesting to utilise medical aid in dying are enrolled in hospice or 
palliative care programmes and professionals working with them are affiliated with 
health care institutions (Campbell & Black, 2014; Campbell & Cox, 2012; Hesselink et 
al., 2010). The scope of literature reviews that gather evidence of professionals’ 
understanding of hastened death and their response to these concerns 
predominantly include countries and communities where there are no laws 
regulating medical aid in dying, including assisted suicide or euthanasia (Drum, 
White, Taitano, & Horner-Johnson, 2010; Hendry et al., 2013; Hudson et al., 2006; 
Monforte-Royo et al., 2011; Tomlinson & Stott, 2014). This review will gather the 
evidence of professionals’ experiences to understand specific challenges 
professionals face serving patients around issues of suicide and hastened death in 
areas that allow medical aid in dying.  
 
Much of the research evidence is about professionals’ attitudes about assisted 
suicide or euthanasia and does not include information about professional 
experiences of unassisted suicide or hastened death (Brauer, Bolliger, & Strub, 2015; 
Broeckaert, Gielen, Van Lersel, & Van den Branden, 2009; Emanuel et al., 2016; 
Bilsen, Mortier, & Deliens, 2009; Sercu et al., 2012).  
 
Some literature on professionals’ experiences with patients around issues of suicide 
and hastened death include guidelines for professionals’ conversations but it is 
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unclear how or if these guidelines would apply in the same way where medical aid in 
dying is allowed (Hudson et al., 2006; Kleespies, Hough, & Romeo, 2009; Kolva, 
Rosenfeld, Brescia, & Comfort, 2014; Olden, Pessin, Lictenthal, & Breitbart, 2009; 
Rosenfeld et al., 2014; Schroepfer, Linder, & Miller, 2011; Weinberger, Sreenivasan, 
& Garrick, 2014). In addition, evidence of professionals’ experiences with patients in 
hospice care who died by unassisted suicide is sparse and limited to areas where 
there is no legal medical aid in dying (Fairman et al., 2014; Filiberti et al., 2001; 
Grzybowska & Finlay, 1997; Warren & Zinn, 2010).  
 
This review includes studies on the impact of medical aid in dying on issues of 
hastened death and suicide from the experiences of palliative care and hospice 
professionals in jurisdictions that allow medical aid in dying. Studies from areas 
where there is a court ruling, such as the state of Montana in the United States, or 
Switzerland where there is an article in the penal code that allows assisted suicide 
are also included.  Implementation of the laws, regulation, provision of hospice care, 
language, and complex cultural differences vary around the world and will be 
considered (Burkhardt, La Harpe, Harding, & Sobel, 2006). 
 
This literature review establishes the need for further research on issues of suicide in 
hospice care and contributes to my PhD thesis investigating professionals’ 





3.3 Review question and literature search 
The review question that I aim to answer is: What are hospice professionals’ 
experiences of suicide and hastened death with patients in areas where medical aid 
in dying is allowed? To search literature answering this question I searched five 
electronic databases from inception to June 2017 using a strategy developed for 
PubMED and adapted for other databases including Academic Search Complete, 
AMED, CINAHL, and PsycINFO.   I searched PubMED using keywords in four 
groupings.  The first grouping focused on terms associated with suicide or assisted 
suicide and included “suicide,” “assisted suicide,” “assisted dying,” “aid in dying,” 
“death with dignity” and “active euthanasia”. The second grouping included terms 
associated with hospice and included “hospice care,” “hospices,” “hospice and 
palliative nursing,” “palliative care” and “palliative medicine”.  The third group 
specified terms about professional groups and included “professional,” “clinician” 
“physician”, “nurse”, “social worker”, and “chaplain”. Finally, the fourth group 
included the terms “experiences”, “views”, “attitudes”, “feelings”, and “opinions” in 
the title or abstract of each citation.   I filtered out and refined my search using 
Medical Subject Headings (MeSH) and adapted and expanded some terms to apply to 
each of the databases.  I also examined reference lists of relevant studies and 
identified them using Google Scholar.  These additional references are identified as 
‘citation pearls’ (Booth, 2016). Appendix 2 identifies details of the searches from 
each of the databases and numbers of titles and abstracts reviewed. Table 3.1 below 
includes the identified search terms and groups used initially in PubMED and 
adapted for other databases: 
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Table 3.1. PubMED search terms 
Subject Group Search Terms Used 
Suicide "suicide"[MeSH Terms] OR "suicide, assisted"[MeSH Terms] OR 
"suicide, attempted"[MeSH Terms] OR "euthanasia, active, 
voluntary"[MeSH Terms] OR  
 "assisted suicide"[Title/Abstract] OR "assisted 
dying"[Title/Abstract] OR "aid in dying"[Title/Abstract] OR "death 
with dignity"[Title/Abstract] AND 
Hospice or 
palliative care 
"hospice care"[MeSH Terms] OR "hospices"[MeSH Terms] OR 
"hospice and palliative care nursing"[MeSH Terms] OR 
 "palliative care"[MeSH Terms] OR "palliative medicine"[MeSH 
Terms] OR "terminal care"[MeSH Terms] OR 
 "end of life"[Title/Abstract] OR hospice*[Title/Abstract] AND 
Professionals "health personnel"[MeSH Terms]OR  
"attitude of health personnel"[MeSH Terms] OR  
 professional*[Title/Abstract] OR clinician*[Title/Abstract] OR 
physician*[Title/Abstract] OR nurse*[Title/Abstract] OR social 
worker*[Title/Abstract] OR chaplain*[Title/Abstract]AND 
Experience experience*[Title/Abstract] OR view*[Title/Abstract] OR 
feel*[Title/Abstract] OR opinion*[Title/Abstract] OR 
attitude*[Title/Abstract] 
 
Citations that did not meet inclusion criteria were grouped into categories within 
Endnote, a software tool managing bibliographies.  Full-text articles of 46 studies 
were reviewed before selecting studies for quality. Some studies not meeting 
inclusion criteria were about patients, attitudes, involvement, and opinion pieces 
were completed before medical aid in dying options were authorised or from 
locations where it was not clear if they included professional experiences impacted 
by medical aid in dying.  One study was excluded because it was a description of the 
implementation of a Death with Dignity (DWD) program in Washington State but not 
about professional experiences (Loggers et al., 2013). Other studies were excluded 
because the data were collected prior to implementation of laws (Craig et al., 2007; 
de Casterlé et al., 2006; Fenn & Ganzini, 1999a, 1999b; Karesa & McBride, 2016; 
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Wright et al., 2017), or the research primarily investigated attitudes and not 
experiences (Brauer et al., 2015; De Hert et al., 2015; Smets et al., 2011).  
 
No data or evidence could be found on the impact of the legal ruling of Montana, 
Luxembourg, or from the country of Colombia. In addition, as of June 2017 no 
completed or published research could be located from Canada, where Medical 
Assistance in Dying (MAiD) was implemented in 2016, or the states of California, 
Vermont, and Colorado, where laws were implemented between 2015 and 2017. 
 
The initial search strategy was found to miss a few important papers that for 
instance, Dixon-Woods, et al (2005) suggest might not fit a conventional systematic 
approach. I checked reference lists and tracked citations, looking at how many times 
a reference was cited, and I then searched those references, identifying an additional 
29 citations described previously as ‘citation pearls’.  Duplicates were deleted and 
abstracts then screened against the inclusion criteria before considering study 
quality. An adapted version of the Preferred Reporting Items for Systematic Reviews 


















Academic Search Complete n= 346 
CINAHL n=382 




About patients: 23 
Before laws: 16 
From areas without laws: 28 
About attitude: 5 
Public perspective: 5 
Not about professionals: 7: 5 
Not about professionals: 7 
Records after obtaining full text 
articles and eligibility assessed  
N = 46 
 
Records after screening 
citations for  
inclusion and exclusion criteria 
n = 130 
 
Records after duplicates 
deleted 
n = 1540 
 
Articles meeting inclusion 
criteria 
Qualitative n = 17  




Data collected before 
laws implemented: 5 
About attitude, 
perspective, or stance: 
12 
 





























Figure 3.1. Literature search process: Modified PRISMA chart  
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3.4 Deciding what is relevant  
A table of inclusion and exclusion criteria recommended for systematic reviews was 
developed to decide what is relevant to include in this review. Table 3.2 follows the 
recommendation that the review question has clearly defined terms regarding 
population, intervention, comparators, outcomes, and study design (PICOS) 
(University of York, NHS Centre for Reviews & Dissemination, 2009):  
Table 3.2 Inclusion and exclusion criteria 
 
Inclusion Exclusion 
Population Professionals in a palliative 
care and hospice context: 
nurses, physicians, social 
workers, chaplains working 
in locations where medical 
aid in dying is allowed 
Patients, public, other 
carers.  Locations where 
medical aid in dying, 
including euthanasia and 
assisted suicide is not 
allowed  
Intervention Hastened Death, 
Euthanasia, Suicide, 
Assisted Suicide, Physician 
Assisted Suicide 
 
Outcomes Professionals’ experiences 
with patients who died by 
suicide, self-administered 
medications prescribed by 
medical professional, or 
administered medications 
by another with intent to 
hasten death 
Research that does not 




Study design Any research 
method/design 




Data obtained from reports 
from inception to present 
Studies conducted prior 
to implementation of the 
medical aid-in-dying laws, 
code, or ruling of each 
country or state 
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Included professionals have worked in a palliative care or hospice context with 
patients who intentionally hastened their death, died by suicide, or hastened their 
death by self-administered medications prescribed by a physician or nurse 
practitioner or through medically administered euthanasia.  As stated in the previous 
Introduction chapter, hastened death is broadly defined as a death that is anticipated 
due to an advanced illness but intentionally accelerated with or without the 
assistance of a healthcare professional.  
 
Only studies completed in areas where medical aid in dying is allowed were included. 
Regulations around the world vary and literature suggests characteristics of persons 
who have died from medical aid in dying are different in each country (Steck et al., 
2013). For example, a person in the Netherlands, Belgium, Luxemburg, or 
Switzerland does not have to be diagnosed with a life-threatening illness to pursue 
assistance with dying (Emanuel et al., 2016; Kouwenhoven et al., 2013). Yet medical 
aid in dying in the United States requires a person to have a prognosis of six months 
or less and nearly 90% of patients who utilise it are under hospice care (Campbell & 
Black, 2014).  
 
Opinion pieces and editorials are excluded from this study. There are many essays 
and commentaries published in response to proposed or passed legislation or 
provoked by evidence that does not directly address the research question (Gannon 
& Garland, 2008; Loewy, 2004; McBride, 2013; Milliken, 2004; Prokopetz & Lehmann, 
2012; Saunders & Hughes, 1998). Some studies are excluded because they are not 
specifically about experiences (Bilsen, Robijn, Chambaere, Cohen, & Deliens, 2014). 
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Several studies were also excluded because they were conducted prior to 
implementation of the laws (Asch, 1996; Back et al., 2002; de Casterlé, Verpoort, De 
Bal, & Gastmans, 2006; Fenn & Ganzini, 1999a, 1999b; Ogden & Young, 2003; 
Willems, Daniels, van der Wal, van der Maas, & Emanuel, 2000; Wright et al., 2017), 
or because it was unclear how much of the data in the study represented conditions 
after the law was passed (Miller, Mesler, & Eggman, 2002). Finally, there are a 
plethora of opinion pieces in peer-reviewed journals establishing that medical aid in 
dying is a highly debated issue affecting professionals, but these are clearly not 
studies about the impact on professional experiences around issues of suicide in 
hospice or palliative care (Plaisted, 2013; Purvis, 2012; Smith & Pollack, 1998; Tucker, 
2009; Varelius, 2013). 
   
3.5 Characteristics of studies and quality appraisal 
A total of 29 studies were included in this review. Of these studies: 
 Five studies are from Belgium, nine from the Netherlands, two from 
Switzerland, and 13 from the United States 
 Only two of the 29 studies include information about experiences of hastened 
death that is not assisted suicide (self-administered lethal dose of 
medication) or euthanasia (lethal medication injected by professional); 
Ganzini et al (2003) investigate the phenomenon of patients who voluntarily 
refuse food and fluids, and Anquinet et al (2013) compare euthanasia with 
continuous deep sedation 
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 Two studies are part of a larger survey in Europe (Van Bruchem-van de Scheur 
et al., 2008; Van Bruchem‐van de Scheur, Van Der Arend, Spreeuwenberg, H. 
Huijer Abu‐Saad, & Ter Meulen, 2007) 
 Four papers are reported from one survey of physicians in the United States 
(Dobscha et al., 2004; Ganzini, Dobscha, Heintz, & Press, 2003; Ganzini, 
Nelson, Lee, et al., 2001; Ganzini et al., 2000)  
 Four papers are from the same initial survey of hospice workers from 2001, or 
a different phase of the same study (Ganzini et al., 2003; Ganzini et al., 2002;  
Harvath et al., 2006; Miller et al., 2004)  
 
The professionals in the included studies were primarily limited to physicians and 
nurses, with four studies from the United States that included social workers and one 
survey of chaplains (Carlson et al., 2005; Ganzini et al., 2002; Harvath et al., 2006; 
Miller et al., 2004; Norton & Miller, 2012). Categories of professionals studied in each 





Table 3.3. Professionals included in the study 
Professionals 
studied: 
Belgium Netherlands Switzerland United States 
Chaplains  
 





Casterlé et al. 
(2010), 
Inghelbrecht 
et al. (2010) 
 
Francke et al. 
(2016); Van 
Bruchem-van de 
Scheur et al. 
(2008); Van 
Bruchem-van de 
Scheur et al. 
(2007) 
 Clymin et al. 











al. (2013); J. 





Dees et al. 
(2012); Georges 
et al. (2008); 
Norwood 
(2007); Pasman 
et al. (2013); 
Snijdewind et 
al. (2014); van 
Marwijk et al. 
(2007) 
 






Chin et al. (1999); 
Dobscha et al. 
(2004); Ganzini et 
al. (2003); Ganzini 
et al. (2001); 
Ganzini et al. 
(2000); Voorhees 







   Ganzini et al. 
(2002); Harvath et 
al. (2006); Miller 
et al. (2004) 
Number of 
studies 
5 9 2 13 
 
This review used an appraisal scale suggested by Hawker, et al (2002), that 
recognises the complexity of quality assessment from diverse research designs. 
However, critical appraisal tools are subjective, “based on the appraiser’s concept of 
research quality” (Crowe, M. and Sheppard, L. p.87). The appraisal tool chosen for 
this review is utilised because the questions can be used as a guideline to assess the 
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strength of each study relevant to the research question. See Appendix 3 for the 
version of Hawker, et al (2002) question and rating system.  A study is given a score 
between 9 and 36 based on a series of questions. Scores, study results, and 
comments are included in Appendix 4 (Hawker et al., 2002). All studies received a 
score of 20 or above and were included in this review.  
 
Characteristics of each published paper included in this review are identified and 
listed by research location in Table 3.4:
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Table 3.4. Characteristics of included studies 
Reference Participants Study Methods Data Year Research Focus Setting Terminology Used in 
Study 
Belgium            




(n = 8) and 
two groups 
of nurses  
(n = 13) 
Qualitative focus 
groups 
2010 Similarities and 
differences between 
the practice of 
continuous sedation 


















Postal survey 2008 and 
2009 
Cultural differences 




 Unspecified Euthanasia 
Dierckx De 
Casterlé, et al 
(2010) 
18 nurses Qualitative 
in-depth 
interviews 
2005-2006 Nursing care for 
patients requesting 
euthanasia in general 







et al (2010) 
1678 nurses Second phase of 
two-phase postal 
survey 
2007-2008 Nurses involvement 
inconsistent in 
decisions about 
euthanasia or drugs 
to end a patients’ life, 
and nurses administer 
life-ending drugs even 






Administration of life 
ending medications 
without patients’ 
explicit request  
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Meeussen, K., 
et al (2011) 
205 GPs Structured phone 
survey  
2005-2006 Investigated how 
many patients 





these requests, and 
how it was handled 
Focused on 
patients who 
died at home 
Euthanasia 
Netherlands          
Dees, M. K., et 
al (2013) 






making process in 
cases where patients 





Georges, J. J., et 
al (2008) 
30 GPs Qualitative  
in-depth interviews 
2002-2003 Describes experiences 
of general 
practitioners (GPs) in 
Netherlands dealing 
with a request for 
euthanasia from a 
terminally ill patient. 
 Unspecified Euthanasia 
Francke, A. L., 






Postal survey 2011 To give insight into 















2001 Euthanasia, general 
practice, and end-of-
life discourse in the 
Netherlands 
Home Euthanasia 
Pasman, H. R., 








2005-2007 What happens after 
request for 
euthanasia is refused 




C., et al (2014) 
28 







According to the 
physicians and 
relatives, what are the 
characteristics of the 
complexities that can 
arise from the 
moment someone 
requests EAS? 




van de Scheur, 







Postal survey 2003 Euthanasia and 
physician assisted 
suicide in the Dutch 
home care sector: the 
role of the district 
nurse 






van de Scheur, 






Telephone survey   2003 The role of nurses in 
euthanasia and 
physician-assisted 















2003 Impact of euthanasia 
on primary care 
physicians in the 
Netherlands 
Primary care Euthanasia; 
Assisted Suicide 
Switzerland            












Unspecified Physician Assisted 
Suicide 





Qualitative study 2015 Physician responses 
to assisted suicide 
requests 
Unspecified Assisted Suicide 
United States        
Carlson, B, et al 
2005 















Oregon Death with 
Dignity Act (ODDA) 






First year’s experience 
with legalised assisted 
suicide in Oregon  
Unspecified Physician-Assisted 
Suicide 
Clymin, J., et al 
2012 
582 out of 
7500 nurses  
Qualitative 
component of email 
survey 
2010 Nurses knowledge of 
the Death with 
Dignity Act 
Unspecified DWDA  
Physician Assisted 
Death (PAD) 







2000 Physicians responses 
to requests for 
assisted suicide 
Unspecified DWDA ; 
Assisted Suicide 
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2000 Oregon physicians' 
perceptions of 
patients who request 
assisted suicide  
Unspecified Assisted Suicide 







Postal survey 1999 Physicians' 
experiences with the 
Oregon Death with 
Dignity Act 
Unspecified Oregon Death with 
Dignity Act 






Postal survey 1999 Physicians' 
attitudes/experiences 
with end-of-life care 
since passage of the 
Oregon Death with 
Dignity Act 
Unspecified DWDA  







Postal survey 2001 Experiences of nurses 
and social workers 
with hospice patients 
who requested 




Ganzini, L., et al 
2003 
307 nurses 
of 429 (72% 
response) 
Postal survey 2001 Nurses' experiences 
with hospice patients 
who refuse food and 
fluids to hasten death 
Hospice home 
care 
Voluntary Refusal of 
Food and Fluids (VRFF) 
Physician Assisted 
Suicide (PAS) 











hospice workers when 








Miller, L. et al 
2004 
306 nurses 




Postal survey 2001 Attitudes/experiences 
of Oregon hospice 





Assisted Suicide;                                             
Oregon Death with 
Dignity Act (ODDA) 
Norton, E. M. & 
Miller, P. J. 2012 
9 social 
workers 
Focus group Since 
passing of 
the law 





International (Netherlands and Oregon)        
Voorhees, J. R., 







experiences in the 





3.6 Data analysis—themes  
How does the literature suggest medical aid in dying affects professional 
experiences of issues of suicide and hastened death with hospice patients?  The 
focus of this review is to interrogate the literature of included studies with the aim of 
identifying and evaluating relevant themes from diverse methodologies (Dixon-
Woods et al., 2005). Nvivo, a qualitative software package, and hand coding were 
used to code results and discussion sections of each article and to search for key 
words. Each article was reviewed several times to identify codes from which three 
primary themes emerge. Themes include:  
 Physician-assisted suicide is synonymous with the concept of suicide: studies 
were coded by terminology used in the research 
 Professionals have a range of experiences, knowledge, and approaches when 
it comes to issues of hastened death and suicide:  experiences were coded 
and categorised by type 
 Implications of medical aid-in-dying laws require improved interdisciplinary 
communication in end-of-life care: study conclusions were coded, 
categorised, and summarised 
3.6.1 Suicide is synonymous with physician-assisted suicide or assisted suicide 
The terms ‘suicide‘ and ‘physician-assisted suicide‘ are synonymous in the included 
studies. There is almost no literature about suicide in hospice and palliative care 
services in areas that allow medical aid in dying. It is unclear from these articles how 
the terminology of the death by a purposeful overdose of un-prescribed medications 
would be distinguished from the death of a patient from Voluntary Refusal of Food 
or Fluids (VRFF) or medical aid in dying. What is termed physician assisted suicide 
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(PAS), might also be called Physician Aid in Dying or Physician Assisted Death (PAD), 
or only ‘assisted suicide’ in some studies. Chin, et al acknowledge that the Oregon 
law does not “constitute suicide” yet states, “we use the term ‘physician assisted 
suicide’ rather than ‘death with dignity’ to describe the provisions of this law” (Chin 
et al., 1999, p. 578). Only one study from The Netherlands identified patients who 
died by unassisted suicide, attempted an unsuccessful overdose of medications, or 
deliberately stopped eating and drinking when their request for euthanasia was 
refused (Pasman, Willems, & Onwuteaka-Philipsen, 2013). In Switzerland, the word 
‘physician‘ is removed from the term ‘assisted suicide’ because physicians can only 
be present as a private citizen at the time the patient ingests lethal medications 
(Gamondi et al., 2017)  
 
Most of the included studies from the United States use the word ‘suicide’ in the title 
or in the content of their research. Several authors often use only the unqualified 
term ‘suicide’ when discussing physician-assisted suicide. Carlson et al, suggest that 
patients die by suicide when pursuing DWD when discussing how hospice policies 
may “prohibit employees from assisting the patient in obtaining the prescription or 
attending a suicide” (Carlson et al., 2005, p. 1164). Most authors suggest patients 
who request lethal medications from their physicians end their own life through 
suicide (Clymin, Jablonski, Jacobson, & Feldt, 2012; Dobscha et al., 2004; Ganzini et 
al., 2000).  
 
Most authors acknowledge terminology variation but do not explain their choice of 
terms around this topic. Some authors refer to ‘aid in dying,’ ‘legalised physician 
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assisted suicide,’ ‘PAS,’ ‘assisted suicide,’ or the ‘Oregon Death with Dignity Act’ 
(Ganzini et al., 2000; Otte, Jung, Elger, & Bally, 2016; Snijdewind, van Tol, 
Onwuteaka-Philipsen, & Willems, 2014; Van Bruchem-van de Scheur et al., 2008; Van 
Bruchem‐van de Scheur et al., 2007).  Other authors choose ‘physician-assisted 
death’ or ‘physician–assisted dying’ as a capture term to include both euthanasia and 
assisted suicide instead of the terms ‘physician-assisted suicide‘ or ‘assisted suicide‘ 
(Voorhees et al., 2014). Suicide implies that a person has an intention for self-harm 
resulting in death; however, research suggests that the definition of suicide depends 
on who is doing the research and how the research is completed (Westefeld et al., 
2000). Gamondi, et al (2017) acknowledge that there is controversy over the 
terminology and use ‘assisted dying’ as a neutral term to describe both euthanasia 
and assisted suicide. Whether the pursuit of medical aid in dying is considered 
suicide is debatable and may depend on culture or understanding of the law.  
 
In addition, Voluntary Refusal of Food and Fluids (VRFF), also known as Voluntary 
Stopping of Eating and Drinking (VSED), and continuous deep sedation are 
sometimes characterised as hastened death and as alternatives to medical aid in 
dying (Anquinet et al., 2013; Ganzini et al., 2003). There is a variation of experiences 
and whether they are considered acceptable. Ganzini et al's, study of nurses and 
social workers suggest that VRFF is “... different from suicide” and as an “option 
when patients request physician-assisted suicide” (Ganzini et al., 2003, pp. 360, 364).  
A study of social workers in the United States and a study with physicians from The 
Netherlands were the only ones to identify ‘suicide’ as separate from other forms of 
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hastened death, suggesting suicide occurs separately from medical aid in dying and 
VSFF (Norton & Miller, 2012; Pasman et al., 2013).   
 
Finally, the studies from The Netherlands and Belgium indicate that experiences with 
patients dying from euthanasia are much more frequent than with physician assisted 
suicide (Cohen et al., 2012; Dierckx De Casterlé et al., 2010; Meeussen et al., 2011; 
Snijdewind et al., 2014;  Van Bruchem‐van de Scheur et al., 2007; van Marwijk et al., 
2007). 
3.6.2 Professionals’ range of experiences and approaches 
The terms ‘mentally competent’ or ‘mentally capable’ are frequently used to 
determine whether a patient is eligible to get lethal medications from a physician. 
The literature suggests, however, that different professionals might discern and 
address these issues in diverse ways depending on the policy of their employer, 
institutional and personal interpretation of suicide, and sense of responsibility for the 
patient (Clymin, et al., 2012). 
 
The studies of physicians included in this review describe a range of emotions and 
experiences about responding to requests for medications to end patients’ lives. 
These emotions range from feelings of fear, frustration, and isolation to feelings that 
their experience improved their relationship with patients, and increased quality of 
life and comfort when writing prescriptions or administering lethal medications (Chin 
et al., 1999; Ganzini, Nelson, Lee, et al., 2001; Otte et al., 2016; van Marwijk et al., 
2007; Voorhees et al., 2014). Some literature about physicians’ experiences 
associates the words ‘suicide‘ or ‘suicidal with anxiety and fear‘ as the physician 
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struggles to assess the risk and needs of their patients (Dobscha et al., 2004; Ganzini, 
Dobscha, et al., 2003). The span of emotions demonstrated by these studies suggest 
an increased sense of responsibility for patients compared to other professionals, 
which may be attributed to the power they possess to prescribe lethal medications 
to control timing of death, and from the physicians’ concerns about being able to 
provide comfort until death. 
 
A study by and about social workers explicitly suggests that patients die by suicide 
frequently “and at any given time there is enough medication in a patient’s home to 
kill them. It is just a matter of are they going to go through our legal processes or our 
system’s processes” (Norton & Miller, 2012, p. 252). Other studies explore the 
complexity of the social worker role in understanding and identifying when a patient 
is at risk of suicide and when compared with nurses, indicate that social workers are 
more accepting of patient choices (Ganzini et al., 2002).  
 
Nurses experience fear and ethical conflict, particularly when questions posed by 
patients about access to lethal medications conflicted with their own personal or 
religious beliefs but feel increased acceptance when patients make the decision to 
VRFF (Ganzini et al., 2003). Harvath et al (2006) suggest that nurses understood 
patient choice to hasten death by recognising “the patient’s desire to control the 
circumstances of death was a greater factor in a patient’s choice of PAS than was 
symptom management” (p. 204).  Several authors indicate that organisational policy 
presents dilemmas around needing to prevent hastened death, but most speak of 
the critical need to establish clear guidelines for interdisciplinary team members 
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(Dierckx De Casterlé et al., 2010; Harvath et al., 2006; Van Bruchem-van de Scheur et 
al., 2008). The survey of Washington State nurses follows the notion that 
organisational policy presents dilemmas “of conflict or concern related to their lack 
of knowledge, strong personal beliefs, and uncertainty about facility or professional 
policies” (Clymin et al., 2012, p. 145). Overall, most nurses in these studies indicate 
they would support a patients’ choice but did not address nurses’ experience with 
patients who died by suicide other than through legally prescribed medication by a 
physician or by VRFF.  
 
Inghelbrecht et al, (2010) however, do examine the incidence of nurses 
administering life-ending medications with and without a patient’s explicit request 
for hastened death, despite nurses’ direct administration being unacceptable and 
unregulated by Belgium’s euthanasia law. There is little indication from other studies 
that nurses participate in euthanasia with or without the patient’s consent. 
 
There is only one study about chaplains indicating that whether or not chaplains 
agree with a patients’ decision to hasten death, they support patients’ choices. 
Carlson suggested that chaplain’s working with patients interested in pursuing the 
DWDA did not influence the decision to hasten death (Carlson et al., 2005).  
 
Professionals have a range of experiences that may be attributed to cultural 
differences, as explained by Cohen et al, in a study from Belgium (Cohen et al., 2012). 
Cohen et al (2012) write that “the influence” of a law “on a particular society... is 
affected by the surrounding culture” (p. 852). Understanding cultural differences, 
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including language, religion, and environment may be a key element to understand 
and interpret experiences around issues of suicide and assisted suicide. 
3.6.3 Impact of medical aid in dying on communication in end-of-life care  
A theme that emerges from the literature is the importance of open communication 
about issues of suicide among professionals and between professionals and those 
they serve (Dees et al., 2013; Dobscha et al., 2004; Francke, Albers, Bilsen, de Veer, & 
Onwuteaka-Philipsen, 2016; Norwood, 2007; Otte et al., 2016; Pasman et al., 2013). 
The included articles suggest that with medical aid in dying there is a tendency to 
view professionals’ conversations with patients as opportunities to discuss what is 
relevant and important to the patient, thus improving end-of-life care. Studies of 
physicians assert that passage of the laws is associated with an increased sense of 
responsibility to provide optimal palliative care and serves as “a gateway to 
discussion of many important end-of-life issues that deserve attention” (Voorhees et 
al., 2014, p. 815).  Ganzini et al (2001) suggest that since passage of the DWDA in 
Oregon, physicians have increased referrals and access to hospice care, but 
relationships may have been altered when a physician does not agree to prescribe 
lethal medications (Ganzini, Nelson, Schmidt, et al., 2001).  A Swiss study of 
physicians indicates that while few agree to prescribe lethal medications they 
assume a responsibility to discuss the origin of the patient's request and seek 
alternatives to assisted suicide (Gamondi, et al 2017). 
 
Studies of other professionals corroborate the research about physicians indicating 
“the discussion about assisted suicide opens up the box for them to ask all of the 
other questions they have...” (Harvath et al., 2006, p. 203). Some research, however, 
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indicates that communication with patients is impaired when there is understanding 
that organisational policy, professional code, or lack of training restricts professionals 
from communicating about options for care (Clymin et al., 2012). Several authors 
discuss the need for more training (Anquinet et al., 2013; Otte et al., 2016; Pasman 
et al., 2013).  
 
3.8 Summary 
As searches reveal, this would appear to be the first literature review of 
professionals’ experiences with hospice patients related to issues of suicide and 
hastened death. This review finds that the literature suggests professionals’ 
experiences of suicide with hospice or palliative care patients in areas where medical 
aid in dying is authorised are primarily focused on legalised self-administered lethal 
medications prescribed by a physician in the United States, euthanasia in Belgium or 
Netherlands, or assisted suicide in Switzerland. Authors of some studies indicate that 
experiences about medical aid in dying shift as people learn about the laws and imply 
that these laws may also improve quality of end-of-life care (Ganzini et al., 2002; 
Norwood, 2007). Identified authors of studies included in this review used diverse 
terminology, including the phrase ‘physician-assisted suicide,’ or ‘assisted suicide’, 
with minimal discussion justifying their use of terms. Overall, there is little clarity on 
the question of whether medical aid in dying is deemed suicide or understanding 
about patients who hasten their own deaths and die by suicide. Finally, the 
recommendations of the included studies suggest further research is needed as more 
jurisdictions and nations take steps to legalise medical aid in dying. These 
recommendations include the need to explore organisational policy affecting 
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professionals’ ability to provide information to patients, differences between medical 
aid in dying, VRFF, or continuous deep sedation, and the need to increase 
information to provide guidance for healthcare professionals working with patients 
who report a desire to hasten death (Clymin et al., 2012; Dierckx De Casterlé et al., 
2010; Gamondi et al., 2017; Harvath et al., 2006; Pasman et al., 2013). The review 
findings show that there is great variance in nomenclature and definitions that 
require careful analysis and are important in identifying professionals’ work with 
individuals facing fear, pain, and suffering at end of life. The broader review of 
literature indicates widespread international engagement with these issues. These 
questions truly have global implications. 
 
Overall, this review demonstrates that significant gaps remain in the literature on the 
effects of medical aid in dying on understanding of suicide issues in hospice care. 
Most of the surveys and qualitative studies in the United States, in particular, were 
completed over ten years ago, are limited to Oregon State, and limited to the topic of 
medical aid in dying. The literature, overall, does not address what happens to 
patients who are unable to or do not pursue medical aid in dying but die by suicide or 
hasten their death in other ways. Significant gaps remain to be explored on the scope 
and impact of organisational restrictions on professionals’ ability to have open 
conversations with patients who consider pursuing medical aid in dying. In addition, 
there is little understanding or evidence of cultural issues related to suicide, or 
professionals’ experiences with patients’ that hasten their deaths due to limited 
access to information about options, including palliative and hospice care. It remains 
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uncertain if the implementation of medical aid in dying has shifted professionals’ 
experiences of suicide with patients. 
 
Understanding professionals’ experiences with and interpretation of suicide can 
contribute to improving communication and assessment with patients around issues 
of hastened death and provide needed guidance. Improved communication among 
hospice team members about issues of suicide can help to open up and alleviate fear 
over what has been considered by many to be a taboo topic. If open discussion about 
death was, and may be still, considered taboo, then suicide is likely to trigger even 
deeper anxiety and fear within that taboo of death. If hospice and palliative care is 
indeed patient-centred, then opportunity for open conversation about whatever is 
important to the patient must be available.   The implementation of the medical aid 
in dying laws has created a new dynamic in the culture of hospice. This critical review 
helps to place these changes and experiences in the larger context of healthcare, 
politics, professional ethics and standards, and human rights. The review confirms 
the need for research to inform or influence private organisation’s policies and 





Methodology and Methods 
4.1 Chapter overview 
This chapter explains my rationale for adopting a qualitative research design for the 
study, my data analysis method, and my data collection strategy.  I begin with a 
discussion about the theoretical position of the study and then discuss the 
methodological framework. Next, I describe the methods used for recruitment and 
the sampling process, give an overview of participants’ backgrounds, and describe 
the data collection interviewing process. Thirdly, I provide an account of the method 
of analysis and explain how rigour is applied in the research. Finally, I include a 
description of several ethical issues, including informed consent, safety concerns, 
and a plan for research dissemination. 
 
4.2 Epistemology and ontology 
To understand the philosophical underpinnings of this study, it is important to first 
explain the ontological and epistemological positions, described respectively as the 
theory of the nature of being and the theory of the nature of knowledge (Braun & 
Clarke, 2013). Ontology is concerned with whether reality exists outside of individual 
beliefs, only through the material world, or where there are multiple views, 
perspectives, and meanings that are socially constructed (Creswell, 2013; Ritchie & 
Lewis, 2012). Braun and Clarke (2013) identify ontological positions on a continuum 
from relativism described as “reality that is dependent on the ways we come to know 
it” on one side to realism on the other side described as reality that is “entirely 
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independent of human ways of knowing about it” (p. 26-27). Critical realism lies 
between relativism and realism, indicating “reality exists but we can only partially 
know it” (Braun & Clarke, 2013 p. 26).   This study views reality as dependent on 
many variables and interpretation thus adopts the position of relativism. 
 
Epistemology is concerned with knowledge and how it is attained (Creswell, 2013). 
Snape and Spencer (2003) recognise that the researcher is not completely 
independent of the research and can never fully have a neutral stance. Therefore, it 
is important to reflect on how my own experiences and beliefs might shape or 
influence the research. The epistemological assumption here is that what counts as 
truth is created by the process of the research (Braun & Clarke, 2013).  I adopt a 
constructionist epistemology that suggests that reality is constructed by and 
between the individuals who are experiencing it (Burr, 2015). This is explained 
further in the next section.  
 
4.3 Methodology  
Methodology is the plan behind the chosen method of study and method is the 
technique or process employed to collect and analyse data (Guba & Lincoln, 1994).  
To find a method suitable for this research study, I considered alternative ways 
through which to investigate the topic that included both positivist and interpretive 
frameworks. A positivist approach uses quantitative methods to test hypotheses that 
are quantifiable and measureable (Bowling & Ebrahim, 2005), while interpretive 
frameworks use qualitative methods to collect and analyse data but believe “in 
multiple perspectives rather than a single reality” (Creswell, 2013, p. 24). An 
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interpretivist approach seeks to understand the meaning of the experience from the 
participants’ perspective and recognises that what may be true for one individual 
may not be true for another (Bryman, 2012). Silverman suggests qualitative research 
provides more depth into understanding social phenomena (Silverman, 2013). In a 
sensitive area such as medical aid in dying, a qualitative, interpretivist approach is 
indicated to be most suitable since my research question asks about the experiences 
of professionals, and seeks to gain an understanding of participants’ interpretation of 
suicide and the phenomenon of suicide and hastened death in a hospice context. 
 
I adopted a social constructionist methodological framework to allow what Creswell 
describes as a “complexity of views” but that also recognises the social and historical 
meanings developed from individual perspectives informed by interaction with 
others (Bowling & Ebrahim, 2005; Creswell, 2013, p. 24). I recognise Gergen’s 
interpretation of social constructionism, which places the origin of knowledge in the 
social processes (Gergen, 2015). Those who adopt the social constructionist position 
suggest that the individual’s personality is developed from socially constructed ideas, 
and that context, culture, and communication contribute to the many ways of 
envisioning reality (Burr, 2015; Gergen, 2015; Raskin, 2002). Gergen states, 
“constructionism champions relationship” (Gergen, 2015, p. 30). Adopting a social 
constructionist theoretical position, I am exploring those socially constructed ideas 
about suicide and assisted dying and how context, culture, and language might 
influence the meaning of the participants’ experiences. Social constructionism is 
used as a resource to understand that when individuals are in dialogue with each 
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other they “have the potential to create new and more promising ways of being” 
(Gergen, 2015, p. 32).  
 
The research framework includes an inductive approach, meaning that the data 
direct the theme development (Braun & Clarke, 2013). As a researcher, however, I 
am also bringing a set of ideas that include those developed from the literature 
review and from my previous experience as a hospice professional. A social 
constructionist worldview allows the researcher to use their own experience to 
“make sense of the meanings others have about the world” (Creswell, 2013, p. 25).  
In addition, a social constructionist position examines how the language that is being 
used by participants may have different meanings depending on the context (Burr, 
2006). These meanings also include considering how the terms and language used in 
the interviews are framed. Quantitative inquiry would not allow research into the 
depth of the experiences or raise new issues not previously considered. I used 
thematic analysis, described in more detail in section 4.5. 
 
4.4 On reflexivity 
Braun and Clarke (2013) advise that it would seem odd to conduct research on the 
perspective of participants without reporting on my own standpoint as a researcher 
with a professional background similar to many of those I interviewed (Braun & 
Clarke, 2013). A qualitative design is an approach consistent with my values and 
experiences as a social worker in palliative care that requires careful listening to the 
stories that are told about what is important to the patient. I come from a profession 
that actively engages in this approach. Reflexivity regarding my own experiences and 
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interaction with the participants was an important aspect of this research. If I had 
not been engaged in this work, I would have been unaware of what questions to ask 
and had many questions about context. I did not need to ask general questions, for 
example, about criteria for hospice services or team requirements to understand the 
context because of my knowledge and role as a hospice professional. Entering the 
research as an academic, I embraced formal academic frameworks giving me an 
opportunity to gain insight into the meaning of events for the participants while 
including a reflexive method considered essential in qualitative research (Alvesson & 
Sköldberg, 2009). Alvesson and Sköldberg suggest that reflexive methodology is both 
interpretive and reflective, meaning all parts of the research are the “results of 
interpretation” and that the researcher works to maintain awareness and critical 
reflection (Alvesson & Sköldberg, 2009, p. 9). Interpretation became a central aspect 
of the research that recognised the political context and influence on language and 
meaning. Reflexivity required me to pay attention and distinguish between the story 
that is mine and the story being told by and in relation to the participants (Gergen & 
Gergen, 1991).  
 
4.5 Data collection methods  
4.5.1 Recruitment  
Participants, home hospice professionals in Washington State, were recruited 
through my professional hospice contacts, referrals, professional organizations, 
conferences, and meetings. The Washington State Hospice and Palliative Care 
Organization (WSHPCO) agreed to include a recruitment letter in their newsletter 
and send an email to their membership list asking those interested to contact me.  
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The self-selected participants contacted me by email or telephone to receive 
information about the study and arrange meeting times. A follow-up email was sent 
within two weeks of the initial contact if there was no response from a participant 
who had expressed active interest in the research. Appendix 5 includes information 
included in the newsletter and copies of any emails sent to potential participants. I 
provided the information sheet (Appendix 6) by email or post depending on the 
participant’s preference. I followed up with the participant by phone (or email if they 
stated this as a preference), to review the information, answer any questions about 
the study, confirm willingness to participate, and schedule an interview type, time 
and location. The participant was reminded that they had the option to decline to 
participate in the study, to withdraw before or during the interview, or withdraw 
their data up to two weeks following completion of the interview.  
4.5.2 Interviews 
In-depth, semi-structured, and open-ended questions via face-to-face or telephone 
interviews were conducted to create a “portrait” of experiences collected from the 
viewpoints of different professional perspectives (Rubin & Rubin, 2012, p. 3).  Rubin 
and Rubin suggest qualitative interviewing is optimal when researching sensitive and 
complex topics (Rubin & Rubin, 2012). An interview and example topic guide are 
included in Appendix 7.  The guide helped to facilitate questions, but interviewing 
was an iterative process, thus I addressed any new issues raised by participants.   
 
The topic guide in Appendix 7 is an example of topics that could be included in the 
interview depending on the nature of the stories and experiences that participants 
shared. Rubin and Rubin (2012) suggest that in the beginning of each interview easier 
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questions are asked of participants to develop rapport and empathy. I   encouraged 
rapport by introducing the research topic, and asking questions about the 
participants' background, profession, and length of experience. In addition, as Braun 
and Clarke (2013) recommend, the interview guide was not adhered to rigidly to 
allow the participant to “discuss issues that are important to them and that the 
researcher hasn’t anticipated and aren’t on the interview guide” (p.78). Silverman 
(2013) suggests that in qualitative research, departures from the interview guide 
“are not seen as a problem” and “are often encouraged” (p. 204).  The interviews 
remained focused on the aim of the research, which was to collect stories about 
participants' experiences of suicide and hastened death in their work with hospice 
patients. From these stories of experiences, questions were asked to help identify or 
determine what is considered to be suicide, how the Death with Dignity Act impacts 
experiences of suicide, and how suicide risk is determined from patients seeking or 
utilising medical aid in dying. Questions contained in the guide were helpful to probe 
on a topic that might have been briefly addressed by some participants. 
 
Four areas are included in this interview guide. First, the guide includes questions 
about terminology, meaning questions might be asked about what hastened death 
or desire for hastened death meant to the participant. I found that most participants 
shared stories easily soon after introducing the topic, and the questions about 
terminology were addressed as they spoke about specific experiences. Second, the 
guide included questions about experiences to elicit stories of patients who died 
using the DWDA and patients who died by suicide without assistance. Third, an area 
of questions about communication was guided by literature that suggested 
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organisational policies and might have influenced participants' work with patients 
(Clymin et al., 2012; Ganzini et al., 2002). This area met the objective of 
understanding how or if participants' experiences have been influenced by the 
DWDA. Finally, additional questions were included to meet the objective of 
understanding how participants discern suicide risk from patients who request or 
utilise DWDA.    
 
Two face-to-face pilot interviews with hospice professionals were conducted to 
prepare and develop questions for the study. Face-to-face interviews were 
encouraged but telephone interviews were also offered as an option to allow 
participants who feel more comfortable with this or preferred this method due to 
time and possible geographic constraints. Travel between some areas of Washington 
State can be challenging due to road and/or weather conditions, also making 
telephone interviews more achievable. In addition, telephone interviews are 
increasingly being justified for qualitative research on sensitive subjects (Cachia & 
Millward, 2011; Grinyer, 2012; Sturges & Hanrahan, 2004).   Telephone interviews 
were 15 to 30 minutes longer than face-to-face visits and the participants verbalised 
comfort being able to tell both personal and professional stories. There were no 
notable differences between the quality of data from telephone compared with data 
from face-to-face interviews. 
 
The interviews were digitally recorded, transcribed verbatim, and analysed solely by 
me. Questions were asked about participants’ personal experiences and professional 
training, in addition to social, political, and organisational factors related to 
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conversations and experiences with their patients. Questions were semi-structured 
and open-ended to explore in more depth hospice professionals’ experiences with 
patients around issues of suicide and hastened death.  
 
Participants were offered the option to contact me for a follow-up telephone or face-
to-face interview at their own discretion up to 2 months following their initial 
interview. The purpose of the follow-up interview was to allow participants to add 
any additional information about current experiences or respond to questions after 
more careful consideration. I conducted three brief follow-up interviews with 
participants who contacted me within the time frame. These follow-up interviews 
reiterated themes that had emerged, and no new issues were raised from the initial 
data.  
4.5.3 Face-to-face interview setting 
The research was conducted with hospice professionals who are employed by formal 
organisations providing hospice care in home-based settings in Washington State. I 
offered face-to-face interviews with participants in an agreed upon location where 
anonymity, confidentiality, and safety could be maintained for all involved. Meetings 
were scheduled in locations such library meeting rooms that are not isolated but 
where privacy could be maintained. If a participant did not agree to a meeting room 
option and preferred to meet in their home, I left a sealed envelope containing the 
address with a colleague locally who is also skilled in qualitative research and aware 
of safety policies and procedures regarding home visits. I called my colleague before 
and after the interview was completed with a contingency plan for her to contact 
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authorities to assure my safety if she was not contacted within a designated time 
frame; this contingency was not needed.  
4.5.4 Sample 
A purposive sample of 21 hospice clinicians were recruited in Washington where the 
Death with Dignity Act (DWDA) has been implemented since 2009. Purposive 
sampling is a common method used in qualitative research to identify a sample of 
individuals who have knowledge about and experience of the research topic 
(Creswell & Clark, 2007; Ritchie & Lewis, 2012; Silverman, 2013). Purposive sampling 
is a deliberate approach to ensure populations with specific characteristics and from 
diverse locations are included in the study (Ritchie & Lewis, 2012). I began this study 
with a plan to interview up to twenty hospice professionals from different types of 
organisations, and who worked in rural and urban communities in both eastern and 
western Washington.  
 
Fusch and Ness (2015) suggest saturation is achieved when “there is enough 
information to replicate the study and ... when further coding is no longer feasible” 
(p. 1413).  I chose a sample that was reflective of the hospice team of professionals 
and was feasible for coding. I did not seek thematic saturation since there is no way 
to be certain if new insights would emerge with more interviews (O’Reilly & Parker, 
2013). I approached the challenges of data saturation by thinking of quality data as 
rich, and quantity of data as thick (Fusch & Ness, 2015).  Rich data were collected 
that I considered intricate and detailed, while thick data provided quantity and 
repetition of identified themes. The decision to stop sampling was made once I 
recruited each type of professional that worked in different locations and then 
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reflected theoretically on the concept of suicide, hastened death, and medical aid in 
dying. A total of 21 participants were finally included to assure that the sample 
reflected a diversity of locations and type of professional. 
 
The greater numbers of nurses and social workers who responded to the recruitment 
announcement is likely a reflection of the disproportional presence of these 
disciplines providing home hospice services.  For example, in one organisation, a 
participant reported there were only two physicians, but nearly 40 employees from 
other disciplines. The call for participants resulted in at least ten requests to be 
interviewed by professionals from other disciplines, or who did not directly provide 
home hospice services. These requests may be an indication of the importance of the 
topic of suicide, impact of the DWDA, and interest from professionals of all 
backgrounds.   
 
Professionals were interviewed from non-profit, for-profit, sectarian, and non-
sectarian organisations in diverse geographical locations around Washington State, 
to reflect the diversity of cultural, environmental, organisational, and professional 
experiences. Inclusion and exclusion criteria are included in Table 4.1:  
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 Chaplains/Spiritual care 
counsellors, physicians, nurses, 
nurse practitioners, and social 
workers, and who supervise 
interdisciplinary home hospice 
teams and have had experience 
in providing direct services to 
hospice patients in home or 
nursing home setting in 
Washington State 
 Chaplains/Spiritual care 
counsellors, physicians, nurses, 
nurse practitioners, and social 
workers who provide direct 
services that may include 
assessment for pain and suicide 
risk for hospice patients in the 
home or nursing home setting 
in Washington State 
 Chaplains/Spiritual care 
counsellors, physicians, nurses, 
nurse practitioners, and social 
workers who are currently 
employed as home hospice 
professionals with a minimum 
of 6 months but preferred two 
years minimum experience 
providing or supervising home 
hospice in Washington State.  
 Hospice staff not providing direct 
supervision of staff or providing 
direct services that would include 
assessment of suicide risk and 
pain management 
 Non-clinical staff including 
administrators, schedulers, 
medical records staff, and others 
who do not provide direct 
hospice services to patients in 
the home or nursing home 
 Home health aides/bath aides 
 Hospice volunteers 
 Hospice staff who have not 
worked in Washington State  
 Hospice professionals who are 
employed by the same local 
hospice agency as the researcher  
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Table 4.2 and Table 4.3 contain descriptions of the twenty-one participants 
interviewed between March and July 2015. The terms participants used to describe 
themselves are the terms included in the following tables.   
Table 4.2. Participant demographics 
Demographics of the 21 Participants 
Type of Professional Gender Age range Cultural Identity 
Chaplains:3 Female:18 Unknown: 1 American Indian:2 
Nurses:7 Male:3 30-39 years: 2 Caucasian:18 
Physicians:4 
 
40-49 years: 5 Unspecified:2 
Social Workers:7 
 
50-59 years: 11   
  
 
60-69 years: 2   
 
In Table 4.3, participants described more than one cultural identity, or chose not to 
identify with a specific culture. Some participants described more than one spiritual 
or religious background, or not spiritual at all. Others described their spirituality as 
evolving, inclusive, or eclectic.  Some described clear religious affiliations. Spiritual 
and/or religious influences are listed here without totals because of the many 
overlaps and multiple identities. For example, one person described growing up 
Catholic, but also influenced by Christianity, Buddhism, and Taoism. Finally, the 
primary work location identifies if the participant worked in rural or urban areas 
visiting with patients in their homes or nursing home settings. 
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Table 4.3. Description of participants 
Description of the 21 participants 
Spiritual background Atheist, Baptist, Buddhist, Catholic, 
Christian, Episcopal, Jewish, nature, not 
spiritual, pagan, Taoist, unspecified 
Years of experience 
 
3–5 years: 3 
6–10 years: 1 
10–15 years: 5 
16–20 years: 3 
21–30 years: 6 
30+ years: 3 
Hospice experience 1–2.5 years: 2 
3–5 years: 6 
6–9 years: 2 
10–20 years: 9 
20+: 2 
13 participants had 
experience before and 
after implementation of 
the DWDA in 2009 
Primary work location Rural:11  
Rural/Urban mix: 4  
Urban: 6 
 
Participants were employed by ten hospice organisations located in diverse locations 
around Washington State. The two tables below describe the different types of 
organisations where participants were employed, and numbers interviewed in each. I 
completed these tables to view them in different types of groupings.  For example, 
the preceding Table 4.2 and Table 4.3 describe participants without distinguishing 
them by type of professional or where they are employed. The following Table 4.4 
contains information without disclosing type of professional:  
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Table 4.4. Organisation type 
Type of Organisation 
  # of organisations 
# Participants in this 
type of organisation 
Participating 
in DWDA? 
Non-profit, Catholic 2 5 No 
Non-profit, 
not religiously 
affiliated 6 11 
3: Yes (7) 
3: No (4) 
For-profit, 
not religiously 
affiliated 2 5 No 
  Total = 10 Total = 21   
 
Participants were asked about organisational policy regarding the DWDA. Seven 
participants were employed at three different participating organisations (described 
above). Four participants were employed at a total of three non-participating 
organisations. Table 4.5 is a more detailed description of organisation by type, 
numbers interviewed, and specific professional codes for individual participants: 
Table 4.5. Participants interviewed and organisation type 
Organisation and Participant information  





Type of professional with 
participant code # 
Non-profit, Catholic  1 - S 3 MD1, MSW2, RN4  
 (S) 2 - S 2 MSW3, MSW6 
Non-profit, non-
sectarian (NS) 
3 - NS 2 RN7, CH3 
4 - NS 1 MSW4 




6 - NSP 4 CH1, RN3, RN6, MSW1 
7 - NSP 2 MD3, MSW5 
8 - NSP 1 RN2 
For-profit, non-
sectarian (FP) 
9 - FP 3 MD2, RN5, CH2 
10 - FP 2 RN1, MSW7 
 
Each participant identified themselves as either a physician (MD), social worker 
(MSW), nurse (RN), or chaplain (CH).  
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4.6 Analysis Method 
I used thematic analysis to interpret significant themes extracted from the data, and 
to identify and compare individual and professional experiences.  Thematic analysis 
provided a structure to go beyond the extracted themes to not only what was being 
told but also the social contexts around the issue being discussed. Thematic analysis 
is used widely in health research as a method that is suited to questions about 
peoples’ experiences focused on developing patterned meanings across the data 
(Braun & Clarke, 2014). Joffe suggests good thematic analysis alone is a recognisable 
approach that moves beyond text fragments reflecting “a balanced view of the data, 
and its meaning within a particular context of thoughts (Joffe, 2012, p. 219).”  
According to Braun and Clark (2013), thematic analysis is a flexible approach that 
provides a six-phase process that is not necessarily meant to be rigid or sequential, 
depends on the theoretical framework, and follows these steps. 
1. Familiarisation with the data 
2. Coding 
3. Searching for themes 
4. Reviewing themes 
5. Defining and naming themes 
6. Writing up  
 
Appendix 13 includes an example of how this process was utilised to identify themes. 
Specific coding was developed from fragments of the data that directly answers the 
research question.  The use of thematic analysis in this study allowed me to discuss 
the themes but stories were edited to leave out identifying elements to maintain 
participant, patient, and organisational anonymity. Themes were developed from 
codes after coding and categorising data was completed. Thematic analysis for this 
study was an iterative process built on the identification and comparison of how 
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individual, community, organizational, and political cultures impact the diversity or 
commonalities of experiences.  
 
I explored Qualitative Data Analysis software (QDAS) programmes to assist in the 
process of analysis. Despite critiques that QDAS lacks theoretical strength, there is 
evidence that it can contribute depth through which to interrogate data, and 
visualise results by using coding trees and clustering (Bhattacharya, 2015). I chose to 
use QSR NVivo10 for Windows because of its ease of use and evidence that it 
provides increased reliability and validity in qualitative studies (Bazeley & Jackson, 
2013). The visual tools of NVivo10 “allow us to see large amounts of the data 
condensed into a single page” (2013, p. 217).   
 
Digital recording and note taking were used to record the stories of the participants 
with their consent. I listened to interviews several times to make sure they were 
accurately recorded.  To ensure as much accuracy as possible, I listened to the 
recording while reading the transcription (DiCicco‐Bloom & Crabtree, 2006).  Note-
taking alone would not provide an accurate account of the participants’ stories. 
During face-to-face interviews a digital recorder was placed close by and visible to 
the participant. At the beginning of the telephone interviews the participant was 
reminded that their interview was being recorded and that they could request the 
recording to be turned off or on at any time. Following the interview, the digital 
recording was transferred to a password-protected and encrypted PC at the earliest 
time, accessed only by the researcher. I alone transcribed, edited, and analysed all 
the digital recordings.  
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I transcribed all interviews directly into a Word document, then reviewed and 
reformatted it before uploading it to QSR NVivo10. Transcripts were printed out to 
take notes, re-read, and begin the process of developing initial codes by hand before 
uploading to NVivo10.  Each line was numbered to be able to refer to it as needed. I 
used NVivo10 to create a coding structure, keep track of emerging thoughts (taking 
notes as I coded each interview), and develop new codes. NVivo10 helped to identify 
the depth and richness of the themes by linking them to the data sources.  For 
example, by using the visualisations of the coding tree, I could compare the coding of 
one transcript with another and view the emerging relationships and patterns.  After 
in-depth coding of transcripts, I sorted codes into categories.  These categories were 
re-sorted several times after additional coding of each transcript was completed, 
returning to the data to confirm what had been said and in what context. Themes 
were identified after an iterative process of coding, returning to the data, re-coding, 
and categorising after all coding was completed.  Examples of categories of codes, a 
coding tree, and the process of identifying themes utilising NVivo10 are included in 
Appendices 11-13.     
 
4.7 Rigour and quality assurance 
The concept of rigour in research is often associated with objectivity, replication, 
reliability, and validity, notions often associated with quantitative studies (Davies & 
Dodd, 2002).  Qualitative scholars Mays & Pope (2007) suggest that qualitative 
research requires a different set of skills representing what cannot be rated by the 
same measures as quantitative research.  Qualitative inquiry aims to establish quality 
that assures that the research represents the meanings of the participants, 
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minimising the biases of the researcher (Padgett, 2016). As a researcher, I 
acknowledge that I share a similar professional identity with the participants—which 
helped me to gain trust—and bring my own set of beliefs and experiences to the 
research. The philosophical underpinnings of this research recognise the researcher 
as a part of the research, one that “constructs the findings...as a builder who 
constructs a house” (Willig, 2013). Rigour in this study refers to reliability in the care 
taken in the application of the research, in a reflexive open process, and also 
acknowledges that “interviewing is a social interaction” that includes ethics, 
accountability, and openness about the research process (Davies & Dodd, 2002, 
p.286).  
 
Member checking and triangulation are two techniques suggested to be suitable for 
qualitative studies conducted within a realist rather than interpretivist framework 
(Braun & Clarke, 2013). Therefore, this study utilised Braun and Clarke’s 15-point 
checklist of criteria for good thematic analysis (see Appendix 8).  In addition, 
Yardley’s quality principles are indicated as appropriate for studies adopting different 
frameworks that are “open and flexible” (Braun & Clarke, 2013, p. 289). Yardley’s 
criteria (2000, 2008), with an explanation of how these were achieved, are described 
in Table 4.6: 
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Table 4.6. Yardley’s quality principles 
Principle How achieved 
Sensitivity to context Being sensitive to participants’ experiences and how 
their sociocultural context shapes accounts  
 
Being sensitive to ethical issues, and not impose 
researcher’s meaning to the data 
Commitment and rigour In-depth engagement with the topic 
 




Transparency of how data were collected and 
presentation of data extracts 
 
Reflexivity through how researcher shaped the 
research 
 
Description of interpretation of data 
Impact and importance Practical impact for a particular group  
 
Sociocultural impact through contributing to positive 
social change 
Yardley’s quality principles adapted from Braun & Clarke (2013) 
 
4.8 Ethical issues  
The research protocol was reviewed by the Lancaster University (LU) Faculty of 
Health and Medicine Research Ethics Committee (FHMREC) and approved by the LU 
University Research Ethics Committee (UREC). A letter from the Washington State 
Hospice and Palliative Care Organization participating in recruitment of participants 
was also included in the ethics application to demonstrate support and cooperation 
with this research (Appendix 9).  
 
Ethical concerns are a key component of this research and go beyond the boundaries 
of standard guidelines. Charmaz (2004) suggests that the emerging ethics of 
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qualitative inquiry requires the need to tolerate ambiguity where general ethical 
guidelines would not be appropriate. All ethical considerations were brought to my 
Lancaster academic advisors for consultation as the research progressed.  Despite 
early concerns, there were no disclosures of participation in illegal activities or 
concerns about the safety of the lives, or deaths, of individuals that required a report 
to local authorities. However, the boundaries of what is considered ethical was a 
constant theme throughout this study, given that participants shared stories about 
being asked to participate in or discuss an experience they may have considered 
unethical. How the participants expressed their approach to ethical values and 
behaviours within interviews, and how they are in dialogue about the story of this 
experience, is at the heart of this research. If there was any doubt about ethical 
issues raised by participants, I discussed this with my academic advisors and with a 
skilled psychotherapist familiar with qualitative research on sensitive topics in the 
United States. As a researcher and as a licensed social worker, I am required to abide 
by a code of ethics that includes protecting participants’ anonymity and 
confidentiality and protecting participants and those they serve from harm 
(N.A.S.W., 2008).  However, I have an ethical responsibility to report to the 
authorities if a participant had reported information about being at risk of causing 
harm to another (DiCicco‐Bloom & Crabtree, 2006; N.A.S.W., 2008), though this 
course of action proved unnecessary.  
 
Rosenblatt highlighted some of the significant ethical issues experienced by bereaved 
families that has relevance to this study, which includes professionals who may be 
grieving both personally and professionally (Rosenblatt, 1995). Some of the issues 
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include considering how and what participants view as ethical, the importance of 
recognising the boundaries between therapy and research, and being prepared to 
co-construct “a set of ethical guidelines as the interview unfolds” (Rosenblatt, 1995, 
p. 155). 
 
Confidentiality and anonymity was maintained by restricting information about 
participants such as if they worked in urban or rural locations and the type of 
organisation they worked for. Contact information about participants who consented 
to participate in the study was kept in a secure locked file until the research was 
completed. Participants were informed that if they disclosed information about risk 
of harm to themselves or others, that I had a duty to report, as discussed below in 
the following section.  
 
4.9 Informed consent 
Informed consent is a process of ensuring that participants in this research have the 
right to be informed about the research, and that they agree to voluntarily 
participate without coercion (Denzin & Lincoln, 2011; Ritchie & Lewis, 2012).  
Participants being interviewed by phone were sent a research consent form 
(Appendix 10) to review, sign, and return to the researcher via fax, post, or scanned 
and sent in email prior to beginning the interview. Participants were asked to review 
and sign the research consent form prior to beginning face-to-face interviews.  No 
participants declined participation after initial consent. At consent, participants were 
made aware of the possibility that the interview might cause some distress. 
Participants were reminded that they had the option of removing themselves from 
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the study and stopping the interview at any time. The consent form also included an 
item covering the eventuality that participants would request a follow-up interview. 
The consent form included a statement that there may be limitations to 
confidentiality if there was concern the participant may be at risk of harm to 
themselves or others.   
 
4.10 Risk of harm to participants 
There was minimal risk of physical harm related to participation in this research 
study. There was some risk that participants might experience emotional distress due 
to the sensitive and emotionally provocative nature of recalling distressing 
experiences about dying, death, and suicide (Ritchie & Lewis, 2012).  Distress was 
minimised with an empathetic and sensitive approach to questions and a reminder 
to the participant that all their responses are voluntary. Rosenblatt suggests that 
good interview skills on sensitive topics require empathy where research and 
therapeutic boundaries are unclear (Rosenblatt, 1995). Participation in this research 
may have been therapeutic because of the participant having the opportunity to 
discuss the topic, but “therapeutic intervention” was avoided (Ritchie & Lewis, 2012; 
Rosenblatt, 1995, p. 155). To minimise risk, participants were offered an opportunity 
to debrief after completion of the interviews and were provided with details of 
where and how to access additional support as needed.  Participants were offered 
information about counselling and support in the beginning and at the end of the 
interview. Finally, participants were informed that they could withdraw from the 
study at any time before or during the interview and up to two weeks following 
completion of the interview.    
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4.11 Risk of harm to researcher 
Ritchie and Lewis (2012) recommend arrangements need to be made to minimise 
any possible risk to the researcher. It was anticipated that ambiguous ethical issues 
might arise in the process of the research that may require consultation with 
supervisors and obtaining additional information before continuing.   
 
To minimise personal risks to myself as a researcher, I maintained a relationship 
throughout the process of this research with a therapeutic mentor, who is also a 
psychotherapist skilled in qualitative research on sensitive topics. The role of the 
mentor was to be available to me for counselling on any personal issues that may 
arise because of this research. The mentor did not have access to any of the research 
data and was not provided with any information about participants.  The mentor was 
available to help me maintain emotional well-being through this process. 
 
4.12 Ethical data management 
As a researcher, I am responsible for protecting the anonymity and confidentiality of 
participants (Bryman, 2012). To comply with the need for anonymity, participants 
were informed that all names and identifying features would be removed from the 
transcripts and a code assigned to them (Ritchie & Lewis, 2012).  I maintained a list of 
these codes with the participants’ names that will be destroyed after awarding of the 
PhD by Lancaster University. This coded list with names of the participants, notes, 
recordings, and transcriptions and any other materials that might identify the 
participant in any way, are kept in a secure locked cabinet in a secured research 
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office in my home in the United States. Participants' contact information will be kept 
in an encrypted computer file that only the researcher can access.   
 
The interviews were recorded on a device that allows direct encryption to take place. 
The data were transferred to the computer after transcription, and then archived on 
encrypted files. Any data emailed to my supervisors was sent via an encrypted 
password-protected file. Confidentiality was maintained by using a code to identify a 
participant in comments without attributing any distinguishable characteristics 
(Ritchie & Lewis, 2012). Data obtained from the interviews will be kept securely in a 
locked cabinet for 10 years after the research has been completed. I will delete all 
the recorded and transcribed data 10 years after I have been awarded a PhD.  I will 
also destroy all information that might identify the participants including 
geographical location, gender, age, or professional background after I have been 
awarded a PhD.   
 
4.13 Dissemination  
The primary ethical issue concerning dissemination is the need to preserve 
confidentiality and anonymity of the participants.  The informed consent for 
participation in the research provided information about how participants would not 
be able to be identified in any way during the dissemination of the research. Possible 
presentations and articles limit characteristics of participants to gender and 
profession, organisations are not named but identified only by type of organisation, 
and geographic locations are limited to identification of urban or rural environments 
in eastern or western Washington. Articles and reports synthesised from the findings 
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of the research may be submitted for publications to journals and conference 
presentations. The final study will be shared with participants at their request. 
 
In this chapter, I have discussed the methodology, methods, and ethical issues 
applied to this research.  In the next two chapters, I turn to examine the themes 
identified from the findings. In Chapter Five, I examine the primary theme of how 
there is a relationship with medical aid in dying and hospice care with subthemes 
identified from within each professional group. Chapter Six examines themes 
identified from across the data set and includes issues of social justice, experiences 
of patient suicide, and interpretation of suicide within home hospice care. The 
influence of power emerges throughout the research findings and is discussed in 
more depth in Chapter Seven.  
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Introduction to the findings 
Findings are divided into two chapters (Chapters 5 and 6).  The purpose of dividing 
the findings into two chapters is to separate experiences based on professional role 
from the experiences described across the groups. The first chapter of findings, 
Chapter Five, offers an analysis of the results from experiences of each specific 
discipline and distinguishes varied experiences based on professional role. Chapter 
Six presents findings identified across disciplines, meaning that the primary theme 
and subthemes were identified across the professional groups. Table 5.1 provides an 
outline of the primary themes and subthemes identified in Chapter Five and Chapter 
Six: 
Table 5.1 Table of themes 
Chapter Themes and subthemes 
Chapter Five: 
Relationship of 
Medical Aid in Dying 
with Hospice Care 
Physicians— “there is a weight to it; that weight is crucial” 
Nurses— “It just seems like another option” 
Social workers— “creating a space; uncharted territory” 
Chaplains— “they don’t have to go to Oregon anymore” 
Chapter Six: 
Medical Aid in 
Dying, Hastened 
Death, and Suicide 







- Using medications to hasten death  
- Palliative sedation as alternative for 
DWDA: asking us to do it for them 
- Voluntary Stopping of Eating and 
Drinking 
 The blurry 
boundaries of 
suicide: 
- Suicide is a loaded word 
- Death with dignity: There isn’t a 
great word for this kind of death 
- Interpreting suicide and impact on 
work with patients 
 
A primary theme identified in the analysis of the separate disciplines in Chapter Five 
is that, despite the professional role, when asked about experiences with suicide or 
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hastened death, participants spoke of experiences with patients who utilised the 
Death with Dignity Act (DWDA). The chapter title and overall theme is called the 
relationship of hospice care with medical aid in dying, because in each professional 
group participants identified Death with Dignity (DWD) as an experience of hastened 
death or suicide despite their role or place of work. Professionals interviewed for this 
research identified a different sense of power or responsibility over the ability to 
assist or support patients who have utilised medical aid in dying. Subthemes 
examined in this chapter are identified and organized around each of the 
professional groups starting with physicians, followed by nurses, social workers, and 
chaplains. Each role is identified by a subtheme explained further in 5.1.  An 
introduction to Chapter Six provides additional explanations of the included themes 
and subthemes in that chapter.  
 
The term ‘medical aid in dying’ is used in addition to DWD in these findings chapters 
because these are terms most participants used during the time of the interviews.  
 
5.1 The relationship of medical aid in dying with hospice care 
The overall theme from within each professional group suggests that there is a 
relationship between hospice and medical aid in dying containing tension and 
challenges, that the DWDA has impacted professionals’ experiences of hastened 
death in hospice, and that home hospice and medical aid in dying are not mutually 
exclusive. Examining the experiences through the contributions made in their 
professional groups offers a clearer understanding of the professional role within the 
hospice team structure as well as their relationship with other team members, the 
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organisation, and with patients.  Themes from within each professional group are 
described in Figure 5.1. The patient (and family) at the center of each group of 
professionals also demonstrates the collaborative process between team members 
essential to focus on the patient’s goal. 
 
Figure 5.1 Themes by professional group 
 
5.1.1. Physicians— “There is a weight to it; that weight is crucial.” 
The interviews with hospice physicians suggest they have fewer direct experiences 
with hospice patients in the home than participants in other professional groups. 
Physicians spoke about providing oversight of hospice treatment teams but that they 
do also work directly with hospice patients in either face-to-face visits if a patient has 
received hospice services for over 6 months (explained in Chapter One) or in other 
positions. The following Figure 5.2 demonstrates the various professional roles 
described by participants. Physicians identified several roles in addition to serving as 
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hospice medical director such as nursing home medical director, private practice, and 
palliative care consultation in the hospital. Three of the physicians also spoke about 
serving on hospital ethics committees where experiences with patients who want to 
pursue the option of life-ending medications are often reviewed. All participants 
spoke about their attitude and experience with hospice patients around the DWDA 
and with DWD.  
 
 
Figure 5.2. Professional roles 
 
Patients receive medical aid in dying prescriptions from either their attending 
physician, who is in most cases not the hospice medical director, or they may have 
been referred to another physician if their physician is unable or unwilling to 
prescribe lethal medications. The physicians interviewed reported they are not 
currently prescribing medications; two of them due to personal reasons, one due to 
organisational policy that prohibits employees from participating in medical aid in 
dying, and the other due to the organisational policy that considers it to be a conflict 
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of roles if a physician is acting as both medical director of hospice and as a 
prescribing physician. The patient is likely to go to their physician most familiar with 
them—who in most cases will be their attending physician and not the hospice 
medical director. If their physician does not agree or cannot prescribe, they can seek 
referrals from the physician or through an advocacy organisation. Despite differences 
in experiences prescribing, physicians spoke openly about hospice patients known to 
hasten death with medical aid in dying as if it is an element of their work.  
 
Physicians made statements that under certain circumstances they could understand 
a patient’s wish to hasten death even when they did not support medical aid in 
dying.  MD2, for example, had previously written prescriptions for patients 
requesting life-ending medications but no longer prescribes because it conflicts with 
his commitment to his newly found faith-based beliefs.  Despite his current personal 
opposition to the DWDA, MD2 acknowledged the legitimacy of patient’s wish to 
hasten death: 
 
“...it is about control, ... and I don’t disagree at all philosophically with people 
who want to control their end of life, the timing and so on.” MD2 
 
All the physicians interviewed in the study expressed some degree of moral conflict 
with the DWDA. Some described previous experiences prescribing DWDA 
medications but not in their current positions as hospice medical director.  MD3, 
however, indicated that education about and provision of home-based hospice 
services contributed to decreased requests for life-ending medications. Another 
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physician said that with hospice care, patients have more resources to help them 
cope with the range of emotions and experiences that might come with the dying 
process. Despite differences, the physicians suggest that a sense of responsibility and 
power that comes with being a physician that places them in a position that is 
different from other professionals. Both MD3 and MD1, who work in different 
institutions, in different parts of the state, suggest that decisions that contribute to a 
hastened death even when they do not administer the dose of medications or 
withdraw life support, where they feel they have the power of life and death, do not 
come easily: 
 
“Terrible to be asked and you know... there is such a desire to be a fixer when 
you are a doctor...it makes you question yourself. And it also feels like an 
honor if you know the person … well enough to be confident that they are 
making a really well considered choice…but the first time someone ended 
their life with a prescription...it was a big moment.… I wrote a prescription 
and this person is now dead. And I won’t say that I didn’t feel guilty, and there 
is a jumble to it...there is a weight to it [but] I think that weight is crucial and 
we have that weight every time…” MD3 
 
“And when you are the one writing the prescription that is a big 
responsibility…and when I have withdrawn supports for patients who have 
died, it was totally the right thing to do, it was still very tough...MD1 
 
The sense of weight with the decision to prescribe life-ending medication is 
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suggested to be crucial.  It is as if writing a prescription might not be taken seriously 
without this added weighted-ness. The physician does not take the patients’ request 
for assistance to die and make the decision to help them easily or lightly. The ‘big 
moment’ making the decision to aid a patient’s request to hasten death requires a 
constant questioning about what is right, and what is ‘well considered’. It takes time, 
and perhaps a sense of intimacy to know the patient well enough to feel confident 
the right decision has been made; a decision that they can live with based on 
personal values or beliefs.   There is a sense that the physicians question if they did 
enough to help the patient who has died, whether it is through medical aid in dying, 
withdrawal of life support, or other cause. Some of these experiences physicians 
suggest DWD may be heavier than other decisions, such as withdrawal of life support 
even when the patient is self-administering the medications independently and in 
their own time.  
 
Physicians expressed feelings of increased confidence when patients are receiving 
home hospice care, possibly because of the team members’ observations when 
visiting patients several times weekly in the home or nursing home setting. 
Physicians suggest there is a difference between patients in home hospice and 
patients requesting DWD in the hospital.  MD3 suggests that hospice and palliative 
care minimises requests for DWD:  
 
“...sometimes people in the hospital are suffering so much they are looking for 
any way out, so when patients are asking me for Death with Dignity in the 
hospital, when they learn about hospice they are not interested in Death with 
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Dignity anymore ... the vast majority of my patients around Death with 
Dignity are ok and understand that on hospice if ‘my pain becomes so severe 
medication may be given that I don’t have to do that’ then the vast majority 
of people back down from Death with Dignity.” MD3 
 
Two physicians suggested that one reason they don’t prescribe life-ending 
medications is because they live and work in rural communities and they would not 
want to be targeted as the ‘DWDA doctor’. This again implies feelings of burden and 
responsibility with making these crucial life and death decisions. Both MD2 and MD4 
describe the dilemma of isolation if they were to prescribe life-ending medication. 
The law places physicians in a precarious position of power and vulnerability, 
especially if they are isolated: 
 
“Too much power…One, I’m isolated, and two, is at the end of the day, when 
we take away everything, I don’t want to be a part of it.... you take away 
palliative care, you take away the knowledge of medicine, you strip it down to 
the basics. I don’t want to hand someone a loaded gun. Go shop for your own 
gun. Buy it yourself...I can understand why someone couldn’t go through the 
legal steps too...and I know people who are dying don’t have the means. And I 
like the law, but don’t make me a part of it.” MD4 
 
 “I’ll just say for me personally in a semi-rural community where I wear a lot of 
different hats, literally from day to day ... I would personally have to be very 




Both MD4 and MD2 express conflict with prescribing life-ending medications. 
Palliative care is indicated by MD4 as being the ‘knowledge of medicine’, implying 
that medicine is not about hastening death, but about comfort and allowing a natural 
process. MD4 conveys that writing a lethal prescription is akin to purchasing a gun 
for a patient and can better live with the patient's death by suicide without assisting 
in any way.  MD4 reflects what other physicians expressed, that they are supportive 
of the law, but don’t feel able to participate as a prescriber because they might be 
targeted by members of their community. In the process of the interview, however, 
MD3 realised the importance of taking an open stance in support of medical aid in 
dying: 
 
 “...usually I am talking about it with hospice colleagues where we are all very 
accepting of it as a right...but it’s reminding me that there is a whole lot of 
people out there that think it’s immoral or wrong... it is something that 
belongs in our community, the ability to use the Death with Dignity law, but 
there are lots of places where it is a super-hot topic, and we are not allowed 
to talk about it...” MD3 
 
Overall, physicians’ experiences suggest that there are emotional, professional, and 
ethical challenges that come with being a professional responsible for DWD even 
when they are not the physician who prescribes the medication.   The ‘weight’ or 
burden associated with caring for patients who seek DWD indicates a sense of 
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unwanted power that comes with a death considered to be unnatural or hastened.  
5.1.2 Nurses— “It just seems like another option.” 
Overall nurses’ stories indicated that they view medical aid in dying as another 
option for patients facing end of life despite some who have personal or moral 
conflict with the law. Nurses’ stories, however, suggest that there is a relationship 
with hospice even when a patient’s choice may conflict with their own personal 
beliefs. This may be attributed to the ability of hospice nurses to focus on the 
patient’s goal more easily when the care setting is in the patient’s home. This 
relationship is demonstrated in the quotes of two nurses: 
 
 “... she approached us about it and we explained she needed to talk to her 
doctor about the actual mechanics, getting the medications and go through 
all the legal hoops that had to be done... and she had a chance to say 
goodbye... thank ... and talk to people and things she had on her mind. She 
was able to do that life work.” RN7 
 
  “I have to say, well, I can tell you what the medications are, and the way you 
take the medications, but I really need you to talk to [social worker] about it. 
First you take the Reglan4, you know, and then you take the ondansetron5, 
                                                     
4 Reglan is a brand name for metoclopramide, a medication used to treat 
gastroesophageal reflux disease 
(https://www.fda.gov/downloads/Drugs/DrugSafety/UCM176362.pdf) 




and then you wait half an hour, and then you mix the secobarbitol, we tell 
them to mix it with a little vodka...” RN6 
 
RN7 and RN6 are employed in different organisations in different parts of the state. 
The nurses spoke openly about their understanding of the DWDA process in both 
stories. RN6 suggests that when asked by patients she feels some limitations about 
what she can share because the organisation identifies a specific professional to 
assess and work with patients requesting DWDA. Yet she felt able to share the 
practicalities of the process when asked.  RN7, on the other hand, who works with an 
organisation considered non-participating, did not explain the process, but 
supported the patient’s option.  Both nurses indicated they worked consistently to 
support patients’ wishes even if the wish is to use the DWDA.   
 
Nurses' stories imply that the relationship of hospice to DWDA is enhanced by the 
intimacy of the connection between nurses and patients when patients are seen in 
their own homes. This intimacy is described particularly in rural communities where 
patients and hospice professionals are often familiar with each other especially if 
they live and work in the same area.  RN1, who had difficulties accepting the 
patient's choice, said that another staff person was related to the patient, which is 
not unusual in rural areas where few staff are available to serve the community: 
 
“...Not sure I agreed with it, … I want to be supportive of patients…in their 
choices, but first I was uncomfortable with it ... I went back and spoke to my 
administrator about this. … who was a great support … and in this situation, 
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the whole family was on board. As her disease progressed … she had a lot of 
nausea and couldn’t eat very well ….”  RN1 
 
RN1 faced a dilemma evoking a sense of power and responsibility, like participants 
from other disciplines, to support the patient’s decision to utilise medical aid in 
dying. Assistance from the administrator helped to alleviate her discomfort; 
however, this leads one to question how she might have proceeded if she did not 
feel she could continue to work with the patient. These types of ethical dilemmas are 
not limited to medical aid in dying in more rural communities. Nurses, like other 
professionals in this study, are often told by their employers that they can refuse to 
work with patients who choose to take DWDA medications if it conflicts with 
personal beliefs. But participants interviewed said they would be with and care for a 
patient even if they did not agree with the patient's decision to ingest life-ending 
medication.  
 
RN3, who is employed at an organisation that discourages professionals from being 
involved in the DWDA process, told a story of a patient she had known many years. 
Her experience with this patient suffering from a prolonged dying process, suggested 
an intimacy in the relationship that developed from consistent weekly visits in the 
patient’s home. While the organisational policy discouraged this nurse from being 
involved in the DWDA process, her supervisors supported her when it appeared to be 
in the best interest of the patient: 
 
“I have…. been present for two of many DWD deaths... company policy does 
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not want us engaged in the process, but will allow it if I am specifically asked 
... And it just seemed ...appropriate that she would be asking me to be there 
to make sure everything would be ok from a nursing perspective... It was 
great ... And she died ... And I let my supervisor know about her dying process 
and I felt that it appropriately made sense that I be there.”  RN3 
 
Participants were often surprised at how some of the deaths were, in fact, 
celebratory. It is as if the decision to control timing of death allowed an opportunity 
to face the reality of death and avoid a prolonged dying process.  RN2 remarked that 
speaking of being happy for someone about this experience might be considered 
‘weird’ but also senses a shift in attitude as medical aid in dying becomes understood 
as an option at end of life rather than something to fear: 
  
“I’ve cared for several patients who then went on to use their prescription...I 
have not heard of any bad experiences… yeah it just doesn’t seem so 
unsettling to me anymore … it just seems like another option ... one patient 
literally died with a smile on his face.  He just had this wonderful interaction 
with everyone he loved and how amazing that he had that experience of 
knowing what people would have said after he was gone…I know that might 
sound weird, but I was happy for him.”  RN2 
 
Both RN5 and RN6 expressed conflicted feelings about some experiences with 
patients who died with DWDA: 
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“I have mixed feelings about it. Because I have seen that we can give people 
quality of life at the end and it gives them the opportunity to resolve life 
stresses ... I don’t know for this man if it ever would have happened. I mean he 
didn’t even tell his siblings that he was dying. He didn’t know how to tell 
them. Dying on hospice can make death a beautiful experience.”  RN5 
 
RN5 implied that a natural death on hospice can be beautiful, allowing for time to say 
goodbye and communicate with family members.  This suggests that some DWDA 
deaths may be avoided by patients, depending on the circumstances of the 
individual.  RN6 expressed emotional distress when supporting one of her patient’s 
decisions to control timing of death through DWDA: 
 
“... it was hard to see him, all of his family surrounding him, he wanted me to 
come to confirm death after he had taken the meds, which I did.  But one 
minute I was talking to him and having a very deep conversation and then he 
was gone ... I have the feeling that Death with Dignity is like a C-section for 
the convenience of the doctor and ... the patient, you know, I’m going to have 
this planned delivery so I know exactly what time I’m going to deliver and 
know exactly what day, so that it doesn’t interfere with my life ... and so, to 
keep it clean.  That kind of bothers me. There should be some mystery to life.” 
RN6 
 
The ‘scheduled C-section’, as stated by RN6, dismisses the possibility that the ‘labour’ 
of the dying experience might offer something beneficial even though it might be 
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difficult and painful.  Control over the timing of death is associated with the loss of 
the mystery of this dying time, which may be important for those with faith-based or 
spiritual beliefs who regard suffering as a part of life and death. It is as if they miss an 
opportunity to experience the process of dying that may be just as much about living.  
Despite the conflicted feelings about patients who seek DWDA, both RN5 and RN6 
continued to support their patients’ wishes. RN6 developed a relationship with the 
patient who could trust that she would be present to confirm death if he chose 
DWDA. RN6 witnessed not only the death but also experienced the process of caring 
for the patient while he was dying in the intimacy of his own home.  
 
The following experience of RN7 is an example of how some participants described 
patients concerned that they needed to keep the intention to pursue DWD from the 
hospice team members: 
 
“I think we had him on for a couple months ... and at first they didn’t tell us 
that they were thinking about Death with Dignity. I think they were afraid that 
we were going to be negative about it ... So they were relieved to discover 
that we weren’t going to stop them or shame them but that we were just 
going to be supportive. He actually did not even let us know when he was 
going to do it. He just one evening said I am done, and took the medications 
and afterwards the wife called the hospice nurse.” RN7 
 
The experience of RN7 signifies that while professionals may support the patients’ 
wishes, there remains stigma and fear associated with medical aid in dying. A sense 
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of shame may have prevented the patient from initially sharing his intentions. The 
patient’s sense of relief that they could be honest about their plan to pursue DWDA 
may have increased the ability of team members to address his overall well-being. He 
could then speak openly about his concerns and trust team members to ease 
symptoms associated with the illness. His choice to control timing of death was not 
mutually exclusive from care given by the hospice team even though they may not 
have been present at the moment of death.  
 
Nurses and other professionals spoke about patients accepting hospice services only 
because it was recommended by a DWDA advocacy organisation.  RN2 spoke about a 
woman who was initially reluctant to accept home hospice services because she did 
not want involvement of hospice team members when she took the medications. 
RN2 said she was employed in a hospice organization allowing professionals to be 
present at time of death from DWD and speak openly about the option: 
  
“...And she told us right off the bat when she signed up for hospice that she 
had already signed up with death with dignity and already gone through all of 
the steps with getting a doctor and then another doctor to sign off on it 
and…she actually had the prescription in her home... but later she made the 
decision to take the medication... and then we got a call from her family who 
said that it was very peaceful... and she just nodded off and stopped 
breathing.  It was incredibly low key and non-traumatizing for everyone.”  RN2 
 
The ‘low key’ approach described above, suggests that the impact of the death was 
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not much different from the anticipated deaths of other hospice patients; that DWD 
is one of several options a patient might pursue within the context of their life and 
death. RN4, who worked for a Catholic organization, shared a story about another 
female patient:  
 
…I came to do the hospice admission in the home after she had just met …to 
be prescribed Death with Dignity medications…she, and her family, had come 
to peace with the fact that she didn’t want to live like this anymore. And we 
have a policy at our organization...we are not allowed to discuss these options 
with our patients.  And in this situation the patient was already educated 
about all of it so there wasn’t anything that I would have told her that would 
have violated the policy…I explained to her that hospice care could still come 
and be involved with her end-of-life care, but that we would not be allowed to 
be in the home with her at that time she chose to take the medications, but 
that we could be on call...And the family understood that…so I know that she 
had gotten to make her choice…RN4 
 
Patients appeared to choose hospice secondary to their decision to pursue DWD in 
both stories told by RN4 and RN2. The nurses worked for organisations with different 
policies about participation with medical aid in dying. Both patients accepted hospice 
services, and both ingested the medications without the presence of hospice 
professionals.    The nurses had no personal conflict with the patient's choice but the 
policy of RN4’s employer influenced the degree to which she could educate her 
patient about legal options. The differences in employers’ practices suggest that 
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professionals may be influenced by policy but also demonstrates how medical aid in 
dying is integrated into their care despite the policy. Organisational policy often 
indicates that hospice is distinguished from aid in dying (discussed in the next 
section), but participants suggest that when patients are aware of and pursue the 
option of medical aid in dying it cannot be ignored as part of their care.  
5.1.3 Social workers— “Creating a space; uncharted territory.” 
The social workers interviewed had various perspectives on how the relationship of 
medical aid in dying is integrated with hospice, but all responded with stories about 
their experiences with the DWDA. Social workers, like those in other disciplines, 
often described themselves as advocates for patients’ options even when the option 
was about seeking DWD:   
 
 “In hospice, a lot of times it is just about being there and listening to the 
person and creating a space for them... I thought that this was a very difficult 
thing that she was going through and you know I was going to be there for 
her as much as I could within my role.” MSW3 
 
MSW3 above described her experience providing counselling for the patient as she 
went through the DWDA process in a way that she may have described working with 
other patients facing a natural death. The social worker said her role was limited by 
organisational policy regarding her ability to educate and inform about the DWDA 
process. When the patient made the decision to pursue DWD, the social worker 
‘created a space’ to allow the patient to control timing of death and continue to 
receive the support from hospice professionals. However, social workers may feel 
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limited by their positions depending on where they are employed. 
 
The following comments demonstrate how social workers in different hospice 
organizations might advocate for or be with patients who die utilising DWD. MSW5 
voiced that where she works, social workers have an integral role educating patients 
about options; however, MSW7 reports limitations: 
 
 “...especially the social workers are tasked with helping the patients deal with 
the timeline, and written requirements. ... in general, that is the one way of 
guaranteeing that peaceful death ... Death with Dignity. And I have been 
really blessed to be with ... patients during that process ... and get to 
experience that type of death versus one where you are waiting, you are doing 
the vigil, or like the sudden death...” MSW5 
 
 “We can help them ... What we can’t do is we can’t sit with them ... while they 
take the pills. We can be there before and after...and we have been...” MSW7 
 
MSW7 put forward that there are times when they can be present and times when 
they cannot, but that most professionals work with the patient regardless of their 
choice.  MSW7 understood that the guidelines of her organisation only allowed her 
to be present before and after but not during the time the patient ingests the 
medication. The law does not prohibit any professional from being present. How 
social workers and other professionals provide education, counselling, and support 
may depend on their employer. 
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The contradiction of the DWDA as being both separate yet integrated into hospice 
care was prevalent among professionals who seemed to struggle to make sense of 
policies that did not conform to their own personal or professional ethical standards:  
 
“I find the intersection between Death with Dignity and hospice really 
interesting because we are trying to keep them very distinct programs, ... but 
the reality is ... that most people that are doing Death with Dignity are on 
hospice.... This is uncharted territory for the culture....” MSW1   
 
MSW1 offers that most people who request DWD are receiving hospice services even 
though the organisation she works for identifies a separate program for patients 
pursuing DWD. MSW1 continued to work with the family members coping with the 
grief from what she described as ‘uncharted territory’.  Even when it is suggested 
that DWD is considered ‘separate’ from hospice, the relationship between the 
professionals working with the patient and family continues. Most social workers and 
nurses interviewed, however, said they were prohibited from bringing up the option 
of DWD unless the patient initiated the discussion.  The ‘uncharted territory’ MSW1 
refers to may mean that as professionals have more experiences, they and the 
organisations they work for map out clearer guidelines as they find their way.  
 
Social workers who work for Catholic organisations that publicly oppose the DWDA 
imply that professionals do, in fact, work directly with patients who pursue medical 
aid in dying. The following comments from social workers that work for two different 
Catholic organisations indicate that professionals having open conversations with 
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patients about DWDA may be impacted by these policies, but continue to work 
openly with patients throughout the dying process. Social workers infer that as more 
patients die with DWD, organisational policy is shifting toward supporting patients’ 
wishes:   
 
“Well, personally...I love that I live in a Death with Dignity State......that is my 
own personal belief system being able to choose how you die, and I work for 
an agency ...that publicly opposes Death with Dignity, and doesn’t participate 
with Death with Dignity...we actually have a reputation in the community of 
being dismissive of patients and not supporting them... she took the 
medications to end her life... I was able to be a part of her end-of-life 
experience ... but I also did it as an employee ... I’m assuming it would have 
been different if I worked for a participating organisation ...” MSW2  
 
MSW2 expressed her own views that the organisation she works for has a reputation 
of being dismissive of patients who pursue DWD and she has found herself struggling 
to support the patient as part of her role as a hospice social worker. How much 
MSW2 felt she could communicate with her patient about DWD is vague but she 
provided counsel within her role to support patient goals. MSW2 suggests that if she 
worked for a participating organisation she would not have had to be concerned 
about the reputation of her employer as unsupportive of patients' options and policy 
would have allowed her to be present at time of her patient’s planned death. Other 
comments, however, indicate that as medical aid in dying becomes an option familiar 
to patients, policies are shifting: 
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“I think that now they are realising how crazy making our policy is and they 
are revisiting it to make it easier for us to deal with because it is...how do you 
give emotional support and yet then if they talk about doing the act are you 
going to stop giving them emotional support around that?   It’s not really 
possible to be supportive of a person, you are either supportive of a person 
and are there in their corner, or are being judgmental, like a parent...”  MSW3 
 
“...For me it is a fine line of following the policies but also wanting to do what I 
can to support my patient in investigating this.” MSW6 
 
These comments from social workers indicate their roles are blurry when it comes to 
how they support a patient who pursues medical aid in dying. MSW3 implies that her 
employer policy is patronising, which parallels reports of other organisations that 
also have a reputation of being dismissive of DWD.  The conflicts between 
organisational policy and professional role present increased challenges when the 
professional believes their role is to support the patients’ choice.  MSW3 and MSW6 
indicate that their positions as social workers are compromised when they feel their 
professional role conflicts with policy and might cost them their job. This may 
contribute to their feelings of powerlessness to support the patient’s goal, or, 
alternately, asserting power by interpreting policy or practice in ways they believe 
are right. As MSW6 suggests, it is treading a ‘fine line’ between the organisation and 
the patient’s wishes. Social workers, however, demonstrate differences in how they 
might be influenced by policies and work with patients who pursue DWD: 
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“every single one of them [social workers and chaplains] has been at the 
bedside and felt honoured and....there have been celebrations prior to them 
utilising the medications, quiet moments....” MSW5  
 
“I am not allowed to support Death with Dignity, my organisation has told me 
that. I have absolutely, legally, professionally, no need to know what the law 
is...I’m not allowed to support it...If they want me to be trained in it in my job, 
they will train me in it ... MSW3 
 
MSW5, who works in what is considered a participating organisation, mentions 
overall positive experiences working with patients who have pursued DWD. MSW3, 
however, voiced that if she is told that she has no need to know about the law then 
she cannot counsel openly about the DWDA process and alternatives that might help 
the patient.  This suggests that organisations that regard the DWDA as separate from 
hospice care cause confusion and blur the boundaries about their role when a 
patient might ask for information about the DWDA options. In the following 
comment, MSW4 sought her own education about the DWDA. After speaking with 
the director of an advocacy program, she returned to her work cautious about her 
support for the DWDA:  
 
“And after talking with the medical director for [Death with Dignity advocacy 
organisation] ... I would say my impression after seeing the work that we as 
hospice practitioners do, including the options that encompass palliative 
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sedation, that patients who are in distress can be treated with dignity and 
comfort in most scenarios...” MSW4 
 
Hospice care, as MSW4 suggests, may have the care needed to avoid medical aid in 
dying and implies that alternatives such as palliative sedation may seem to be more 
acceptable when a patients’ dignity or comfort are compromised.   
5.1.4 Chaplains— “They don’t have to go to Oregon anymore.” 
The three chaplains interviewed for this study all told stories about experiences with 
hospice patients who died with medical aid in dying. Stories were shared that 
demonstrated an intimacy with patients’ experiences and support for patients’ 
choices similar to the experiences of nurses and social workers. CH3 described 
experiences with patients who have hastened their deaths: 
 
“...They used to say, well, I have to move to Oregon.  Well, they don’t have to 
move to Oregon anymore. And so, for religious people who might be 
considering hastening, it is a double whammy. As for non-religious people, ‘it’s 
like, hey, my life sucks, it’s not worth it, but I don’t want to hurt my family.” 
CH3 
 
CH3 suggests medical aid in dying may be more difficult for family members to 
accept if the patient or their family is religious. It is as if the pain from this type of 
loss is doubled when a patient dies from an intentional hastened death. The pain of 
going against religious beliefs and the knowledge that their death could hurt family 
members causes patients to consider other options. A contradiction remains 
 119 
between what is acceptable for religious people and what is possible with DWDA. 
CH3 summarized this contradiction with a story about how his own views shifted 
when someone he had known died using medical aid in dying: 
 
“...I might have done the same thing in his circumstance...I understand 
completely why he did it, the integrity with which he approached his decision 
and the way he involved his family... his dying made it extremely real.  And I 
sat with a lot of dead bodies, ...watched them die and go from life to death ... 
So, I have...a real strong sense of that...but still to have this deliberate 
purposefulness, was a [most] sobering thing that I’ve ever experienced ...CH3   
 
CH3 recounts how his personal experience created a shift in attitude about what 
might be acceptable. The ‘sobering’ thing suggests he might not have thought he 
could accept a ‘deliberate purposeful’ control over the timing of death.  This shift in 
thinking emerged as a thread throughout this study. After most personal and 
professional experiences, professionals interviewed come to a greater acceptance of 
patients’ need for autonomy and respect for what it might mean to suffer, even 
when they feel professionally or personally opposed to the DWDA. CH1 summarised 
the intimacy of the experience meeting with patients in their homes that might be 
different than in clinical settings: 
 
 “...also, it is important to know that some boundaries have to be very flexible 
because of the nature of the work. It is like no other work…we are inside 
people’s homes. And it is not just coming in … Bing, 50 minutes … got to go … I 
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mean I could spend hours with people.”  CH1 
 
The nature of working with patients in their own environments, as CH1 indicated, 
requires professionals to be flexible with both their own personal views, and their 
time. CH2 spoke of the contradiction among religious staff who might be opposed to 
medical aid in dying yet continue to support and have been present with patients 
while they go through the process of ingesting the medications.  
 
“It’s not a policy that is written that you can’t do this.... you know... unspoken 
rules that run organizations. Where they expect you to go in and tie it up with 
a bow and make them feel better.  And make them say a nice prayer to close 
it up....We need to make space for talking about these issues.“ CH2 
 
CH2 expressed how, as a chaplain, assumptions are often made about beliefs. There 
are what is considered ‘unspoken’ rules or expectations about professional roles and 
responsibilities. CH2 also implied that policy might be covert and that there are 
assumptions about the chaplain role. Chaplains demonstrate that despite 
expectations from others they also have power and a sense of responsibility in their 
role to work in coordination with, but independent from, these unspoken rules.  
 
Professionals of all disciplines suggest that they work autonomously from others 
when working in the home and that there is frequently an overlapping of roles. CH1 
demonstrated professional autonomy with her stories of support for patients who 
hastened death: 
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“When I am with a patient it is my experience with a patient.  I don’t really 
have a sense of the organization when I am doing my work…do you know 
what I mean? ...when you are out in the field you are out by yourself, so 
nobody is going to know about my conversation ...”  CH1 
 
CH1, who did not work for a religious institution, made the comment above in 
response to a question about organisational policy regarding medical aid in dying. 
This comment implies a sense of autonomy in her work independent of the 
organisational policy that suggests a separation of the DWDA from hospice. This 
sense of autonomy was conveyed by many of the other professionals who described 
driving from one visit to another serving patients in the patient's home setting. The 
home appears to offer a place where patients might feel they can have more honest 
conversations with professionals around life and death issues than they would in a 
more clinical environment.  
 
5.2 Conclusion 
Participants across all professions interviewed suggest that despite conflict and 
challenges demonstrated by personal beliefs and organisational policy, that DWD is 
an option provided and supported within the context of interdisciplinary hospice 
care if and when it is a patient-initiated request.  Hospice care is not mutually 
exclusive from medical aid in dying for patients who choose it and have information, 
education, and resources about options.  The next chapter examines themes that 
emerged from across professional groups highlighting issues of suicide, culture, and 
economic disparities.  
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Introduction: Social justice and DWDA, suicide and hastened death, and the blurry 
boundaries of suicide 
The relationship of medical aid in dying to hospice care, a primary theme examined 
in the previous chapter, is only one aspect of hastened death and suicide that 
emerged from this research. This chapter, separated into three sections, examines 
themes identified across professional groups. The first overall theme of this chapter, 
social justice and the Death with Dignity Act (DWDA), is distinguished by different 
types of experiences that are impacted by the DWDA. This theme explores how 
participants from across professional groups identified challenges of the DWDA that 
are associated with the subthemes of affordability, access, and aspects of culture.  
The second theme, labelled ‘hastened death‘ and ‘suicide‘, investigates experiences 
recognised as hastened death and suicide outside of the DWDA. These experiences 
are identified in three subthemes: using medications to hasten death, using palliative 
sedation as an alternative to DWD, and voluntary stopping of eating and drinking.  
The overall theme explores how participants identify the blurry boundaries of suicide 
and distinguish suicide from a hastened death.  This theme examines challenges 
participants experienced defining suicide in a hospice context and are described in 
the following subthemes: ‘suicide is a loaded word’, ‘Death with Dignity’, and 





6.1 Social justice and DWDA— “Out of reach for a lot of our patients” 
6.1.1 Affordability 
Most participants explained that in their experience, DWD is not available to all 
hospice patients. Nurses, physicians, and social workers spoke about disparities in 
healthcare, including high cost that often prohibits patients from pursuing DWD.  
 Availability of DWD depends on patients’ ability to afford medications: 
 
“...the cost of the medication now is putting it out of reach for a lot of our 
patients...so this medication that was used early on was $280 when the Death 
with Dignity law was passed...It is now $3000.” MSW5 
 
...She has seen the two physicians and now has the prescription for the 
medications. She has not had it filled yet because it costs $1200...” MSW6 
 
The quotes from these social workers suggest that there is limited access to the 
DWDA due to the high cost of medications. They approached these challenges in the 
same way they might have advocated for patients around limited access to other 
resources: referring to the advocacy organisation for assistance and continuing to 
counsel on the conditions that led to the desire for DWD. In some cases, it was an 
emotional relief for the professional when patients died a natural death.   
 
“…the only thing I know is she was saving her money… for the medication … 
she didn’t have … it was expensive…”  RN1 
“the cost of medications for death with dignity is so high that it is a barrier for 
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so many people...” MD3 
 
These comments indicate that patients experience challenges not only through the 
process of obtaining a prescription but also by discovering unanticipated financial 
barriers. These challenges presented a conflict to some who felt in an unexpected 
position of responsibility and power over the decision to provide options to prevent 
patients from suicide. The availability and cost variability of medications prescribed 
by physicians for medical aid in dying have been explained in the background section 
2.2.  
6.1.2 Access  
Professionals from all disciplines indicate that communication about a desire for 
hastened death is common but observe that in most cases patients die a natural 
death. Concern, however, remains that some patients may hasten death or die by 
suicide when access to DWD is limited. MSW7 described a patient who tried to 
pursue DWD but could not find a physician or assistance to complete the paperwork 
for the request: 
 
“...she was in bed at the end and for months she couldn’t move well and 
people had to come to her...she kept saying... I want to do this Death with 
Dignity... She actually found it hard to not eat and drink...Wanted it over.... 
But she couldn’t do the paperwork, couldn’t go anywhere and didn’t have a 
doctor who would do it for her as well.”  MSW7 
 
In this story, the patient explored other options to hasten death, such as stopping 
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eating and drinking, and desired to have legal lethal means to hasten death. MSW7 
recalled this story among many other stories of patients who asked for assistance but 
died a natural death.  
 
It may also be difficult finding a pharmacy able or willing to fill the prescriptions. 
MSW1 described several experiences that included stories of patients having 
difficulty finding a pharmacy that had the medications to dispense:  
 
“… we had a few years of … people buying hundreds of dollars worth of drugs 
and then not using them... and then there wasn’t the drugs available for the 
next person because they couldn’t be returned.” MSW1   
 
MSW1 explains that limited supply and difficult access to medications makes it a 
challenge for anyone who wishes and is eligible to utilise the DWDA. Patients who 
don’t use dispensed medications are prohibited from returning these to the 
pharmacy, thus exacerbating the limited availability.  
6.1.3 Culture  
Several participants expressed how social and cultural inequities affect limited access 
to any healthcare options, including DWD for many patients. Medical aid in dying 
may not be a priority for patients who do not have access to general healthcare, 
including pain management and curative treatment options, because of distrust of 
the dominant biomedical system.  
 
The bioethical principle of autonomy assumed to be a societal norm in the United 
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States, and purported to be a reason why patients choose to pursue DWD, is 
challenged in stories shared by professionals about patients who may be 
undocumented, uninsured, or from the Indian Nations: 
 
“...feel like the system is screwing them instead of supporting them... the 
family wants what is best for the patient as the final goal even if there are 
drug issues with the patient or many other issues, they still do pretty good 
with caring for their loved ones ...” MD4 
 
As MD4 articulated, hospice patients she serves who are members of Indian Nations 
are unlikely to seek DWD because of distrust that they are being offered all 
healthcare options. The planning required with DWD may not succeed when the 
system that created it is distrusted as suggested by others: 
 
“the Indians don’t do that. They don’t do any preplanning and they don’t...it’s 
just something, you just don’t talk about.” RN7 
 
“There is always the sense...this fear, this distrust at first, ... and also, working 
with a lot of Native American people, you don’t want some white woman who 
looks like your basic social worker... it’s like, who is she trying to get?” CH2 
 
RN7 explains that she is familiar with members of Indian Nations who do not speak 
openly about death or anyone who has died. Communication about preplanning a 
death for oneself or another is often unacceptable.  CH2 emphasized the fear and 
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distrust, recognizing how her own role as a white professional might perpetuate the 
distrust, particularly when experiences with other professionals, such as social 
workers, might have caused trauma in the past.  
 
Participants also commented on experiences with patients of Asian heritage, 
suggesting that most would not be interested in DWD for several reasons: 
 
“It tends to be with Vietnamese patients that are Buddhist and they tend to be 
very stoic. Suffering is a part of life and you know they are very reluctant to 
take medications to decrease their symptoms ….” RN2 
 
 “Some people won’t talk about funeral home or planning until the person 
dies... in the Asian culture they just don’t do that. The Buddhists don’t because 
I feel like if they even mention it, it will bring on the death ... we don’t even 
talk about the word hospice. People are extremely uncomfortable with that, 
especially the elderly....” MSW3 
 
These comments address the challenges of communicating about most aspects of an 
anticipated death.  Both RN2 and MSW3, who describe themselves as Caucasian, 
bring their own set of belief systems about what it might mean to another to be 
‘stoic’, to have ‘suffering,’ or what might bring on a death. Their experience, 
however, demonstrates that medical aid in dying may not be a priority or even of 
interest for patients of many different ethnic or religious backgrounds.  
Cultural disparities include challenges in serving patients who may be undocumented 
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and with access to limited or no healthcare at all prior to their hospice admission:  
 
“...if you have the language barrier alone, negotiating the medical system for 
simple things ... and you are illegal ... you have no insurance and now you are 
dying ... but when you break it down to access, when you break it down to 
someone who has limited education, limited ability to get in a car and drive 
somewhere, limited ability to communicate with a doctor effectively... if you 
say, here is the packet of information, ... people who can’t read ... So they 
have so many layers of obstacles that is not really fair.” MD4 
 
MD4 suggests that providing information alone is not enough to inform and educate 
everyone about options, and an abstract concept is of little use to patients with no 
health insurance. Information alone is of little or no value when patients lack 
transportation and financial resources they need for other necessities.  Getting 
simple daily needs met is challenging for many people facing end of life. Patients may 
potentially be at risk of increased suffering that often accompanies advanced illness 
if they lack resources, making it less likely that they would utilise the DWDA. Social 
workers also commented on how information about choices is not the only obstacle 
to helping patients access different options: 
 
“Some people can’t do the paperwork...Some can’t leave the house... one 
didn’t have a doctor who would do it for her as well....”  MSW7 
 
The comment of MSW7 highlights an array of inequities that are experienced by 
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hospice patients who are vulnerable socioeconomically, live in more rural areas of 
the state, or are from diverse ethnic and cultural groups.  Patients may not be able to 
fill out the forms or have the physical capacity to get out of bed due to illness. These 
inequities—such as access to necessities including healthcare—influence how or if 
DWDA impacts their lives and options if they are facing death.  
 
6.2 Suicide 
6.2.1 Hastened death— “Using medications to commit suicide” 
Participants shared several stories about patients who were considering DWD but 
pursued alternative means to hasten death.  Both of the following stories indicate 
how discussing suicide is relevant in the discourse of experiences with DWD. Reasons 
why patients did not begin or complete the process of DWD in these stories include 
not having information about legal options or the desire or ability to follow through 
with the DWD process. In some stories, the death of the patient was entered as 
suicide on the death certificate. In other stories, the cause of death was listed as the 
disease depending on whether the death was reported as a suicide: 
 
“One very ill woman with advanced cancer took all of her comfort medicines 
in a suicide attempt...she was thinking about pursuing death with dignity, but 
she didn’t…she just took all of her meds…she ended up dying of a medicine 
overdose, and so technically it was a suicide that we had to put on her death 
certificate, but if it was a death with dignity, you put the cause of whatever 
the terminal illness was…so that’s a pretty big distinction there…It’s a fine line 
but it is a distinction.” MD1 
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The distinctive ‘fine line’ discussed by MD1 emphasises that because the death 
wasn’t within the guidelines of the DWDA and instead from an overdose of 
prescribed medications, it is called suicide. But, in the end, the patient has controlled 
timing of death in both situations. This fine line—the boundary between what is and 
is not classified as suicide—is very blurry, especially when the cause of death is not 
listed as suicide, but the professional is aware the patient used hospice medications 
to hasten death: 
 
“...a couple of incidents where patients have ended their own lives with the 
hospice prescribed medication, ... at least in one case it wasn’t someone who 
was pursuing death with dignity, and in another case, it was somebody who 
was actively pursuing the Death with Dignity law....so they used their hospice 
related medications to commit suicide.” MD3 
 
Patients may not know, however, how much medication will be effective to end life, 
and if they would suffer in the process of taking the medication.  
 
MSW5 told stories of patients who went through the process of medical aid in dying 
but then hastened death with an intentional overdose from drugs obtained illegally 
or medications saved from previous prescriptions, because of their lack of access to 
legal life-ending medications from local pharmacies: 
 
“... and everything was going along and then he got his prescription, and the 
pharmacy didn’t have his medication, saying they would have to order 
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it....and at that point in time, he was frustrated with the whole process and 
took all of his morphine and all of his Lorazepam that was in the home, and 
became unconscious and died.”  MSW5 
 
Thus, MSW5 explains that lack of access to DWDA medications was the cause of this 
patient dying of an overdose from comfort medications that were prescribed to him, 
but not prescribed for ending life. However, the death of this patient was not 
identified as a suicide by the hospice team or the coroner, another indication that 
open discussion about the patient’s death could cause additional grief for families or 
complications for the professional who may be held accountable if the death is 
deemed a suicide.  If the social worker assessed the patient for suicidal ideation and 
found them not to be at risk then they could not necessarily be held responsible; 
however, they might feel responsible for the death. In some cases, participants 
suggested that family members knew and supported a patient's intent to hasten 
death. However, all healthcare providers are required to report when patients are at 
risk of harm to themselves, which may cause some professionals to feel conflicted 
when determining and reporting risk when a patient seeks but is unable to obtain 
DWD and intentionally ends their life in another way.  
 
Participants also shared stories of patients who took an intentional overdose of 
medications years prior to the passing of the DWDA. Several of these deaths were 
not identified as suicide: 
 
“I think some of those patients took more morphine and more Lorazepam just 
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to, I wouldn’t say commit suicide, but make themselves just go out 
unconscious.” RN6 
 
RN6 thinks that patients purposefully hastened their death with hospice medications, 
and the circumstances of these deaths were not discussed openly as suicides, or 
intentionally hastened deaths. MSW1 had also experienced similar situations: 
 
“I have direct experience with a patient who took all of his medications... 
knowing that the nurse and I were coming ... And he had expired... And 
because when he was on hospice the cause of death is presumed to be the 
disease process ... it was not classified as suicide by the coroner, it was 
classified as death by disease... he was sitting upright when we found him, 
and his medications were not there, so it seems like that’s what it was, given 
what I knew about him ...it was his desire to be in control of how he died, even 
though he didn’t use a formal program that was sanctioned culturally and 
legally.” MSW1 
 
The stories of MSW1 and RN6 both indicate that patients receiving home hospice 
services have died by suicide both before and after the DWDA was implemented.  
Healthcare professionals want to support the patient to end suffering, however, it is 
as if they are put in the position of power betraying the patient if they call a death 
from intentional overdose a suicide.  Participants imply that these stories are not 
easily shared and that lack of open communication about these deaths cause added 
emotional distress. Professionals may be afraid to speak openly about suicide 
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because they feel responsible for not being able to help someone experience a 
natural death free from pain and suffering. 
6.2.2 Palliative Sedation as an alternative to DWD— “Asking us to do it for them” 
Palliative sedation was brought up by several of the participants as an alternative to 
DWD for patients who have intractable suffering. Palliative sedation is primarily 
defined by participants as being medications administered to the patient to provide 
relief from symptoms, resulting in unconsciousness:  
 
“usually patients are in facilities, hospitals” MD1 
 
“we have an excellent policy on palliative sedation…it involves an ethics 
consultation immediately, that it involves everybody involved in the case” RN4 
 
“There are probably different definitions of it... if you are giving someone a 
combination of morphine or some other combination of Lorazepam or other 
benzodiazepine you are sedating them palliatively as death approaches so I 
find that to be palliative sedation” MD2 
 
Others said that palliative sedation was unavailable in more rural areas due to lack of 
staff to administer and monitor it safely. Some participants commented that 
palliative sedation is oral medications administered by carers of patients at home in 
consultation with hospice nurses but were unaware if there is an organisational 
policy around this practice. The diversity of experiences indicates that the 
understanding or implementation of palliative sedation is inconsistent among 
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participants.   
 
MD3 points out that the high cost for a legal lethal dose of medications has become a 
bigger issue because patients who cannot afford the medications are asking for 
alternative options:   
 
“And one of the reasons why it has become a bigger issue is because the cost 
of medications for death with dignity is so high that it is a barrier for so many 
people ... that were pursuing death with dignity now, that would have it if 
they could afford it, are now asking us to do it for them so to speak...” MD3 
 
In this comment, MD3 explains that palliative sedation was offered for patients who 
could not afford or were not eligible for medical aid in dying. Participants from more 
than one organization spoke of the use of palliative sedation as an alternative to 
DWD. In the following story, MSW5 describes how patients who cannot afford the 
medical aid in dying medications could request palliative sedation through hospice 
services.  The patient felt suicide would be difficult for his family to accept and could 
not afford the DWD medications. Palliative sedation, provided by the hospice service, 
was used as an alternative for this patient:   
 
“... we had a patient who couldn’t utilise the death with dignity process, pain 
was controlled... but in his mind, there were other pieces of the pain puzzle 
that was going on...a lot of psychosocial pain... He had done the process but 
couldn’t afford the medication. And he said that he would take all of his pain 
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meds if he could do it but didn’t want to do that to his family and he was 
miserable...he asked for palliative sedation...he wanted to sleep the rest of the 
time.”  MSW5 
 
MSW5 says that the patient’s physical pain was controlled but that his mind was 
suffering despite all efforts to address his suffering. 
 
“I had a patient who had quite a bit of pain... He wanted to die in the worst 
possible way. He asked about death with dignity ... He had a history of 
depression ... but in the end because we were committed to helping to end his 
suffering he was titrated on pain medications until he was comfortable, which 
took us to palliative sedation in this case.” MSW4 
 
MSW4, employed at a different organisation from MSW5, describes a similar 
situation but where the patient would not be eligible for DWD because of his history 
of depression. In both cases, palliative sedation was used and considered an 
alternative to DWD. Hospice professionals assist in providing palliative care that 
supports and pays for medications used for palliative sedation for patients suffering 
from severe and refractory symptoms.  
6.2.3 Voluntary Stopping of Eating and Drinking  
Voluntary stopping of eating and drinking (VSED) was discussed by most participants 
as another way patients sought to hasten death. This was unrelated to access of 
DWD in most of the stories. Participants did not identify VSED as a form of suicide 
but acknowledged that hospice patients might have hastened death from days to 
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potentially several months using this method.   
 
“She said I am going to stop eating and drinking on a certain date, and she 
said I want to know that you will be there to support me, ... and the nurse 
visited at least once a day and she monitored her suffering, her grimacing, 
and she would help the husband medicate ... and I think it took about 5 days.  
And when she was gone, it was an amazing experience. We didn’t have 
support after that ...We didn’t have permission to openly ... talk about it.” 
MSW7 
 
Most of the participants from all the disciplines thought that patients who voluntarily 
stopped eating and drinking had control over their deaths. However, as indicated by 
this participant, openly communicating about patients’ choices is not always 
supported in the organisation or with other team members. Indeed, MSW7 
considered that discussing VSED was taboo within her organisation or team. 
Participants did not comment on whether there was organisational policy about 
VSED, but there might have been what has been called ‘unwritten rules’.  Staff who 
work with a patient may feel emotionally isolated from professional scrutiny, but 
support the patient's decision independently from the team, as explained by MSW4 
and MD1:  
 
“I went to see him the first time for the hospice information session. The first 
question he asked me is how would you feel about my decision to stop eating 
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and drinking. And I said well, I will respect your decision to stop eating and 
drinking and he said ok you can be my social worker.” MSW4 
 
“I remember being just a little uncomfortable ... but the bottom line is as her 
doctor I am there to support her ... in her decisions.” MD1 
 
In both of these comments the participants supported the patient's decision despite 
personal discomfort. These statements suggest less of a taboo within the team 
emphasising patients’ choice as primary.   MD1 expressed discomfort but supported 
the patient with her decision when he might not have been able to support her if she 
had chosen DWD because his employer would not likely have allowed it. 
 
 “it took her 15 days to die…she was discerning about every aspect of her life 
during this period, and she let me in and that you know, the amazing 
trust…this is what is so beautiful about this work … the level of trust that 
happens.” CH1 
 
CH1 demonstrates what most participants describe: that the intimacy of their 
experiences in home hospice promotes a trust in the relationship with the patient 
that is not easily found in the clinical setting.  
 
 “She couldn’t get death with dignity, which she really wanted. So, she decided 
to stop eating and drinking and she died within about 2 weeks.” RN6 
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RN6 suggests VSED as an alternative to DWD, and she had no conflict in supporting 
this patient’s wish.  The goal of hospice care is comfort and quality of life, and not to 
hasten death. In some stories, it is suggested that VSED is slightly more acceptable to 
professionals and within organisations than DWD or suicide, but a cultural taboo 
clearly remains if not all feel that they can speak openly about these experiences. 
Hospice professionals struggle between helping someone to live as well as they can 
until the end of their life and supporting them with their desire to control timing of 
death. But in the preceding stories, there were several statements referring to a level 
of trust patients had with the staff member and what it takes to facilitate a life facing 
illness and dying.   
 
6.3 The blurry boundaries of suicide  
6.3.1 “Suicide is a loaded word.” 
Participants presented a range of emotions when speaking about experiences with 
patients who died by suicide.  This raises questions about how an experience was 
noted as suicide and how participants defined suicide. This section examines 
participants’ interpretations of suicide, and the terms participants used when 
speaking about medical aid in dying.  
 
There is a range of uncertainty about what is considered suicide.  Participants from 




“Because suicide is a loaded word in our culture. Some people...are angry for 
not trying harder…suicide has all this religious background…technically it is 
illegal, but what are you going to do, go arrest the person after they have 
killed themselves?”  RN4 
 
Many of the professionals interviewed have the understanding that suicide is illegal 
even though this is not true in the United States (Mishara & Weisstub, 2016). RN4 
thinks that this understanding is guided by religious beliefs. It is as if the act of 
suicide is committing a crime that is only punishable in the afterlife.  
 
“Suicide is such a loaded word...such a loaded word.... Suicide.... in some 
cases, there is anger behind that, certainly hopelessness and helplessness, but 
anger as well” MSW6 
 
MSW6 believes a range of emotions influence the experiences of professionals 
communicating about suicide.  Both RN4 and MSW6 suggest that when someone 
takes their life, loved ones might experience anger because only the survivors seem 
to be the ones punished. However, professionals also indicate that they experience 
these emotions, including feelings of helplessness when patients succeed in 
hastening their own death.   
 




“That word is a huge barrier to understanding...it is a loaded word. When 
discussing the law with families or patients we do not use the word suicide for 
sure. But I don’t think it helps us to pretend that our patients aren’t actively 
taking their own lives....” MD3 
 
MD3 believes avoiding the use of the word 'suicide' makes it easier to discuss DWDA 
as an option yet acknowledges that technically it could be called suicide when 
patients are actively taking their own lives. The comments of MD3 and RN6 indicate 
that despite the use of the term 'suicide' it could be a rational decision to hasten 
death.  
 
“Suicide has all this stuff attached to it.” CH1 
 
CH1 expresses what professionals of all disciplines suggest, that strong emotions are 
attached to the word 'suicide'. Participants had a range of emotions and experiences 
indicating suicide is not easily discussed.  
 
Professionals’ interpretations of suicide highlight the problem of the blurring 
between discerning death by suicide while in hospice care from death with legal life- 
ending medications as a form of suicide. MD3 summarised what many participants of 
all professional groups expressed about these blurry lines: 
 
“... and I think the open conversation about where the blurry lines are morally 
and ethically in terms of assistance in the line between physician aid in dying 
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and euthanasia versus suicide.  I think those blurry lines should always be 
explored” MD3 
 
Having open communication for professionals to speak about the uncertainties about 
suicide and issues of hastened death is a common theme among all participants.  
6.3.2 Death with Dignity— “It isn’t a great word for this kind of death.” 
When describing experiences with patients who died with a legal lethal dose of 
medications, participants expressed difficulty using the word ‘suicide ‘: 
 
“I’ve had one patient that has actually gone through with it...who did die with 
physician assisted.... I hate to use the word suicide.... she took the medications 
to end her life.”  MSW2 
 
MSW2 did not want to use the word ‘suicide‘ when describing a patient who used 
the DWDA to hasten death. It is as if she felt an obligation to call it suicide but was 
uncomfortable describing that the patient had died in this way. In contrast, MSW7 
notes the need for more language to describe death from DWD; that different 
language makes the act of hastening death with DWD more comfortable and 
acceptable: 
 
“I wish we had more language.  I wish there was another word for it ... A word 
besides suicide.  It isn’t a great word for this kind of death.”  MSW7 
 
And RN7 goes even further, avoiding this definition altogether: 
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“I try to stay away from assisted suicide. That sounds a bit rough.” RN7 
 
Professionals interviewed all appear to agree that the language of suicide does make 
a difference, even when they might have felt the patient has the right to make the 
decision to end their life. Using the word suicide, however, has negative influences 
on other aspects of life and death, such as financial matters and life insurance. Some 
faith traditions prohibit persons who die by suicide from having certain funeral 
rituals, or from being buried in sacred ground.  An intentionally hastened death is 
taboo when it is called suicide, at least in the culture of the participants.  Use of 
different language softens the reaction and experience for those who do not feel 
suicide or hastening of death should be prohibited in all cases.  
 
Table 6.1 demonstrates that nearly all of the participants (18) interviewed identified 
the term ‘death with dignity‘ or the acronyms DWDA or DWD when describing 
experiences with patients around the legal option to request a lethal dose of 
medications to end their lives. Some participants used more than one term: 
Table 6.1. Terms used by participants 
TERMS                                                                      PARTICIPANT 
Aid in dying or medical aid in dying  
Assisted death, physician-assisted death MD1 
Assisted dying  
Assisted suicide MSW7, RN7 
Death with dignity MD1, MD3, MD4, CH1, CH2, MSW2, 
MSW3, MSW6, MSW7, RN5, RN7 
DWDA RN1, MSW1 MD4 
DWD MSW1, MSW4, MSW5, RN2, RN3, 
RN4, RN6 
Physician aid in dying MD3, MSW4 
Physician-assisted suicide, PAS CH3, MD2 
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Only two participants used the word ‘suicide‘ when describing DWD experiences with 
patients.  Two others, MSW7 and RN7, mentioned suicide but also referred to death 
with dignity when describing experiences. Only two participants, MD3 and MSW4, 
identified physician aid in dying as a term. The name of the Act is the primary 
influence of the language used by participants; however, when a participant said 
they felt morally conflicted with DWDA, they were more likely to use the term 
physician assisted suicide.  
 
The terms we use for DWD do make a difference according to most of the 
participants. When medical aid in dying is called ‘physician assisted suicide’, RN4 
considers the term itself places the burden on the physician rather than the act that 
is technically committed by the patient: 
 
“So, physician-assisted Suicide.  That bugs the shit out of me and here is why… 
it uses the word suicide …and it says physician assisted, so it puts all of the 
emphasis on the physician.  The physician isn’t the one dying…the physician 
isn’t the one making the choice ... it puts the burden on the physician. It makes 
the physician responsible.”  RN4 
 
This comment by RN4 implies that combining the word ‘physician’ with the term 
‘assisted’ is a contradiction because the physician is not assisting in the action of the 
patient ingesting the medication, and in many cases, is not present at the time of 
ingestion. RN4 challenges the physician's experience, set out in the previous chapter, 
that they have feelings of responsibility yet it is the patient causing their own death 
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when they are dying. Use of the term ‘suicide‘, coupled with the role of physician, 
conflicts with the act itself.  
 
Interpreting suicide was found to be challenging for most of the participants. Cause 
of death can sometimes be ambiguous, making it difficult to differentiate between a 
suicide death and a natural death. A continuum of experiences was described that 
might be best illustrated in Figure 6.1.  Natural death is on the left side of the arrow, 
with suicide on the far right of the arrow.  Medical aid in dying is in the middle, with 
other described causes of death on the side of suicide or the side of natural death.  
This figure suggests what many participants suggested: that boundaries between 
them are blurry. The arrow pointing up and down (the vertical axis) considers how a 
perception of medical aid in dying and some forms of hastened death are a form of 













Figure 6.1. Interpretations of hastened death and suicide 
Natural 
Death
SuicideMedical Aid in Dying 
Voluntary Stopping of 
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Palliative Sedation 
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Intentional Overdose 
Gunshot 
Self-inflicted injury  
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Death was anticipated in all the stories and interpretations of suicide and hastened 
death. How patients died, however, affected professionals based on their 
relationship with the patient, the cause of death, and the organisational system 
involved. Most of the participants explained that they referred to the social worker 
to assess patients at risk of suicide. Some of the most challenging stories were those 
shared about patients who tried to end their lives with a gun, and sometimes 
successfully did so: 
 
“He had...fear of getting into pain... so I am not sure he trusted us in hospice 
that we could mitigate pain if he got into it...he shot himself in the head. He 
left a suicide note, and apologised to his family for leaving a mess... never saw 
it coming, there was no depression notable leading up to his suicide.” MSW4 
 
MSW4 felt that the patient had not previously demonstrated suicidal ideation or 
intent. This death, like many other suicides described by professionals, caused 
emotional distress among staff, and made it difficult for them to know how to 
prevent a violent death, when their purpose is to help patients to be comfortable.  If 
the patient had been identified as a suicide risk, determining how to implement 
safety measures and mental health treatment to prevent suicide, in addition to 
treatment for physical symptoms associated with the advanced disease, may require 
hospitalisation against the patient's will. However, in the following case the risk was 
apparent: 
 
“.... And they wanted control over what was going to happen and they were 
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not going to hang around after a certain point...the family knew, the children 
knew, the wife knew... he was the one who said “You know I wouldn’t let my 
dog go through this. I feel I deserve the same.”  He went out one day on the 
lawn and killed himself so he didn’t splatter anything in the house.   I talked to 
him til the cows came home about alternate methods. But he wasn’t having 
it.”   MSW7 
 
This story shared by MSW7 indicates that both she and the family were aware of the 
patient's risk of suicide, were unable to prevent it, and were accepting of the 
patient’s decision to die. In this story, the patient lived at home in a rural setting, 
which may also be an indication of an overall lack of options, including suicide 
prevention in rural areas. But the social worker implied that despite her efforts to 
counsel the patient, there were also no structured ways to communicate and treat 
suicidal intent with other team members to prevent this violent death.  
 
“... and we had one person who attempted to shoot themselves ... That was in 
hospice in a home.  He missed.” CH3 
 
Patients who killed themselves with a gun or other violent method where cause of 
death was obvious were identified as a suicide. Participants’ reactions to these 
experiences suggest the risk of causing emotional and physical harm to others, 
including hospice staff and family members, is tremendous. Participants shared 
several traumatic stories of arriving at a patient’s home to find they had died by 
gunshot wound, and in some cases the patient had not yet died. Some of the 
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participants reported that when a patient is referred to hospice care the staff screen 
for guns in the home. If there is any indication that there are guns in the home, staff 
can request that the guns be removed to provide home hospice service to ensure 
safety for the patient, family members, and hospice staff. However, patients and 
families might still have access to guns even if they indicate there is no access to 
them or the guns are locked up.  In most of these stories, participants said they did 
not identify the patient as a suicide risk, but as patients who valued independence 
and autonomy, much like patients who might seek DWD. This raises the question of 
the difference in suicide assessment for someone who is physically healthy with a 
depressive illness from one with an advanced disease.  The stories of participants 
emphasise that despite efforts to reduce the risk of a violent death, patients still die 
violently by suicide under some circumstances such as with guns. 
 
Participants expressed feelings of conflict and powerlessness regarding needing to 
prevent suicide on the one hand, supporting patient autonomy on the other, and 
discerning suicide risk, as MSW2 explains: 
 
“You know you have to intervene if someone is suicidal, ... I will always follow 
the law ... I had a client ... very mentally ill, and terminally ill ... We made a 
plan. He did eventually die from his disease process, but that actually stuck 
with me...I said, you know, sometimes, I think people do have the right to kill 
themselves...so the law and social work values are not always in line with my 
personal values...” MSW2 
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MSW2 referred to a comprehensive suicide prevention initiative in Washington State 
that includes mandated reporting and training for professionals (Washington State 
Department of Health, 2016b). The act of suicide is not illegal but professionals are 
mandated to report to authorities if a patient is known to be a suicide risk. The 
dilemma, MSW2 notes, comes from feeling that the law regarding the need to report 
a patient at risk for suicide conflicts with her role to support patient autonomy. She 
identifies the difference between someone who would be considered suicidal due to 
depression or mental illness from someone who does not want to experience decline 
and dependence from illness.  
 
 “... hospice patients fall in another category.  I’m not going to sit here and 
make a plan for how to keep someone alive ...this is not the purpose of end-of- 
life counselling...” MSW7 
 
MSW7 points out that distinguishing a suicidal patient from a patient who seeks to 
hasten death is not so simple because hospice patients are dying anyway. Some 
social workers suggested that traditional psychiatric treatment is not available for 
patients with advanced illness: 
 
“...if somebody is so desperate and can’t go on living, who am I to stand in 
their way. You know, maybe it is hard for me if my goal is to make them more 
comfortable. Maybe if they do commit suicide or do hasten their death, I’m 
going to have to deal with that... I don’t think ethically I can stand in their 
way. I think arresting someone for trying to commit suicide is stupid. Like 
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really, like closing the barn door after the horses left. Society has to make a 
change.” RN6 
 
In the quote from RN6, she may be referring to the fact that someone who is at risk 
of harm to themselves could potentially be hospitalized against their will if they are 
determined to be suicidal. RN6 makes the point that suicide is a crime that can be 
punished, yet feels it is her duty to support her patients wishes if she feels she 
cannot help them feel more comfortable and they wish to die. Suicide is not a crime 
in the United States, but a cultural taboo persists that it is unlawful (Mishara & 
Weisstub, 2016):   
 
“I give great reverence to life and the idea of ending a life is no little thing so I 
don’t feel like I have any kind of like, strong political feelings about people’s 
rights, but I do feel like it should always give us pause to consider what is 
happening with that person and to help them ... explore all of their thoughts 
and feelings around ending their life or hastening their death ... it is no little 
thing and should be treated in that way.”  MSW6 
 
MSW6 explains that allowing patients to communicate their fears and desire to 
hasten death needs to be taken seriously and with skilful care. As she says, “it is no 
little” thing for professionals to witness countless experiences of suffering and 
patients who successfully ended their lives despite the interdisciplinary team and 
hospice support. This experience presents a conundrum for most of the participants 
who had contradictory emotional responses ranging from feelings of responsibility 
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for some deaths, to strong reactions in support of equality, patient autonomy, and 
the right to control the timing of death.  
 
RN3 summarised what many participants expressed after being interviewed for this 
study: hospice professionals feel isolated and alone and need to communicate about 
issues of suicide and hastened death:  
 
“Probably the biggest thing in the last five years is that everything has 
changed and everything is computerised and we have very little social contact 
with one another in the field so I work alone all the time and I find it isolating 
and it leaves me starved for somebody to talk about my job.” RN3 
 
There were many stories of patients who were either unable to complete the process 
of DWD and instead chose to stop eating and drinking, take an intentional overdose 
of medications, or end life with a gun. The lack of ability to provide free access to 
lethal medication, coupled with patients withholding information on their intentions 
to hasten death, would suggest professionals have limited ability or power to 
intervene. The results of this research suggest that patients receiving home hospice 
care hasten death with or without the DWDA, which is not often shared openly with 
each other.  
 
In the previous two chapters, I explained themes identified from within and across 
professional groups. During data analysis, I began to realise how much issues of 
power apply to the participants interviewed for the study and to the patients they 
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work with: people who are sick, dying, and may also be marginalised and 
disadvantaged.  In the next chapter I bring together the themes to examine theories 







Dame Cicely Saunders, founder of the modern hospice movement, was keen to 
emphasise that, “what we are doing” in hospice care, “is not managing the dying 
patients but managing terminal illness in itself in order to leave the patient as free as 
possible to manage this part of life” (Saunders, 2005, p. 96). In this statement, 
Saunders draws attention to an individual being free to manage their own experience 
of living and dying.  Care of the dying, in other words, is caring for a patient’s illness, 
not caring for their way of life and death but being with them to address spiritual, 
emotional, and physical pain, what Saunders called ‘total pain’ (see Clark, 1999). This 
statement by Saunders led me to question how palliative care professionals are 
managing illness and leaving patients free to manage their own lives.  It implies that 
professionals have power over one aspect of the individual—the illness—and are 
handing the individual power to decide how they want to live and die.  
 
Saunders is known for her clear objection to euthanasia, and in personal letters 
mentioned that it, “should be unnecessary if terminal cancer patients are properly 
cared for” (Saunders, 2005, p. 14). Saunders doesn’t clarify, however, what it means 
to be properly cared for or what might happen, as the participants in the study 
suggest, when an individual’s wishes for life and death are unavailable or 
inaccessible. Saunders recognised that the ‘wish to die’ is a wish that is not 
necessarily acted upon (2005, p.48). This research is about professionals’ experiences 
and response to patients who attempt to take control over their lives and deaths, 
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with or without assistance, but raises the question of what happens when these 
decisions are in the ‘management’ of the medical professionals and a patient feels 
powerless.  
 
This study began with the aim of understanding hospice professionals’ experiences 
with patients who have died by suicide and hastened death.  The objectives included 
gaining an understanding of how professionals identify suicide and how they discern 
between patients at risk of dying by suicide or when patients are considering utilising 
the Death with Dignity Act (DWDA). Assessing suicide risk is confusing if, as the 
results of this research suggests, the interpretation of suicide is blurry.  From a social 
constructionist point of view, a question about the language of suicide and discourse 
needs to be considered in a broader social context. In social constructionism, 
discourse theory refers to the way we think and say something, what we do, and 
what can be done to us, all of which can be attributed to the work of French 
philosopher and social theorist, Michel Foucault (Burr, 2006). Discourse, according to 
Laclau and Mouffe, can be defined as representation, as opposed to being purely 
linguistic (Van Brussel & Carpentier, 2014: Laclau & Mouffe, 1985).  Thus, if a 
professional is uncertain about what is suicide, they feel reluctant to label an 
intentionally hastened death as suicide, or if they feel the patient’s decision to 
intentionally hasten death outside of the DWDA is rational, then a different view or 
approach to suicide assessment and prevention might be required than has been 
traditionally expected.  Discourse theory is investigated further in the next section.  
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The findings of the study recognise that both intentionally hastened death, and 
suicide, are aspects of hospice care that are rarely acknowledged. These deaths are 
often assumed to be exclusively about Death with Dignity (DWD), but hastened 
deaths also include suicides that are not with the assistance of a legal lethal 
prescription. If the patient chooses to die by suicide or by a legal lethal prescription, 
they take the power of life and death into their own hands.  Prescribing physicians, 
however, have the power to decide if a patient can obtain the DWDA medications 
but then place the power of timing of death in the persons’ own hands, thus 
suggesting this is suicide as a medicalised intervention (Karsoho, Fishman, Wright, & 
Macdonald, 2016; Salem, 1999). This led me to question the experience of power in 
the relationship between the professional and the patient who hastens death or dies 
by suicide. To answer this question, I will first examine theories of power, explain the 
concept of the three dimensions of power as developed by Lukes (2005), and then 
apply these concepts to each of three key conclusions. 
 
7.1 Applying the concept of power to this research 
My research results identified that people who are sick and suffering submit to the 
authority of the medical profession who have some power over how they live and 
die. The professionals who work with them also submit to the power of the 
organization or government that governs their practice. To help make sense of the 
phenomenon of power, I examined theories that included the concept of bio-power, 
or ‘bio-politics’, conceived by Michel Foucault (Rabinow & Rose, 2006). Foucault 
discussed how power is present in all aspects of life, all levels of society and how one 
must look beyond the people who “submit to it and reveal the problem of 
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domination and subjugation” (Foucault, 2003, p. 27). Bio-politics is simply defined 
here as a power over life and death (Agamben, 1998; Rabinow & Rose, 2006). I 
subsequently examined the phenomenon of power developed by sociologist Steven 
Lukes, who suggested a three-dimensional view that positions many levels and 
aspects of power within a framework (Lukes, 2005). Lukes argues that a three-
dimensional view helps us to understand power that is not only visible and 
measurable, but also aspects of power that are invisible and unobservable (Lukes, 
2005). Lukes asks fundamental questions about domination and what causes those 
who are dominated to acquiesce to power (Dowding, 2006). Lukes presents three 
distinctive views of power that are explained in Table 7.1: 
Table 7.1. Lukes' three dimensions of power 
Lukes' Three Dimensions of Power 
One-Dimensional View 
“focus is on behaviour in 
making of decisions in which 
there is an observable conflict 
of interests” p. 19 
Focus on:  
 Behaviour  
 Decision making 
 Observable, overt conflict 
 Preferences revealed by political 
participation 
Two-Dimensional View 
Considers “ways in which 
decisions are prevented from 
being taken on potential issues 
over which there is an 
observable conflict of interests” 
p. 25 
Focus on: 
 Decision making and non-decision 
making 
 Issues and potential issues 
 Observable and non-observable conflict 
 Subjective interests 
Three-Dimensional View 
Considers how people acquiesce 
to power by believing the values 
that oppress them or are 
resigned to them 
Focus on: 
 Decision making and control over 
political agenda 
 Issues and potential issues 
 Observable and latent conflict 
 Subjective and real interests 
Adapted from:  Lukes, S. (2005). Power. A radical view. The original text with two 
major new chapters: Basingstoke: Palgrave Macmillan, p. 29 
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Figure 7.1) is an adapted model of Lukes' three-dimensional view of power 
developed by advocates and educators, VeneKlasen and Miller, that further helps to 
understand power in the context of this research (Gaventa, 2006; Lukes, 2005; 
VeneKlasen, Miller, Budlender, & Clark, 2007).  VeneKlasen and Miller build on Lukes’ 
three-dimensional view that does not see power as a purely negative consequence of 
domination, suggesting instead that “power is dynamic and relational, rather than 
absolute” (VeneKlasen et al., 2007). Figure 7.1 demonstrates how these dimensions 
may be viewed as interrelated, and interdependent, meaning that in some 
experiences there is a dynamic process between and within the different views. The 
first dimension is embedded in the second and third dimensions.  A dynamic process 
of power often identifies a dominator having power over an oppressed, but elements 
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Adapted from:  
VeneKlasen, L., Miller, V., Budlender, D., & Clark, C. (2007). A new weave of power, people and politics: the 
action guide for advocacy and citizen participation: Practical Action Pub. 
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Professionals who believe DWDA is wrong because they are told it is 
wrong yet support an intentional hastened death in some cases 
People are led to believe they have autonomy with DWDA but are dependent 
on medical professionals for approval, and the organisation for information 
There is an agenda in some organisations that is not 
explicit 
Unspoken deaths: Suicide deaths that are observed but 
not identified as suicide – professionals protecting 
patient autonomy 
Individual beliefs are shaped to believe they have access 
when in fact DWDA may not be accessible if they cannot get 
or afford the medication 
Power of the professional to determine decisional capacity  
Medical aid in dying is referred to as 
DWDA or DWD, the name of the law – It 
is not considered suicide 
 Figure 7.1. Three Dimensions of Power 
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In the first dimension, there are formal rules and structures of decision making that 
are visible.    The first-dimensional view, also called the one-dimensional view (Lukes, 
2005), can be explained as the individual that wins the argument in a conflict is the 
one who possesses the power. The first-dimensional power may also include the 
authority that establishes clear boundaries about what is right and wrong. An 
authority may be an individual, an institution, or the people within the institution 
who assert power over others who must abide by the rules.  In this first-dimensional 
view, the physician has the authority, or power over life and death, to determine if a 
patient is eligible for the DWDA. This one-dimensional view is power that is visible, 
observable, and measureable.  
 
The second-dimensional view, also called the two-dimensional view, refers to the 
one who controls the agenda in the power relationship. For example, the law that is 
created by those who have decision-making power influences the terminology used 
to describe the law.  A concrete example of this second dimension is with study 
participants who use different terms for DWDA. The Death with Dignity Act is not 
referred to as ‘assisted suicide’, ‘assisted dying’, or ‘physician assisted dying’, but 
primarily referred to and discussed using the name of law, DWDA, or DWD. The 
decision making might be covert or overt in the second dimension, but there is a 
hidden agenda if all are not involved in the decision-making process. Institutions 
might also have an agenda that is not explicit in policy. The policy of some 
institutions refers to the law as ‘assisted suicide’, suggesting hidden values that are 
against the DWDA.  The institution uses words that can influence meaning and 
beliefs of others working for them, which is also a factor of the third dimension. This 
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is demonstrated by the different interpretations and implementation of policy by 
participants who worked for the same organisation and are uncertain what to 
believe is true about policy or the law. Another second-dimensional view includes 
the professional who has reason to believe a patient died by suicide but chooses not 
to report the death as a suicide, thus controlling the agenda and protecting survivors 
from suffering the social, ethical, religious, and legal consequences of a suicide 
death. 
 
The third dimension is about the unobservable, invisible conflicts that arise in a 
power relationship—when those in power shape the thinking of those who are 
governed by the law. This approach attempts to identify less measurable phenomena 
and hegemonic processes that operate at an institutional and societal level. Culture, 
customs, and religion have power that is very hard to measure, but can be applied to 
different settings (Dowding, 2006; Lukes, 2005). In the context of this study, 
individuals are led to believe they have the option to use the DWDA, but, in fact, they 
do not if they do not have access to information about DWDA, if there is a limited 
supply of medications, or if they cannot afford the drugs. In the third dimension, 
truth is hard to see and talk about. 
 
Van Brussel and Carpentier (2014) describe how discourse about death has gone 
from denial of death, where it was hidden from public view, that suggests not 
knowing about imminent death makes it a lie and unreal, to death becoming 
institutionalized, and made public through hospitalizing individuals as they are dying 
and following death through the process of issuing death certificates. Death 
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discourse has, thus, shifted from a medical rational approach in the eighteenth 
century to a ‘medical revivalist’ alternative in the late twentieth century (Van Brussel 
& Carpentier, 2014). Revivalist discourse is described as the hegemony of the current 
death awareness and palliative care movements striving to have a ‘good death’.  
“Requested death is perhaps the ultimate contemporary expression” of the modern 
efforts to control death (p. 106).  This ideal good death in this modern revivalist 
death awareness movement is when “the dying person is in control of her/his own 
death” but is in conflict with the discourse of the palliative care movement that 
emphasises the goal of a natural death focused “less on independence, autonomy, 
and awareness in defining dignity (p. 20-21). Discourses provide a framework that 
can help to understand some of the stories about patients who have hastened their 
deaths that were not with medical aid in dying and help to understand the conflict 
between the palliative care professionals, the institutions, and the patients that they 
work with who are seeking control and autonomy.  
 
Individual beliefs about autonomy are shaped by the law, with an emphasis on 
choice rather than acquiescing to strict regulations, the power of the physician to 
determine eligibility, and an organisational structure that controls the information.  
In the preceding Figure 7.1, the first and second dimensions are embedded in the 
third dimension, meaning some aspects of policy implementation can be aspects of 
all dimensions. A professional may believe the DWDA is wrong because they are told 
it is wrong, or they might be convinced to support a patient who chooses the DWDA 
when it is against their own beliefs. In both situations, the professional navigates 
between the first and third dimensions, suggesting interpersonal and moral conflicts 
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that might arise from these experiences between knowledge and understanding of 
right and wrong.  I now elaborate on these concepts of the three-dimensional view of 
power by applying them to the key conclusions of this study. 
 
7.2 Key conclusions 
By examining professionals’ experiences of suicide in a hospice context, I found three 
key conclusions. First, the findings support the concept that some suicides with 
patients who have advanced illness are considered rational. Medical aid in dying is 
one form of ‘rational suicide’ that implies “a person can make a well-reasoned 
decision to die” (Werth & Holdwick, 2000, p. 511). There is literature documenting a 
history of voluntary, sanctioned suicide among those who are elderly, and suffering 
with pain (Fontana, 2002; Richards, 2017).  Some cultures, including Eskimo, Norse, 
and Samoan, accept suicide among persons facing end of life (Battin, 2015b; Ingram 
& Ellis, 1992; Jamison, 2011; Matzo, 1997), and there remain a few conditions that 
make a case for suicide as a rational act (Downing, 1970; Graber, 1981; Werth, 1992; 
Werth & Holdwick, 2000).  
 
Second, I argue that the perceived taboo of suicide limits open conversations among 
professionals about suicide. The DWDA, however, creates an opportunity for 
dialogue about what is often emotionally and ethically complex. Some of these 
complex issues are found to include financial and rural inequities, how interpretation 
of organisational policy about the DWDA might limit professionals’ care of patients, 
and how personal and religious beliefs impact experiences. I also observed that 
where patients live, what knowledge they have about options, and how patients are 
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supported by their community and family make a difference to the professionals and 
how they are influenced in their work.  
 
Finally, the research results indicate that medical aid in dying and home hospice care 
are not mutually exclusive. This does not mean that hospice professionals offer DWD 
among an array of palliative care options, but that professionals work with patients 
regardless of the choices they make about their death, particularly when the choice 
is medically sanctioned.    
 
 Only two of the 21 study participants said that they can offer the DWDA as an option 
for patients who do not initially bring it up themselves. Some participants strongly 
suggested that to adhere to organisational policy, they do not provide information or 
referral about the DWDA but others indicated they would go against policy to give 
information to their patients, demonstrating the power of the professional to have 
influence over the agenda. Medical aid in dying, however, is only available when 
patients have information, meet the DWDA eligibility criteria, have access to and can 
afford the medication, a different example of how formal rules in the first-dimension 
influence approach. There is a relationship between all who are involved, and a 
relationship between hospice and the DWDA process.    Hospice professionals work 
closely with their patients who choose it as an option and support their patients with 





7.2.1 Rational suicide 
These findings support the concept of rational suicide for someone who is 
considered mentally capable, diagnosed with a life-threatening illness, who made the 
decision for hastened death without coercion, and followed a process of making the 
decision to die (Werth & Holdrick, 2000).  Regardless of whether hospice 
professionals assist their patients to hasten death, there are some individuals who 
will succeed in hastening their own death, and some who will potentially create more 
harm with a failed violent or botched attempt. The individual may take their death 
into their own hands, but in the third dimension of power, the individual may not 
have freedom if the system has influenced their ultimate choice to kill themselves 
without assistance. Suicide is not unlawful in the United States, but the unobservable 
dimensions of power include the emotional and legal repercussions that often result 
from this type of death.   It is up to the individual professional to decide if they can 
assist or support the patients who are receiving home hospice services to pursue the 
DWDA.   
 
This study demonstrates that hastened death and suicide are most often interpreted 
by professionals as people who die with the DWDA.  When patients die by Voluntary 
Stopping of Eating and Drinking (VSED), and medication toxicity, however, these 
deaths appear to be regarded as rational by some of those interviewed for this study. 
Some participants called these deaths ‘suicide’ yet seemed to feel these deaths were 
different from other, more violent suicide deaths. Professionals are also reluctant to 
call these deaths suicide because to do so would imply that they failed in enabling a 
natural death, especially in cases where they did not report that a patient was a 
 164 
suicide risk.   This is another example of the third dimension of power; when 
participants indicated that they acquiesce to the power and do not speak about 
these suicide deaths. As Lukes states, “one can consent to power and resent the 
mode of its exercise” (Lukes, 2005, p. 150). Professionals consent to institutional 
policy and restrictions, acquiescing to power as instruments of the larger institution.  
If these deaths are called ‘rational suicides’, however, the power is left to the 
professionals, carers and family members, to determine the mental capacity of the 
individual who has died, and if the decision to die is considered ‘well-reasoned’. The 
individuals who hasten death are not necessarily powerless, but risk consequences 
that may not be rational.  
 
Medical aid in dying is only one form of rational suicide, but in fact we might benefit 
from looking at these other aspects: including patients who die by VSED, or patients 
who might intentionally overdose on medication. VSED may be one aspect of rational 
suicide that professionals interviewed felt more likely to support and even offer as an 
option for some patients. Professionals have the power to make the decision to offer 
and support the patient because VSED is considered morally acceptable, legally 
permissible, and not a form of ‘assisted suicide’ but requires the support of carers 
and health professionals to manage possible unpleasant symptoms (Menzel, 2016; 
Pope & Anderson, 2011). This suggests the second dimension of power since 
professionals have the power or believe they have the power to control the agenda 
of how support might be given to the patient. Other hastened deaths may be 
considered rational for some people, but are laden with difficult emotional 
consequences for the carers, families and others. Some of these suicides may be a 
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consequence of the limited access to the DWDA and would benefit from being a 
focus of concern.  
 
Medical aid in dying specifies a framework for the DWDA, a government regulated 
rational suicide, the formal rules indicating this is the first visible dimension of 
power, where one is dominated by the authority of another. The framework is 
implemented by the regulations of this ‘rational suicide’ required by the DWDA. This 
regulated ‘rational suicide’ may be one reason why participants in the study spoke 
initially about deaths by DWD, power in the first dimension that is visible, when 
asked about patients’ suicide. The regulation of DWD makes it permissible to speak 
openly about the subject, as if DWD is the only way that individuals hasten their 
deaths. The problem, however, is when access to the approved ‘rational suicide’ is 
limited and patients die violent, and potentially difficult, deaths. The unpredictable 
outcome of the limitations of the DWDA is that unsupported suicides continue to 
occur, many hospice professionals feel powerless to discuss or prevent these deaths, 
and the law lives in tension with traditional views that any death by suicide is 
‘wrong’.  
 
However, professionals in this study were not powerless in the face of domination, 
despite, as Lukes asserts, “the radical maintains that people’s wants may themselves 
be a product of a system which works against their interests” (Lukes, 2005, p. 38). An 
example of this is with the social worker who commented that the organisation she 
works for does not want her to talk about or provide education about the DWDA. 
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She says she cannot give information about it, yet she works with the patient 
supporting the individual choice for what she considers to be a ‘rational suicide’. 
 
The definition of suicide, in general, is unclear when someone is suffering and the 
goal is providing patient-focused care. It may conflict with personal, moral, and 
professional obligations. The findings of this research suggest defining suicide is 
often blurry, especially when professionals empathise with patients who do hasten 
death. Employing the concept of rational suicide might help professionals working 
with patients in hospice and palliative care to navigate the blurry boundaries of 
suicide, bringing the hidden, second dimension of power into visibility. The second-
dimensional view is the power to control the agenda of what is defined as suicide 
and culturally acceptable, even for those who have a conflict with a patient’s 
decision. 
7.2.2 Taboo of suicide 
Interpretation of suicide is challenging in a culture where open dialogue, even in 
circumstances where it might be considered rational, is taboo. Participants in this 
research used the word ‘taboo‘ when asked about suicide, suggesting suicide is 
forbidden (Chapple et al., 2015). Chapple et al (2015) indicate the taboo of suicide is 
associated with feelings of “shame and blame” that is different from emotions 
expressed from other losses or deaths (p. 622). The DWDA, however, indicates that 
this death is somehow ‘less suicide’ than the individual who takes an intentional 
overdose of saved-up prescribed medication, or the individual who does not have 
access to medical aid in dying, and chooses to end their life by gunshot. This and 
other research demonstrates that VSED also seems to be acceptable (Ganzini et al., 
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2003). When the action of hastening death is not considered suicide, it pushes the 
boundaries of religious and other authorities when open discussion of suicide—even 
in circumstances where it might be considered rational—is taboo.  Calling DWD, or 
medical aid in dying, by the name ‘suicide‘ creates the potential for insurance 
benefits to be affected, religious death rituals to be restricted, or family members to 
suffer and possibly try to hide the cause of death (Oregon Public Health Division, 
2016).  
 
The laws in the United States distinguish between a death from DWD and a death by 
suicide, as described in the background chapter. This leaves the professional in the 
position of power to determine when to distinguish, or at least question, if a patient 
died by suicide. They put themselves at risk if they suggest that a patient, for 
example, overdosed on medications to hasten their death. Professionals are bound 
in the first dimension of power to report to legal authorities when confronted with 
ethical and moral dilemmas if there is any indication that a patient is a risk of harm to 
self.  The medical aid-in-dying laws can reinforce and maintain taboos but can also 
challenge taboos. The laws have the potential to reduce the suffering experienced by 
family members coping with the effects of religious and economic consequences of 
suicide, and to reduce these ethical dilemmas faced by professionals—but only if the 
patient has the social, cultural, and financial capital to utilise the law. 
 
When a community’s healthcare system is dominated by a religiously sponsored 
system, including hospice services, then the norms associated with the church 
institutions play a powerful role in determining how suicide is discussed, 
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acknowledged, and responded to beyond just the regulation and language of the 
law, another aspect of the third dimension. This powerful cultural influence was cited 
by several of the professionals interviewed. Organisations that have vague or 
uncertain guidelines have influence over those they serve to think they are making 
autonomous decisions. This vagueness is the third dimension of power that silences 
professionals’ ability to tell the story when it is about suicide.  
 
The taboo, however, transcended Catholic settings and was widely described as a 
source of frustration and a barrier to fulfilling their professional responsibilities. This 
is best reflected by participants who said they did not speak openly in teams about 
how patients intentionally hastened death without the DWDA and who indicated 
that open discussion might risk their employment. 
7.2.3 Medical aid in dying and hospice 
The results of this research indicate that hospice care and medical aid in dying 
cannot be treated as separate facets of end-of-life care, especially when most 
individuals who use the DWDA are referred for and utilise hospice services.   The 
process of maintaining rigorous boundaries is challenging when hospice professionals 
are working with patients who are dying with DWDA drugs.  The policy of several 
organisations discourages professionals from being present during the time that 
patients ingest the lethal dose of medications. Yet, despite these policies, there are 
occasions when health professionals chose to remain with the patient, empowering 
both themselves and the patient. Professionals, however, were interviewed during a 
time of profound institutional, legal, and cultural shifts because medical aid in dying 
laws have passed in two more states in the United States, the District of Columbia 
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also in the United States, in Canada, and in Colombia since 2015. These broader 
shifts are experienced by professionals who are impacted by organisational policies 
that seem to be contradictory, underdeveloped, or invisible. They demonstrate they 
are governed by a set of rules that are difficult to achieve in practice.  
 
Professionals may be limited in how they respond to requests for DWD because of 
personal or institutional restrictions, including their own lack of knowledge about the 
law.  However, participants in this study, most of whom are nurses and social 
workers, supported patients’ choices to hasten death with DWD or unassisted non-
violent deaths. They witnessed patients dying with DWD medications, and when 
possible referred patients to an advocacy organisation to find a physician who would 
agree to prescribe, and they withheld information on some intentionally hastened 
deaths without DWD.  The debate between the hospice movement discourse to 
control symptoms of the dying process to promote a ‘natural death’ and the right-to-
die movement to control timing of death is, perhaps, what Van Brussel and 
Carpentier (2014) describe as the ‘good death’ versus the ‘heroic death’. A heroic 
death—described as a death that is rational, controlled, and supporting autonomy 
and independence—is in this context also a good death, emphasising that an 
individuals’ wishes are heard as they die naturally, potentially surrounded by family 
within their community.  
 
Policy provides guidelines and a framework, but how policy is translated into practice 
might be different than the policy makers intended.  This is seen in at least half of the 
organisations where professionals were employed and is not limited to religious or 
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secular employers. From a Foucauldian perspective, however, power is not fixed, is 
ever changing, and is ‘multi-directional’ (Polifroni, 2010). Professionals do not easily 
acquiesce to power, meaning they are not convinced to believe policy is exactly as it 
is stated. Lukes described this as a “minimal view of freedom,” suggesting the 
authority has ‘less’ power until it infringes on one’s freedom (Lukes, 2005, p. 115).   
Power is not dependent on a hierarchical structure but changes as truth and 
knowledge change. Organisations have power over what knowledge might be 
disseminated by professionals, but individuals might then interpret and implement 
the policy in a different way than originally intended. In the three-dimensional view 
of power, however, patients are vulnerable to the interpretation and 
implementation of policies, meaning they are made to believe they have control 
when they do not.   During a time of shifting policy and practice, professionals are 
innovative and creative in interpreting policies that work to maintain the integrity of 
the relationship with patients being served in the intimate setting of the home.   This 
research indicates that the shift toward integration of medical aid in dying with 
hospice care will continue, but not necessarily be offered as an option among an 
array of options at end of life.   
 
7.3 Contribution to practice  
“Getting to understand power may begin as a personal process where the simple 
act of talking about it openly can help people grapple with the controversy and 
discomfort surrounding the topic.” (VeneKlasen et al., 2007) 
 
There are several implications resulting from this research that can affect policy, 
practice, and future research. This research brings the invisibility of the topic of 
suicide in hospice care into visibility, exposing the hidden dimensions of power and 
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making known the unintended consequences of broader inequities affecting the 
provision of palliative care. Policies designed to strengthen participation and 
inclusion of groups that have not been involved in decision making about issues that 
affect quality of life and death make visible the invisible dimensions of power.  
 
I adapted a tool developed by VeneKlasen et al that can be utilised to apply the three 
dimensions of power to implications of this research for future policy, and practice. 
Table 7.2 includes examples of each dimension of power in one column, followed by 
a column of examples and implications: 
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Table 7.2. Implications of dimensions of power 
Dimensions of 
power 













- DWDA legislation and 
regulation 
 
- Power of professional 
to determine mental 
competence 
 
- Policy requiring 
suicide assessment 
 
- Access to palliative care  
- Lobbying for access to 
affordable healthcare 
- Survey professionals 
about suicide in areas 
where DWDA is legal to 
develop suicide 
assessment/treatment 
specifically focused for 













- Inexplicit agenda by 
some organisations 
 
- Name of the law is 
terminology used  
 
- Lack of affordable 
care options and 
access to palliative 
care 
 
- Participatory research on 
value of autonomy vs. 
community focused on: 
individual, familial, 
communal, and cultural 
aspects of dying  
- Include diverse groups in 
decision making about 
DWDA related to quality 
of life and death  
- Expand the scope of 
DWDA terms  
















- People are told they 
have options but 
options are not 
accessible 
 
- Taboo of suicide  
 
- Cultural norm that 
guns are safe   
 
- Notion of autonomy 
not a value for 
everyone   
 
 
- Education regarding legal 
options, including VSED  
- Open communication 
about incidence of 
suicide among people 
with advanced illnesses  
- Sharing stories, speaking 
out about experiences 
with suicide 
- Investigate impact of 
access to guns on violent 
death among patients 
with advanced illnesses 
- Research on the effect of 
suicide on family  
Adapted from: 
VeneKlasen, L., Miller, V., Budlender, D., & Clark, C. (2007). A new weave of power, 
people and politics: the action guide for advocacy and citizen participation: Practical 
Action Pub. 
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As noted by MD4 “... there is a huge obstacle for rural patients ... these people don’t 
even have enough gas money ... such huge obstacles in the way”. When people do 
not have access to basic needs to survive, they cannot think about access for 
medication to die.  Those whose voices are not included in the decision-making 
process regarding medical aid in dying need to be included in policy decisions 
affecting options for living and for dying.  Table 7.2 suggests a response to this 
hidden dimension of power is to include diverse groups in decision making about 
quality of life and death that would address cultural differences and inequities. From 
my findings, it seems that an unintended consequence of the DWDA is that it 
perpetuates disparities, protecting the interests of those who respect autonomy and 
control despite the intention of broadening options at end of life. The DWDA is 
available to the few who are eligible, can navigate the formal process, and can afford 
or have access to information about how to get resources to pay for the physician 
visits and the medications. However, individuals with less social, cultural, and 
financial capital and therefore less power, who have life threatening illness, still die 
from uncontrolled and distressing deaths by suicide while receiving hospice care.  
 
Medical anthropologist Dominique Memmi suggests “self-determination is a central 
feature of contemporary bio-politics”, as medical aid in dying supports the growing 
need for autonomy in this culture (Memmi, 2003).  Medical aid in dying might be an 
acceptable shift toward the expectation of individual autonomy rather than the state 
being responsible for life and death decisions. But it continues to conform to 
regulation that she calls a “new type of social control.”  Medical aid in dying is 
acceptable, and not considered suicide, for those that fit within the guidelines and 
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criteria.  But the data collected from Oregon and Washington indicate that it is for 
the educated, white, and mostly socially or politically privileged population.  Others 
who live in more rural communities, are poorer, or are less educated have reduced 
access to healthcare and do not have the same choices over life and relief from 
suffering with palliative and hospice care or medical aid in dying.  The privileged few 
who know about their options may avoid a painful death and the stigma associated 
with suicide and they are supported by a self-determined life closure.  
 
The discussion of these issues raises the question about outcomes for individuals 
with a life-threatening illness who are not eligible for the DWDA, do not have 
knowledge or access to the DWDA process, and hasten death in other ways. 
Participants in the study described how patients overdose on medications, suffocate, 
or shoot themselves, options that in some cases cost nothing or much less than the 
medical aid in dying drugs. Others might choose to voluntarily stop eating and 
drinking, which can be challenging and require dependence on the support of their 
families or caregivers (Quill, 2015).  The response to these examples of the invisible 
third dimension of power can be found by speaking out about experiences of suicide 
and hastened death as demonstrated by Table 7.2.  
 
Institutional policies and professionals use a wide range of vocabulary that includes 
use of the term ‘assisted suicide’.  To call medical aid in dying ‘suicide’ makes it 
confusing when public policy is simultaneously focused on suicide prevention 
(Washington State Department of Health, 2016b). This exposes how professionals 
are trying to prevent a particular kind of unsanctioned suicide or supporting what 
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they might feel to be a rational decision. Professionals may not have the resources, 
training required, and time needed to discern what might be determined a rational 
decision. These complex issues need to be in the hands of not only the physician but 
all those involved, including the team members, carers, and family members. This is 
the foundation of palliative care: that it is patient and family-centred care by an 
interdisciplinary team (National Hospice and Palliative Care Organization, 2015). 
Suicide assessment and treatment options to meet the needs of people who have 
life-threatening illness must be an integrated part of care. Treating underlying 
depression, feelings of hopelessness, and being a burden is only part of the issue.   
 
Those who advocate for medical aid in dying should be made aware of the social 
justice implications suggested by the results of this study: that it is not accessible for 
everyone due to cost, access to a physician or pharmacy to distribute the 
medications, and that the medications may be difficult to self-administer.  Questions 
have arisen about what happens to the lethal medications if a patient does not use 
them, implications of symptoms and reactions from the medications, and in some 
cases, the possibility of taking several hours to die after ingestion (Oregon Public 
Health Division, 2016; Washington State Department of Health, 2016a).  
 
Those who are opposed to the DWDA should be aware that there are some 
individuals suffering from a terminal illness who will try to take their lives in a violent 
or unsafe way, with or without the DWDA. Providing a legal provision for a safe 
death with the support of a palliative-care team of professionals can make the 
difference between a botched or violent suicide attempt and a natural death or a 
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death from medical aid in dying. 
 
7.4 Literature in relation to findings: contribution to knowledge 
The key themes identified in the literature search provided a context in which to 
examine themes identified in the research, and to explore gaps in the knowledge 
about suicide and hastened death in areas where medical aid in dying is allowed.  
This research confirmed the results of the findings from the literature review in 
chapter two: that the concept of assisted suicide is often synonymous with medical 
aid in dying or DWD and DWDA.  Studies completed in areas where medical aid in 
dying is allowed often have used the term ‘assisted suicide,’ but there is evidence of 
a language shift as more countries are moving toward legalising euthanasia and 
‘assisted suicide’ (Ebbott, 2010; Westerhoff, 2017). None of the studies included in 
the literature review investigated overall issues of hastened death and suicide in 
areas where medical aid in dying is allowed. Ganzini et al’s (2003) research on nurses’ 
experiences with Voluntary Refusal of Food and Fluids (VRFF), Anquinet et al’s (2013) 
investigation of continuous sedation until death, and Pasman et al’s (2013) study of 
euthanasia requests that were refused, are indications that hastened death is not 
only about assisted suicide, euthanasia, or medical aid in dying.  
 
There have been several research studies indicating that there is a sort of ‘euthanasia 
underground’ suggesting that with or without medical aid in dying, patients 
diagnosed with terminal illness do seek ways to hasten their death to avoid suffering 
and, in some cases, are assisted by someone else (Asch, 1996; Magnusson, 2004; 
Richards, 2016). These studies, however, were not completed in locations where 
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euthanasia or medical aid in dying laws were implemented at the time this research 
was completed, though some may seek to go to Switzerland where assisted suicide is 
available for nonresidents (Richards, 2016). Back et al’s (2002), qualitative research 
about clinician and patient interactions in Washington State revealed that some of 
the patients did receive clinician assistance to hasten death several years before the 
DWDA was implemented. Magnusson’s (2002) research of covert euthanasia in areas 
where medical aid in dying is not allowed, suggests that patients and their families 
are at risk of experiencing negative unintended consequences from a violent suicide. 
 
Studies do not take account of the intimacy inherent in home hospice care as 
suggested by findings of this research. Hospice professionals working with patients in 
the home are not directly monitored by others as they would be in an institutional 
environment and spend longer times with patients than they might in the clinical 
setting. In rare circumstances, lack of monitoring could lead to an abuse of power as 
demonstrated in the case of Dr. Harold Shipman, who in 2000 was found guilty of 
murdering significant numbers of his patients in the United Kingdom (Baker, 2004; 
Ramsay, 2001). This study did not reveal any information about healthcare 
professionals consenting to help kill a patient. 
 
7.5 Study limitations 
There are several limitations to this study. This study is not generalisable but 
provides a foundation for a measurable study including surveys about suicide in 
hospice care across professional groups.  
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My experience and role as both a hospice social worker and a researcher impacted 
the results of this research.  Braun and Clarke (2013), however, emphasise the 
researcher has an active role “in the research process and in constructing 
knowledge” and comes with “values, interests and standpoints that shape our 
research” (p.303).  Reflective notes were taken throughout the research and used to 
help distinguish my previous experiences from the experiences of participants I 
interviewed. For example, these notes revealed my interest, early in the interview 
process, in the stories of unassisted suicides rather than deaths from the DWDA. It 
was in the process of additional interviews that I realised the importance of the 
initial responses of the participants to the research question. Participants’ knowledge 
of my role as a hospice social worker may also have influenced their responses to 
questions, possibly inhibiting them from sharing experiences or how they discussed 
their role in the process. They may have wanted to tell me something because I was 
a social worker, or perhaps refrained from telling a story because of my previous 
role.  In addition, my own experiences, values, and beliefs shaped the interpretation 
and how I might have viewed and preferred to include some of the comments over 
others. In addition, my desire to ask additional probing questions in the interviews to 
elicit more stories may have influenced the responses. Some of the stories resulting 
from these questions may not have been about first-hand experiences. Thus, the 
stories shared may have been altered in the retelling, and not a true reflection of the 
death.  
 
This study did not include other groups such as nurse assistants who may have 
important roles, contributions, and additional information about professional team 
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approaches to working with patients on issues of suicide and hastened death.   Some 
of the groups not included in this study also have much experience and potential 
knowledge about patients who died by suicide or DWD.  An investigation of the 
experiences with these other groups could be an area for further research, however, 
recruitment in this study focused on professional groups identified to have an active 
role in assessment and communicating with patients about the DWDA and suicide.  
 
The results of this study are impacted by the sample of the participants who were 
self-selected after responding to an email invitation and follow-up phone calls. Those 
that responded may have had a specific agenda to discuss that may have biased the 
results.  Some participants said they volunteered to be interviewed because they 
specifically wanted to support a social worker completing this research. Most 
participants identified as white, educated, and experienced. Results would likely 
have been different with a more ethnically and socially diverse sample. Their 
knowledge of my professional role as a social worker could have biased the results 
and may have prevented some of them from freely discussing topics. For example, 
participants may not have felt able to discuss active participation in euthanasia, 
when or if they had information about an illegal act, protecting either themselves, a 
third party, or myself from this knowledge.  
 
This study is dependent on the reports from the memories of the professionals 
during the time of the interview.  Some participants who had worked with hospice 
patients over 6 years could not remember if the story they were reporting occurred 
before or after the implementation of the DWDA. This may have biased results about 
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how or if the DWDA influenced the stories of suicide. 
 
Finally, some concepts went unexamined due to the limitations of this study. These 
include the important concept of moral distress experienced by many of the 
participants, which is described as “the experience of being seriously compromised 
as a moral agent in practicing in accordance with accepted professional values and 
standards” (Varcoe et al., 2012 p. 59). Participants in this study expressed conflict 
with decision making and coping with organisational constraints. Experiences of 
moral distress may constitute an independent thesis topic worthy of deeper inquiry.  
 
7.6 Conclusion 
In this chapter, I have applied Lukes' three-dimensional views of power to key 
conclusions resulting from this research.  Participants empower themselves to 
support patients who choose assistance in dying and often despite hospice policy 
governing practice differently. How professionals relate to power is key to how they 
manage the integration of medical aid in dying in their work with hospice patients.  
Professionals interpret some suicides to be rational but discerning suicide risk from 
rational suicide is challenging when there is no open dialogue among team members. 
Understanding and acknowledging the limitations of palliative care and the hospice 





This research is the culmination of many years of reflection about the subject of 
suicide and hastened death among people who are dying. When I initially began this 
research, there were only two states in the United States that had passed the Death 
with Dignity Act (DWDA): Oregon and Washington.  Since July 2015, when interviews 
were completed, four more jurisdictions in the United States passed medical aid in 
dying laws, and Canada implemented Medical Assistance in Dying (MAiD). Initial 
research results from California and Canada indicate that the profile of patients is 
similar to those from Oregon and Washington; white, educated, and from middle to 
upper income levels (Li et al., 2017; Oregon Public Health Division, 2016). 
 
The results of this research indicate that despite the DWDA, hospice patients in 
Washington State are at risk of suicide, but in some cases these suicides might be 
considered rational. The legalisation of medical aid in dying, considered by some to 
be a rational form of suicide, does not necessarily mean that there is a decrease in 
patients who die by suicide (Richards, 2016, 2017; Werth & Holdwick, 2000). It is very 
difficult to measure the incidence of patients who do hasten their death, if the 
suicide is not identified as a suicide.  This research demonstrates that suicide, 
rational or not, continues to be a crucial and unexamined facet for some individuals 
facing the end of their lives in home hospice care. The reflections of professionals in 
this research study indicate that some people experience suffering on some level 
that is not alleviated when dying takes too long.  
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Hastened death is not only about medical aid in dying, but the reality of medical aid 
in dying offers an opportunity for public dialogue about the blurry boundaries of 
suicide and hastened death, access to care, palliative care, and safe options for the 
few individuals who seek to control timing of death.  
 
Patients are hastening their deaths in ways that are sometimes violent and can lead 
to uncertain consequences. Simply preventing people from having access to lethal 
means will not alter their feelings of hopelessness and feelings of burden. Medical 
aid in dying or suicide is not the solution to the larger issue of lack of affordable 
community care options for someone who is facing loss of autonomy, or feelings of 
being a burden, important issues for those seeking to use the DWDA (Lee & New 
York Acad, 2014). Having a safe and legal option gives some people who have 
knowledge and information about medical aid in dying an element of power over 
their lives that, paradoxically, may minimise their desire to die and encourage them 
to utilise palliative care (Wang et al., 2015).   Finally, medical aid in dying is not 
available to all people, and all persons facing end of life do not have access to or 
interest in going through the formal process. Very few patients will end their lives 
utilising DWDA or die by suicide, but some of them will. If palliative care is truly 
patient centred, with the goal of minimising suffering, then palliative care 
professionals need to have open communication with patients and each other about 
legal and safe options to live until they face the possibility of a comfortable and safe 




8.1 Areas for future research   
This study contributes to understanding that the issue of hastened death in hospice 
care goes beyond a discussion of the DWDA. These areas include the critical need for 
further research that focuses more precisely on how social inequities in healthcare 
affect suicidality, and increases an understanding of how professionals, carers, and 
family members are impacted by these deaths.  There are many additional areas to 
expand on this research including utilising the research results to design and 
implement a broader survey of professionals about suicide and hastened death in 
areas where medical aid in dying is legal or allowed. The results of this broader 
survey could be implemented across cultures and represent a greater number of 
participants to contribute to a better understanding how or if medical aid in dying 
laws are impacting both reported and unreported suicides among individuals who 
are terminally ill and are receiving hospice or palliative care.   
  
Little is known about the management and treatment of suicide risk for patients on 
home hospice care in jurisdictions where medical aid in dying is allowed.  Though 
there have been some studies about suicidality among hospice patients in the United 
States, these have not been in areas where medical aid in dying was legal at the time 
of the research (Arnold, 2004; Fairman et al., 2014; Washington et al., 2016). This 
research only begins to discuss the management of patients at risk of suicide. There 
is a paucity of evidence, however, about access to effective nonpharmacological 
treatment options in home hospice such as Dignity Therapy or Meaning Centered 
Therapy for home hospice patients who continue to have desire to die manifested in 
statements, or indications that they may hasten death; for example, a gun stored 
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closely by them, or stored-up medications (Breitbart, 2016; Chochinov et al., 2005; 
Fitchett, Emanuel, Handzo, Boyken, & Wilkie, 2015). Continued research in this area 
can contribute to developing guidelines for professionals to evaluate and serve those 
suffering toward end of life. 
 
Van Brussel and Carpentier (2014) offer a discourse-theoretical analysis emphasizing 
hegemony focusing on the construction of meaning of euthanasia in Belgium, 
however, they do not investigate incidents of unassisted suicide and the relationship 
with the medical revivalist period mentioned in the introduction to this chapter. 
Using a discourse-theoretical analysis applied to the results of this research would be 
an additional area of investigation to develop an understanding of discourse and 
construction of meaning of unassisted suicide and medical aid in dying.  
 
Research is indicated on the concept of moral distress, discussed briefly in section 7.5 
on study limitations. Lack of or poor communication and continuity among team 
members have been suggested as causes of moral distress and interventions are 
needed designed to understand and minimise moral distress (Whitehead et al., 
(2015).  
 
Research investigating violent deaths in the United States has been completed in 
several states, and at the time of writing is underway in Washington State (Centers 
for Disease Control and Prevention, 2017). The information being collected includes 
data about suicide deaths and physical factors related to these deaths. Very limited 
data, however, are available on the circumstances of these deaths, including severity 
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of disease and if hospice or palliative care services were involved with severely ill 
patients that died by suicide.  It would be important to understand how or if physical 
factors contributed to an individual’s suicide if the individual was receiving hospice or 
palliative care services. A retrospective investigation of coroners’ reports to collect 
data on how many individuals who died by suicide were diagnosed with chronic or 
life-threatening illness and the circumstances surrounding these deaths would also 
help to understand the social justice implications of these deaths. In addition, an in-
depth examination of suicides by guns may help the understanding of the impact of 
access to guns among those facing serious illness. These data have the potential to 
contribute to the development of education and training for palliative care 
professionals to understand suicidality and influence how suicide assessment and 
treatment is implemented with individuals coping with advanced illness.  
 
Finally, research with family members of hospice patients who died by suicide would 
contribute important knowledge about the impact of these deaths on bereavement 
and the moral dilemmas that they face to help professionals consider all aspects of 
care. 
 
8.2 Final words 
This study began as an exploration of suicide from the perspective of hospice 
professionals working with patients who sought hastened death. The experiences of 
these professionals reveal that interpretation of suicide within hospice is not clearly 
defined, and yet despite lack of clear boundaries on the definition of suicide within 
hospice services, some of these deaths due to health and social inequities, 
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existential, physical, or emotional suffering are considered rational.  The goal of 
palliative care to provide relief from suffering remains central. This leaves open the 
question of how palliative care and hospice may achieve this primary goal. This study 
encourages necessary dialogue on a subject that has been widely considered taboo.   
 
May efforts focus at looking more deeply into the limitations and the potential of 
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Appendix 1. Terminology examples in literature 
Term Abbreviation Description 
Authors 
defining term 
Assisted suicide AS 
Someone makes the means of 
death available but does not act 
as the direct agent of death 
Clymin et al, 
2012 




Removes physician from 
responsibility for patients’ death 







Legislation enacted in Oregon, 
Washington and Vermont 
allowing competent terminally ill 
adults to request lethal 








Someone other than the patient 
uses the means to intentionally 











Action that will likely result in 
death occurring sooner than it 
would have had this action not 
been taken 
Werth, 2004 
Physician Aid in 
Dying 
PAD 
Represent the physician role in 
assisting with a patient-centred 
decision, removing “suicide” 





Terminology used in studies, continued 






PAD Removes the word “suicide” 
Quill, 2012; 





Medical practice involves a 
physician assisting a terminally 
ill, competent adult in dying by 
writing a prescription for lethal 
dose of a drug to be self-
administered by the patient 
Ganzini et al., 
(2001); Ganzini 




Patient is controlling the act of 
dying 
Jablonski, et al 
2012 
Rational Suicide   
The concept that suicide is not 






Stopping of Eating 
and Drinking 
VSED 
A patient making a conscious 




of Food and Fluids 
VWFF 
VSED 
Competent patients decide to 
forgo eating and drinking to 
hasten death within the 
context of a terminal condition 
Harvath, et al., 





Appendix 2. Searches 
Search Add to 
builder 
PubMED Query. 6.06.17 Items 
found 
#13 Add Search ((((((((("suicide"[MeSH Terms]) OR "suicide, 
assisted"[MeSH Terms]) OR "suicide, 
attempted"[MeSH Terms]) OR "euthanasia, active, 
voluntary"[MeSH Terms])) OR (((("assisted 
suicide"[Title/Abstract]) OR "assisted 
dying"[Title/Abstract]) OR "aid in 
dying"[Title/Abstract]) OR "death with 
dignity"[Title/Abstract]))) AND (((((((("hospice 
care"[MeSH Terms]) OR "hospices"[MeSH Terms]) 
OR ("hospice and palliative care nursing"[MeSH 
Terms])) OR "palliative care"[MeSH Terms]) OR 
"palliative medicine"[MeSH Terms])) OR "terminal 
care"[MeSH Terms]) OR (("end of 
life"[Title/Abstract]) OR hospice*[Title/Abstract]))) 
AND ((("health personnel"[MeSH Terms]) AND 
"attitude of health personnel"[MeSH Terms]) AND 
((((((professional*[Title/Abstract]) OR 
clinician*[Title/Abstract]) OR 
physician*[Title/Abstract]) OR nurse*[Title/Abstract]) 
OR social worker*[Title/Abstract]) OR 
chaplain*[Title/Abstract]))) AND 
(((((experience*[Title/Abstract]) OR 




#12 Add Search (("health personnel"[MeSH Terms]) OR 
"attitude of health personnel"[MeSH Terms]) OR 
((((((professional*[Title/Abstract]) OR 
clinician*[Title/Abstract]) OR 
physician*[Title/Abstract]) OR nurse*[Title/Abstract]) 
OR social worker*[Title/Abstract]) OR 
chaplain*[Title/Abstract]) 
891690 
#11 Add Search ((((((("hospice care"[MeSH Terms]) OR 
"hospices"[MeSH Terms]) OR ("hospice and palliative 
care nursing"[MeSH Terms])) OR "palliative 
care"[MeSH Terms]) OR "palliative medicine"[MeSH 
Terms])) OR "terminal care"[MeSH Terms]) OR (("end 
of life"[Title/Abstract]) OR hospice*[Title/Abstract]) 
93791 
#10 Add Search ((((("suicide"[MeSH Terms]) OR "suicide, 
assisted"[MeSH Terms]) OR "suicide, 
attempted"[MeSH Terms]) OR "euthanasia, active, 
voluntary"[MeSH Terms])) OR (((("assisted 
suicide"[Title/Abstract]) OR "assisted 
55504 
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dying"[Title/Abstract]) OR "aid in 
dying"[Title/Abstract]) OR "death with 
dignity"[Title/Abstract]) 
#9 Add Search ((((experience*[Title/Abstract]) OR 
view*[Title/Abstract]) OR feel*[Title/Abstract]) OR 
opinion*[Title/Abstract]) OR attitude*[Title/Abstract] 
1428552 
#8 Add Search (((((professional*[Title/Abstract]) OR 
clinician*[Title/Abstract]) OR 
physician*[Title/Abstract]) OR nurse*[Title/Abstract]) 
OR social worker*[Title/Abstract]) OR 
chaplain*[Title/Abstract] 
889232 
#7 Add Search "attitude of health personnel"[MeSH Terms] 138209 
#6 Add Search "health personnel"[MeSH Terms] 438357 
#5 Add Search ("end of life"[Title/Abstract]) OR 
hospice*[Title/Abstract] 
25353 
#4 Add Search "terminal care"[MeSH Terms] 45465 
#3 Add Search (((("hospice care"[MeSH Terms]) OR 
"hospices"[MeSH Terms]) OR ("hospice and palliative 
care nursing"[MeSH Terms])) OR "palliative 
care"[MeSH Terms]) OR "palliative medicine"[MeSH 
Terms] 
53774 
#2 Add Search ((("assisted suicide"[Title/Abstract]) OR 
"assisted dying"[Title/Abstract]) OR "aid in 
dying"[Title/Abstract]) OR "death with 
dignity"[Title/Abstract] 
3615 
#1 Add Search ((("suicide"[MeSH Terms]) OR "suicide, 
assisted"[MeSH Terms]) OR "suicide, 







Search ID CINAHL Search Terms   
S14 S10 AND S11 AND S12 AND S13  (382) 
S13 S8 OR S9  
View Results 
(459,611) 
S12 S1 OR S2 OR S3  
View Results 
(16,143) 




TI experience* OR TI view* OR TI feel* OR TI 
opinion* OR TI attitude* OR AB experience* OR AB 




TI professional* OR TI clinician* OR TI physician* 
OR TI nurse* OR TI social worker* OR TI chaplain* 
OR AB professional* OR AB clinician* OR AB 
physician* OR AB nurse* OR AB social worker* OR 




(MH "Health Personnel") OR (MH "Attitude of 




TI end of life OR TI hospice* OR AB end of life OR 
AB hospice*  
View Results 
(25,119) 
S6 (MH "Terminal Care")  
View Results 
(12,405) 




(MH "Hospice Care") OR (MH "Hospice and 




TI assisted suicide OR TI assisted dying OR TI aid in 
dying OR TI death with dignity OR AB assisted 
suicide OR AB assisted dying OR AB aid in dying OR 
AB death with dignity  
View Results 
(2,192) 




(MH "Suicide") OR (MH "Suicide, Assisted") OR (MH 






Search Options PsychINFO Search 9.06.2017   
S12 (S6 OR S7) AND (S8 AND S9 AND S10 
AND S11)  
View Results (313) 
S11 S6 OR S7  View Results (329,041) 
S10 S4 OR S5  View Results (29,417) 
S9 S1 OR S2 OR S3  View Results (36,158) 
S8 TI experience* OR TI view* OR TI 
feel* OR TI opinion* OR TI attitude* 
OR AB experience* OR AB view* OR 
AB feel* OR AB opinion* OR AB 
attitude*  
View Results (975,407) 
S7 TI professional* OR TI clinician* OR 
TI physician* OR TI nurse* OR TI 
social worker* OR TI chaplain* OR 
AB professional* OR AB chaplain* 
OR AB physician* OR AB nurse* OR 
AB social worker* OR AB chaplain*  
View Results (316,741) 
S6 DE "Health Personnel" OR DE 
"Health Personnel Attitudes"  
View Results (33,358) 
S5 TI end of life OR TI hospice* OR AB 
end of life OR AB hospice*  
View Results (23,894) 
S4 DE "Hospice" OR DE "Palliative 
Care"  
View Results (12,890) 
S3 TI assisted suicide OR TI assisted 
dying OR TI aid in dying OR TI death 
with dignity OR AB assisted suicide 
OR AB assisted dying OR AB aid in 
dying OR AB death with dignity  
View Results (1,863) 
S2 DE "Euthanasia"  View Results (1,662) 
S1 DE "Suicide" OR DE "Attempted 





Search ID# Academic Search Complete Search Terms 
09.06.2017 
Actions 
S11 S7 AND S8 AND S9 AND S10  View Results (346) 
S10 S5 OR S6  View Results (739,271) 
S9 S3 OR S4  View Results (60,776) 
S8 S1 OR S2  View Results (32,876) 
S7 TI experience* OR TI view* OR TI feel* OR TI 
opinion* OR TI attitude* OR AB experience* 
OR AB view* OR AB feel* OR AB opinion* OR 
AB attitude*  
View Results 
(1,953,268) 
S6 TI professional* OR TI clinician* OR TI 
physician* OR TI nurse* OR TI social worker* 
OR TI chaplain* OR AB professional* OR AB 
clinician* OR AB physician* OR AB nurse* OR 
AB social worker* OR AB chaplain*  
View Results (722,806) 
S5 SU health personnel OR SU health personnel 
attitudes OR SU health personnel experiences  
View Results (30,718) 
S4 TI end of life OR TI hospice* OR AB end of life 
OR AB hospice*  
View Results (53,277) 
S3 SU hospice care OR SU ( hospice and palliative 
care nursing ) OR SU palliative care OR SU 
palliative medicine OR SU terminal care  
View Results (17,327) 
S2 TI assisted suicide OR TI assisted dying OR TI 
aid in dying OR TI death with dignity OR AB 
assisted suicide OR AB assisted dying OR AB 
aid in dying OR AB death with dignity  
View Results (5,432) 
S1 SU suicide OR SU suicide assisted OR SU 






AMED Search Terms 09.06.2017 
S7 AND S8 AND 
S9 AND S10  
Search modes - Find all my search terms  View Results (236) 
S10 S5 OR S6  View Results (34,651) 
S9 S3 OR S4  View Results (15,952) 
S8 S1 OR S2  View Results (2,338) 
S7 TI experience* OR TI view* OR TX feel* 
OR TI opinion* OR TI attitude* OR AB 
experience* OR AB view* OR AB feel* OR 
AB opinion* OR AB attitude*  
View Results (26,872) 
S6 professional* OR clinician* OR 
physician* OR nurse* OR social worker* 
OR chaplain* OR professional* OR 
clinician* OR physician* OR nurse* OR 
social worker* OR chaplain*  
View Results (32,163) 
S5 TX health personnel OR TX health 
personnel attitudes OR TX health 
personnel experiences  
View Results (5,244) 
S4 TI end of life OR TI hospice* OR AB end 
of life OR AB hospice*  
View Results (6,162) 
S3 TX hospice care OR TX ( hospice and 
palliative care nursing ) OR TX palliative 
care OR TX palliative medicine OR TX 
terminal care  
View Results (15,104) 
S2 TI assisted suicide OR TI assisted dying 
OR TI aid in dying OR TI death with 
dignity OR AB assisted suicide OR AB 
assisted dying OR AB aid in dying OR AB 
death with dignity  
View Results (932) 
S1 TX suicide OR TX suicide assisted OR TX 
suicide, attempted OR TX euthanasia  





Appendix 3. Study Quality Form  
(Hawker et al., 2002) 
Studies were given a rating of 1-4 on each of these items from very poor to good 
respectively, as suggested by Hawker, et al (2002): 
 
1. Abstract and title: Did they provide a clear description of the study? 
Good Structured abstract with full information and clear title. 
Fair Abstract with most of the information. 
Poor Inadequate abstract. 
Very Poor No abstract. 
 
2. Introduction and aims: Was there a good background and clear statement of the 
 aims of the research? 
Good Full but concise background to discussion/study containing up-to- 
 date literature review and highlighting gaps in knowledge. 
 Clear statement of aim AND objectives including research questions. 
Fair Some background and literature review. Research questions outlined. 
Poor Some background but no aim/objectives/questions, OR Aims/objectives 
but  inadequate background. 
Very Poor No mention of aims/objectives. No background or literature review. 
 
3. Method and data: Is the method appropriate and clearly explained? 
Good Method is appropriate and described clearly (e.g., questionnaires included). 
 Clear details of the data collection and recording. 
Fair Method appropriate, description could be better. Data described. 
Poor Questionable whether method is appropriate. Method described 
 inadequately. 
 Little description of data. 
Very Poor  No mention of method, AND/OR Method inappropriate, AND/OR No 
details   of data. 
 
4. Sampling: Was the sampling strategy appropriate to address the aims? 
Good Details (age/gender/race/context) of who was studied and how they were 
 recruited. 
 Why this group was targeted. The sample size was justified for the study. 
 Response rates shown and explained. 
Fair Sample size justified. Most information given, but some missing. 
Poor Sampling mentioned but few descriptive details. 
Very Poor No details of sample. 
 
5. Data analysis: Was the description of the data analysis sufficiently rigorous? 
Good Clear description of how analysis was done. Qualitative studies: Description of 
how  themes derived/respondent validation or triangulation. 
 Quantitative studies: Reasons for tests selected hypothesis driven/ 
 numbers add up/statistical significance discussed. 
Fair Qualitative: Descriptive discussion of analysis. Quantitative. 
 213 
Poor Minimal details about analysis. 
Very Poor No discussion of analysis. 
 
6. Ethics and bias: Have ethical issues been addressed, and what has necessary 
 ethical approval gained? Has the relationship between researchers and 
 participants been adequately considered? 
Good Ethics: Where necessary issues of confidentiality, sensitivity, and 
 consent were addressed. 
 Bias: Researcher was reflexive and/or aware of own bias. 
Fair Lip service was paid to above (i.e., these issues were 
 acknowledged). 
Poor Brief mention of issues. 
Very Poor No mention of issues. 
 
7. Results: Is there a clear statement of the findings? 
Good Findings explicit, easy to understand, and in logical progression. 
 Tables, if present, are explained in text. Results relate directly to aims. 
 Sufficient data are presented to support findings. 
Fair Findings mentioned but more explanation could be given. Data presented 
 relate directly to results. 
Poor Findings presented haphazardly, not explained, and do not progress logically 
 from results. 
Very Poor Findings not mentioned or do not relate to aims. 
 
8. Transferability or generalizability: Are the findings of this study transferable 
 (generalizable) to a wider population? 
Good Context and setting of the study is described sufficiently to allow comparison 
 with other contexts and settings, plus high score in Question 4 (sampling). 
Fair Some context and setting described, but more needed to replicate or 
 compare the study with others, PLUS fair score or higher in Question 4. 
Poor Minimal description of context/setting. 
Very Poor No description of context/setting. 
 
9. Implications and usefulness: How important are these findings to policy and 
 practice? 
Good Contributes something new and/or different in terms of 
 understanding/insight or perspective. Suggests ideas for further research. 
 Suggests implications for policy and/or practice. 
Fair Two of the above (state what is missing in comments). 
Poor Only one of the above. 




Appendix 4. Appraisal Findings and Comments 
Authors Score Findings Comments 
Anquinet, L., Raus, 
K., Sterckx, S., 
Smets, T., Deliens, 
L., & Rietjens, J. A. 
(2013) 
36  Differences between continuous sedation and euthanasia 
(some participants stated that the distinction between the 
two is sometimes blurred or even non-existent, especially 
when medication is increased disproportionally or when 
sedation is induced too early) 
At least 10 participants worked in Palliative Care 
unit. This study is included because it is suggested 
that continuous deep sedation is used in conjunction 
with assisted dying in Flanders.  Cultural, social, legal 
factors, and organisational differences explain 
variability in use of continuous deep sedation, and as 
a choice where euthanasia is allowed.  
Carlson, B, et al 
2005 
35 Chaplains divided with responses to request for physician 
assisted suicide. Chaplain discomfort suggested as wanting to 
avoid influencing a patient’s decision, and conflict with belief 
about PAS. Chaplains overall did not believe they had strong 
influence on patients’ decision. 
This study did not investigate experiences with 
patients who might have intentionally hastened 
death or died by an unassisted suicide. 
Chin, et al 1999 23 Main study focused on patients and patient data. 14 
physicians were interviewed about challenges associated with 
writing a prescription for lethal medications.  
Data obtained from first year of DWDA/limited to 
one paragraph of data from interviews with 
physicians. There is limited information about how 
these interviews were conducted.   
Clymin, J., et al 
2012 
28 Fear of job loss, ethical conflict and challenges responding to 
patient questions, lack of knowledge and need to refer 
elsewhere for information about DWDA emerged as 
predominant themes. 
Strength: First identified study about nurses and 
DWDA  Limitation: did not identify nurses working 
with patients with advanced disease. 
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Cohen, J., Van 
Wesemael, Y., 
Smets, T., Bilsen, 
J., & Deliens, L. 
(2012) 
36 Results of physician surveyed: Walloon physicians more often 
not to administer lethal drugs and more likely to administer 
palliative sedation. Flemish physicians have better notion of 
legal obligations and Walloon physicians less likely to consult 
second physician and report officially.  
Use of descriptive questions in survey of physician 
suggests more value neutral responses. 
Dees, M. K., 
Vernooij-Dassen, 
M. J., Dekkers, W. 
J., Elwyn, G., 
Vissers, K. C., & 
van Weel, (2013) 
35 Five main themes emerged: (1) initiation of sharing views and 
values about euthanasia, (2) building relationships as part of 
the negotiation, (3) fulfilling legal requirements, (4) detailed 
work of preparing and performing euthanasia and (5) 
aftercare and closing. 
Making decisions about euthanasia demands a 
proactive approach towards participants' 
preferences and values regarding end of life, towards 
the needs of relatives, towards the burden placed on 
physicians and a careful attention to shared decision-
making. 
Dierckx De 
Casterlé, et al 
(2010) 
36 Flemish nurses wish to be and are are involved in 7 stages of 
euthanasia process (before request, confronting the request, 
decision making, preceding euthanasia, carrying out 
euthanasia, immediate aftercare, later aftercare). 
 There is no indication from this study that patients 
might seek to die by unassisted suicide.  
Dobscha, SK, et al 
2004 
 36  Requests for PAS facilitated discussion. Physicians expressed 
discomfort about managing symptoms, and issues of 
abandonment. 
 There is no indication that physicians spoke about 
patients who died from unassisted suicide.  
Francke, A. L., et al 
(2016)  
 36 Majority of nurses want to be involved in euthansia decision 
making and not all aware that they are not allowed to 
administer lethal drugs.  
There is no indication that nurses experienced 
patients who might have hastened death unassisted 
despite suggestion that they have frequent contact 
at end of life.  
Gamondi, C., 
Borasio, G. D., 
Oliver, P., Preston, 
N., & Payne, S. 
(2017) 
36 Swiss palliative care physicians report being involved in 
assisted suicide decision making with their patients but are 
not willing to prescribe lethal medications. Instead they seek 
alternatives after exploring the origins of patients’ requests. 
Education about structured ways of communicating with 
patients about assisted suicide is recommended.  
There is no mention of alternatives offered for 
patients who are refused assisted suicide and if 
patients refused assisted suicide by palliative care 
physicians are dying by suicide or seeking other 
alternatives to hasten death.  
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Ganzini, L., 
Dobscha, S. K., 
Heintz, R. T. & 
Press, N. 2003 
36 First study of two from same qualitative study of physicians. 
Suggest how care might be improved with patients requesting 
assisted suicide. 
Results theoretical, not generalizable. Informants 
reviewed and verified material before publishing.  
 
Ganzini, L., Nelson, 
H. D., Schmidt, T. 
A., Kraemer, D. F., 
Delorit, M. A. & 
Lee, M. A. 2000 
36 Challenges physicians faced with DWDA: unwanted publicity, 
difficulty obtaining medications, understanding requirements 
of law, ambivalence. Concern about depression with patients 
but not less concern about vulnerable populations being 
affected. 
 Strength: large sample with 65% response. Difficult 
to generalise. Physicians opposed to law unlikely to 
respond to survey.   
 
Ganzini, L., Nelson, 
H. D., Lee, M. A., 
Kraemer, D. F., 
Schmidt, T. A. & 
Deloit M. A. 2001 
36 Physicians more likely to refer to hospice, and conversations 
with patients about DWDA perceived to be more helpful; 
physicians not fully informed about prescribing prescriptions. 
 
 Physician skill in pain and symptom management 
not assessed. Study about whether physician skills 
improved may not be attributed to DWDA.    
 
Ganzini, L., 
Harvath, T. A., 
Jackson, A., Goy, E. 
R., Miller, L. L. & 
Delorit, M. A. 2002 
36 Patient background is described; depression described as less 
likely factor to wishing for PAS, hospice care may be refused 
by 20% of patients who die by PAS. 
73% returned survey; social workers and nurses 
agree that patients request PAS because they want 
to control circumstances of death.    
 
Ganzini, L., Goy, E. 
R., Miller, L. L., 
Harvath, T. A., 
Jackson, A. & 
Delorit, M. A. 2003 
36 Nurses report of patients who stop eating and drinking 
because they wish to die. Nurses rated quality of death an 8 
on scale of 1-9. 
Based on nurses perceptions, but unclear if nurses 
reported on patient's inability to eat and drink due 
to disease.   
 
Georges, J. J., The, 
A. M., B. D, O.-P., 
& van der Wal, G. 
(2008) 
 36 Dealing with requests for euthanasia is very challenging for 
GPs, although they feel committed to alleviate a patient's 
suffering and to promote a peaceful death. 
 
There is no indication that patients pursued an 
unassisted suicide or intentionally hastened death 
after conversation with physician or that this aspect 
was investigated.  
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Harvath, T. A., 
Miller, L. L., Smith, 
K. A., Clark, L. D., 
Jackson, A. & 
Ganzini, L. 2006 
33 Suggests several challenges hospice professionals face when 
patients request PAS, including that PAS is antithetical to 
hospice goal. Professionals feel sense of responsibility to 
dissuade patients from persuing PAS.   
 
Suicide is investigated only as it applies to assisted 
suicide. There is no indication that professionals 
experienced patients intentionally hastening their 
own deaths.    
 
Inghelbrecht, E., 
Bilsen, J., Mortier, 
F., Deliens, L. 
(2010) 
36 Nurses were involved in decisions about euthanasia but not 
consistently.   In euthanasia , 40% of nurses were involved in 
preparation of life ending drugs and administered drugs in 
12% of cases.   In cases of life ending drugs without patient’s 
consent/request, nurses administered drugs in 45% of cases 
Nurses administer life-ending medication without 
request by patient more often and without legal 
regulation. By law physicians are supposed to discuss 
euthanasia requests with nurses but they don’t 
always.  No data was collected about a patient’s 
intent to hasten death  or die by suicide without 
nurse assistance.  
Meeussen, K., Van 
den Block, L., 
Bossuyt, N., 
Echteld, M., Bilsen, 
J., & Deliens, L. 
(2011). 
 35 One of seven terminally ill patients dying at home under the 
care of a GP expresses a euthanasia request in the last phase 
of life but only 19% of those who requested were granted. 
 There is no indication that there were some 
experiences or knowledge of patients who died by 
unassisted suicide. 
Miller, L. L., et al. 
2004 
36 Social workers more supportive of ODDA compared to nurses. 
Professionals need to be prepared for conversations with 
patients about PAS.  Hospice and PAS not mutually exclusive. 
From same survey as Ganzini, et al 2003, 2004.   
 
Norton, E. M. & 
Miller, P. J. 2012 
20  Professionals desire to comply with law but faced with 
competing organizational values. 
 Small sample size.  There is a suggestion that 
suicides happen all the time that are unaccounted.  
Norwood, F. 
(2007) 
 36 Story of discussions that occurred from end of life 
experiences. Talk about euthanasia conforms to at least 5 
stages; initial euthanasia request, written declaration, second 
opinion appointment, scheduling euthanasia, and euthanasia 
death. 
There is no indication that there were unassisted 
suicides.  
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Otte, I. C., Jung, C., 
Elger, B., & Bally, 
K. (2016) 
 35 Three themes: concerns for their own psychological well-
being, conflicting personal values, understanding of 
professional role 
 
No mention of patients who die by unassisted 
suicide. Only the topic of assisted suicide or assisting 
a patient to ‘commit suicide’. 
 
Pasman, H. R., 
Willems, D. L., & 
Onwuteaka-
Philipsen, B. D. 
(2013) 
 32 Patients who are refused may be silent about their risk, and 
quality of life may be further diminished. At least one patient 
tried die with overdose and another intentionally VSED 
  
Patients were not diagnosed with a terminal 
prognosis and not on hospice. A few patients did 
choose to hasten death unassisted.  
 
Snijdewind, M. C., 
van Tol, D. G., 
Onwuteaka-
Philipsen, B. D., & 
Willems, D. L. 
(2014) 
 36 The results show that complexities can be categorized into 
relational difficulties and complexities that arise because of 
unexpected situations.  Process toward EAS may be disrupted, 
influenced by physician and relatives. Communication is key to 
prevent complex situations. 
  
Investigation limited to complexities around requests 
for euthanasia or physician assisted suicide. It is 
uncertain if patients died by suicide unassisted if 
their request was rejected.  
Van Bruchem-van 
de Scheur, G., Van 
der Arend, A., 
Abu-Saad, H. H., 
Spreeuwenberg, 
C., Van Wijmen, F., 
& Ter Meulen, R. 
(2007) 
36  22.3% of 278 cases patients spoke about request with district 
nurse first; 49.8% of 267 cases nurses were not involved in 
GPs decision making, and 13.3 of 264 cases attended 
administration of lethal drugs; district nurses provide some 
aftercare to surviving relatives in 80.3% of 264 cases. 
communication between GPs and district nurses needs 
improvement. 
Part of a larger study of nurses’ role in end of life 
decision making. Investigation limited specifically to 
physician assisted suicide and no investigation of 
patients who might have intentionally hastened 
death without assistance.  
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Van Bruchem-van 
de Scheur, G., Van 
der Arend, A., 
Abu-Saad, H. H., 
Spreeuwenberg, 
C., Van Wijmen, F., 
& Ter Meulen, R. 
(2008) 
36 There is a large difference between role of nurses in home-
care and hospital settings. Consultation between nurse and 
physician needs improvement, as their role varies in the 
various stages of the euthanasia process. 
Suggestion that multidisciplinary institutional guidelines are 
needed  
It is suggested that if a euthanasia request was not 
granted that 37.2% of the nurses held empathy for 
the patient. The study did not investigate if these 
patients were supported and if some of them 
hastened death in other ways.  
 
van Marwijk, H., 
Haverkate, I., van 
Royen, P., & The, 
A.-M. (2007) 
28 Euthanasia has a major impact on PCPs. Their relationship 
with the patient, their loneliness, the role of the family, and 
pressure from society; more training recommended. 
There is no mention of unassisted suicide or patients 
who might have hastened death in other ways.  
Voorhees, J. R., 
Rietjens, J. A., Van 
der Heide, A. & 
Drickamer, M. A. 
2014 
36 Discussions of PAD opens up conversations strengthening 
doctor-patient relationships. 
 Results of study in two countries; PAD regulation 
differs in each country. Limited to perspective of 
physician.   
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Appendix 5. Recruitment letters 
 
Recruitment letter, flyer, emails, and follow up information 
 
Hospice professionals' experiences with patients about suicide and desire for hastened 
death in Washington State 
 




I am inviting you to participate in a research study I am conducting with home hospice 
professionals working in Washington State. The purpose of this research study is to 
understand home hospice professionals’ experiences with patients around issues of suicide or 
desire for hastened death in Washington State.   
 
If you are working as a chaplain/spiritual counsellor, nurse, nurse practitioner, physician, or 
social worker providing or supervising home hospice services in Washington State you may 
be eligible to participate in this study.  
 
It is important to know that participation is voluntary and any identifying information about 
participants will be omitted.  
 
If you are interested in learning more, please call me at 1-503-395-7930 or email me at 
s.gerson@lancaster.ac.uk. You are welcome to distribute the attached flyer to any interested 
colleagues. I am happy to answer questions, and send you additional information about this 
study at your request.  
 
Thank you for your time and consideration. I look forward to hearing from you.  
 
Sheri Mila Gerson, LICSW, ACSW 
Olympia, Washington 
PhD Student in Palliative Care 
Lancaster University, UK 
 
s.gerson@lancaster.ac.uk 







Email invitation to participate in this study for hospice professionals who have expressed 




I am writing to you because you previously expressed interest in research I am conducting 
with home hospice professionals in Washington State. I have now started recruitment and 
would like to invite you to participate in this research.  You are welcome to distribute the 
attached flyer to colleagues who may also be interested in participating in this research. 
 
The purpose of this research study is to understand home hospice professionals’ experiences 
with patients at risk of suicide or who have expressed desire for hastened death.   
 
You may be eligible or know others eligible for this study that are working as a 
chaplain/spiritual counsellor, nurse, nurse practitioner, physician, or social worker providing 
home hospice services in Washington State. I want to understand what desire for hastened 
death might mean to professionals from different disciplines and areas around the state, and 
how their experiences might influence communication with patients at risk of suicide or 
considering a hastened death. 
 
Any identifying information about participants will be omitted and the identity of participants 
who choose to be included in this study will be kept anonymous but extracts of interviews 
may be included in the analysis and final summary.  It is important to know that participation 
is voluntary.  
 
If you are interested in learning more, please call me at 1-503-395-7930 or email me at 
s.gerson@lancaster.ac.uk.   I will answer questions, and send you additional information 
about this study at your request.  
 
 
Thank you for your time and consideration. I look forward to hearing from you.  
 
Sheri Mila Gerson, LICSW, ACSW 
Olympia, Washington 




US Mobile: 1-503-395-7930 
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Follow – up email to participants who have expressed interest in the research, but did 
not respond to first email contact. This will only be sent once two weeks after the initial 




You have expressed interest in a research study I am conducting in Washington State with 
home hospice professionals.  I am following up to ensure that you did receive the first 
message.  
 
The purpose of this research study is to understand home hospice professionals’ experiences 
with patients at risk of suicide or who have expressed desire for hastened death.   
 
You may be eligible or know others eligible for this study that are working as a 
chaplain/spiritual counsellor, nurse, nurse practitioner, physician, or social worker providing 
home hospice services in Washington State. I want to understand what desire for hastened 
death might mean to professionals from different disciplines and areas around the state, and 
how their experiences might influence communication with patients at risk of suicide or 
considering a hastened death. 
 
Any identifying information about participants will be omitted and the identity of participants 
who choose to be included in this study will be kept anonymous but extracts of interviews 
may be included in the analysis and final summary.  It is important to know that participation 
is voluntary.  
 
If you are interested in learning more, please call me at 1-503-395-7930 or email me at 
s.gerson@lancaster.ac.uk.   I will answer questions, and send you additional information 
about this study at your request.  
 
If I do not hear from you in the next two weeks, I will understand that you are unable to 
participate in this study. Thank you for your time and consideration. 
 
Sheri Mila Gerson, LICSW, ACSW 
Olympia, Washington 









Appendix 6. Participant Information Sheet 
 
 
Participant Information Sheet 
 
Hospice professionals' experiences with patients about suicide and desire for 
hastened death in Washington State 
 
My name is Sheri Gerson and I am conducting this research as a student in the 
Palliative Care programme at Lancaster University, Lancaster, United Kingdom. 
 
What is the study about? 
The purpose of this study is to understand experiences of home hospice 
professionals with patients at risk of suicide or who have expressed a desire for 
hastened death in a state that has passed the Death with Dignity Act. I want to 
understand what desire for hastened death might mean to professionals from 
different disciplines and organisations and how this might influence communication 
with patients considering a hastened death.  
 
Why have I been approached? 
You have been approached because you work as a home hospice professional 
providing or supervising direct services that address the comfort and well being of 
patients facing end of life. You could be a chaplain, nurse, nurse practitioner, 
physician or social worker. 
 
Do I have to take part? 
No.  It’s completely up to you to decide whether or not you take part in this study.  If 
you do decide to participate, you will be able to withdraw up to 2 weeks from the day 
of the interview.  
 
What will I be asked to do if I take part? 
If you decide you would like to take part, you will be asked to schedule a meeting at a 
convenient and agreed upon location with me for an interview lasting 1-2 hours. You 
will also be asked to complete and sign a consent form to participate in the study.  
You will be asked questions about your experiences related to the topic. You may 
also choose to have a follow up interview of up to 1 hour within two months of the 
initial interview to add any additional comments about your experiences related to the 
research topic. 
 
Will my data be identifiable? 
The data collected for this study will be stored securely and only I will have access to 
this data: 
 
o Audio recordings will be completed on a device with encryption capability. 
Only I will have access to the recordings. Recordings will be destroyed and/or 
deleted after the award of the PhD. 












o The files on the computer will be encrypted (that is no-one other than I will be 
able to access them) and the computer itself password protected. The 
computer data will  
be deleted and I will destroy any information identifying you after the award of 
the PhD by Lancaster University.  
o At the end of the study, hard copies of data will be kept securely in a locked 
cabinet for ten years. At the end of this period, they will be destroyed.  
o The typed version of your interview will be made anonymous by removing any 
identifying information including your name. Anonymised direct quotations 
from your interview may be used in the reports or publications from the study, 
so your name will not be attached to them. 
 
There are some limits to confidentiality: if what is said in the interview makes me think 
that you, or someone else is at significant risk of harm, I will have to break 
confidentiality and speak to my supervisors.  If possible, I will tell you if I have to do 
this. 
 
What will happen to the results? 
The results will be summarised and reported in a PhD thesis and may be submitted 
for publication in an academic or professional journal or for conference presentations. 
 
Are there any risks? 
There are no major risks anticipated with participating in this study. However, if you 
do experience some distress following participation you are encouraged to inform me 
and contact the resources provided at the end of this sheet. 
 
Are there any benefits to taking part? 
Whilst there are no direct benefits to taking part, many people who take part in 
research find participating interesting. 
 
Who has reviewed the project? 
This study has been reviewed by the Faculty of Health and Medicine Research Ethics 
Committee, and approved by the University Research Ethics Committee at Lancaster 
University. 
 
Where can I obtain further information about the study if I need it? 
If you have any questions about the study, please contact me: 


















If you wish to make a complaint or raise concerns about any aspect of this study and 
do not want to speak to the researcher, you can contact:  
 
Dr. Anne Grinyer 
Senior Lecturer in Health Research 
Division of Health Research, 
Faculty of Health and Medicine, 
Lancaster University, Lancaster LA1 4YD  
Email: a.grinyer@lancaster.ac.uk 
Tel: 01524 592677 
  
If you wish to speak to someone outside of the Faculty of Health and Medicine 
Doctorate Programme, you may also contact:  
 
Professor Roger Pickup  
Associate Dean for Research  
Faculty of Health and Medicine  
Lancaster University, Lancaster LA1 4YD  
Email: r.pickup@lancaster.ac.uk  
Tel: (01524) 593746 
 
Thank you for taking the time to read this information sheet. 
 
Resources in the event of distress 
Should you feel distressed either as a result of taking part, or in the future, the 
following resources may be of assistance:  
 
 Emergency and referral service:  
 24-HOUR CRISIS LINE: 866-4-CRISIS  (866-427-4747)  
 KING COUNTY 2-1-1: DIAL 2-1-1 
 800-621-4636 (M-F 8am-6pm) 
 
For therapy or mental health referrals: 
Washington State Psychological Association (wspa@wapsych.org) 
PO Box 95168 
Seattle, WA 98145-2168 
Phone: (206) 547-4220 
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Appendix 7. Interview Discussion Guide 
 
 
Interview Discussion Guide 
 
This research is to gather the experiences of home hospice professionals around the issues of 
suicide and hastened death in Washington State.  I am interested in hospice professionals’ 
experiences with patients about desire for hastened death (DHD) and the terminology that is 
used in discussing these topics.  
 
The questions below are an example and may be adapted depending on the participants’ 
responses and if they require additional probing. 
 
Questions are separated by terminology, experiences, communication, and discernment; 
however, questions and responses overlap between these elements: 
 
Terminology: Definition of terms 
 What does hastened death mean to you in your work with hospice patients? Tell me 
what desire for hastened death for hospice patients means to you. 
 What terms are used in your agency/organisation? With patients? With other team 
members?  
Experiences: Clinical/professional experiences with suicide/DHD 
 Tell me about the experiences you have had with patients about suicide and hastened 
death in the way that you have described?   This may include patients at risk of 
suicide, or requesting information about or intent to pursue the Death with Dignity 
Act.  
 How have you experienced patients who hastened their deaths or died by suicide? 
 How have these experiences shaped your ability or experience with other patients or 
families you have worked with?  
 What are your experiences with team members when working with patients 
communicating desire for hastened death or around issues of suicide?  
Communication: Organisational policy and professional ethical codes regarding suicide/PAD 
 including assessment, management and training of suicide risk 
 How do organisational policies where you work inform decisions about how you 
work with patients communicating desire for hastened death?  Is there anything that 
you are not allowed to discuss with your patients? 
 Does your agency/organisation have a policy around suicide risk and/or DWDA?  
 If you worked prior to the passing of the DWDA legislation, how has the DWDA 
affected your experiences with patients overall?  With patients communicating DHD?  
 Other influences on your experiences with patients on these topics? 
Discernment: Discernment between suicide risk and hastened death 
 How has your training in suicide risk assessment, management, and treatment applied 
in the home hospice setting?  
 How is the suicide assessment training that you received applicable with your clients?  
 How do you discern between a hospice patient at risk for suicide vs. a patient who has 
hastened their death utilizing the DWDA (if they have had this experience), or 
discussed other methods (voluntary withdrawal from food and fluids, palliative 
sedation, other)? Does your hospice have a protocol for coping with these topics?  




Appendix 8.  Criteria for good thematic analysis  





Transcription 1 The data have been transcribed to an appropriate level of detail, 
and the transcripts have been checked against the tapes for 
accuracy 
Coding 2 Each data item has been given equal attention in the coding 
process. 
 
 3 Themes have not been generated from a few vivid examples (an 
anecdotal approach), but instead the coding process has been 
thorough, inclusive and comprehensive. 
 4 All relevant extracts for all each theme have been collated. 
 
 5 Themes have been checked against each other and back to the 
original dataset 
 6 Themes are internally coherent consistent and distinctive 
 
Analysis 7 Data have been analysed – interpreted, made sense of – rather 
than just paraphrased or described 
 8 Analysis and data match each other –the extracts illustrate the 
analytic claims. 
 9 Analysis tells a convincing and well-organised story about the data 
and topic. 
 10 A good balance between analytic narrative and illustrative extracts 
is provided. 
Overall 11 Enough time has been allocated to complete all phases of the 
analysis adequately, without rushing a phase or giving it a once- 
over-lightly. 
Written report 12 The assumptions about, and specific approach to, thematic 
analysis are clearly explicated. 
 13 There is a good fit between what you claim you do, and what you 
show you have done  
 14 The language and concepts used in the report are consistent with 
the epistemological position of the analysis 
 15 The researcher is positioned as active in the research process; 
themes do not just ‘emerge’ 
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PO Box 6352 • Olympia, WA 98507  •  Phone:  253-661-3739  •  Toll-free:  866-661-3739 





10 November 2014 
 
Sheri Mila Gerson, LICSW 
1962 Orchard DR NW 
Olympia, WA 98502 
 
Dear Ms. Gerson, 
 
The Washington State Hospice and Palliative Care Organization (WSHPCO) is a membership 
organization of 36 of the 37 hospices and over 20 palliative care providers and others working to 
improve statewide hospice and palliative care services.   
 
WSHPCO is responding to your request to recruit hospice professionals for the research you are 
undertaking to complete a thesis as a PhD student in Palliative Care at Lancaster University in 
the UK.  We understand that the title of your research study is: 
 
"Hospice professionals' experiences with patients about suicide and desire for hastened 
death in Washington State" 
 
WSHPCO is confirming that you will have access to our membership through the organization’s 
weekly newsletter.  We will also email your research request to all members to recruit 
participants for your study when you are prepared to begin your research. Please contact us again 
at that time.   
 
We appreciate your interest in this study, as there is an overall lack of research into many facets 



















VRFF Death with Dignity Meds Palliative Sedation 
VRFF as an option Practicing to pass the test Call it assisted suicide 
VRFF not taking 
life (suicide) 
We are going to do what 
makes sense 
alternative to DWD 
VRFF passive don't tell anyone Alternative to suicide by gun 
Don’t always talk 
about it 
Uncharted territory Spouse felt he killed patient 
Rural Story Intentional Overdose Self-inflicted gunshot 
Palliative Sedation 
barrier 
unreported He was a part of that gun 
Cultural 
differences 
Reported as suicide Impact on staff 
higher suicide rate Is it euthanasia really messy 
access to PC 
differences 
DWD process too hard I wouldn't let my dog go 
through this 
     
DWDA Perceptions -suicide DWDA Terminology issues 
Feelings of 
responsibility 
sometimes people have 
right to kill themselves 
actively pursuing Death with 
Dignity law 
not part of natural 
process 
haven't arrived assisted suicide 
die on own terms suicide is a loaded word commit suicide 
DWDA is suicide control at end of life hate term Death with Dignity 
mixed feelings put to sleep like with a vet physician assisted suicide 
can't pretend we 
can always 
manage pain 
law and profession not 
always in line with my 
values 
never going to use suicide with 
DWD 
no value in 
unnecessary 
suffering 
 who am I to stand in their 
way 
Participant in the death with 
dignity program 
couldn't do it 
myself 
hate the word suicide call it what it is 
more willing to 
bend rules 
  determined life closure 
religious/faith   Initiative 1000 
DWDA like C-
section 
 physician aid in dying 
Dilemma/Distress Grey Areas Policy interpretation 
did I make a 
mistake 
honest communication Chinese wall 
feeling like a many unknowns my experience separate from 
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failure organisation 
not knowing who 
is in control 
blurry lines patient must bring it up 
suicide as medical 
emergency 
boundaries should be 
flexible 
cannot be present 
helping pts avoid 
suicide 
unintended consequences attitude toward policy 
I just want to do it 
right 






Cultural Issues Barriers/obstacles 
training does not 
address eol 
access to medical care 
Indian Nations 
barrier to pain management 
rural barrier 
create safe place 
to discuss 
system not seen as 
supportive 
need to keep it secret when 
rural 





limited health care access 
for Latino 
DWDA regulation taxing 
limited resources language barrier/literacy 
barrier 
DWDA access to medications-
scarcity of meds 
suicidal do not 
send signals 
distance to travel to get 
and or receive care 
DWDA - literacy barrier 
screening for risk 
of guns 
autonomy not valued in all 
communities 
 DWDA access to participating 
provider 








Team Issues Challenges 
we can spend 
hours in home 
DWD impact on team denial of death 
Pal Sedation not in 
home 
staff training have to face my own stuff 
It's totally 
different at home 
support by team members managing symptoms and 
quality of life  
with us it’s the end 
of the road 
team members who refuse 
to participate 
not being able to talk about 
death with dignity 
pts have to talk 
about dying at 
home 
 understanding nuances of 
clinical training 
Patient in control 
in the home 









  do diligence 
when pts have 
hospice they don't 
want DWD 
  isolation as professional 
 
Additional Categories 
Professional identity Socioeconomic priorities 
Purpose for participating Story - personal 
Response to initial question Things happen when we aren’t there 




Appendix 12. Example of Coding Tree from NVivo10 
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Appendix 13.  Example of how themes were identified 
Stages of Coding  Process of Coding into theme  
Familiarisation with 
data 
 Researcher completed interviews, and transcribed all data from recordings. 
Recordings were then reviewed against transcription. 
Coding –  
Used Nvivo10 to 




identified as one 
initial category  
 
 
Initially coded across 
entire dataset  
 
Examples of Codes: 
I’m not allowed to know 
Like attending your own wake 
Staying within organisational guidelines 
but still helping patient 
Having a prescription is like a security 
blanket 
Standarising practice is hard 
Not abandon patient 
There is a fine line between policy and 
wanting to support a patient 
Pretending that we can’t always manage 
pain...is naive 
Example of Codes: 
Barriers/Lack of access to: DWD – can’t 
afford, can’t get medicine 
Can’t get to a doctor 
Don’t have money for gas  
Easier to get access to a gun or save up 
pain medications  
Cultural differences – need to do anything 
you can do to keep someone alive  






group – established 
new categories in 
Nvivo10 
Separated codes into professional groups: 
Physicians: sense of responsibility, 
personal/professional conflicts; ... the 
responsibility of signing that and getting 
someone the prescription like that, that is 
a heavy-duty thing, that is a really big 
deal. 
Nurses – choice is theirs, conflict with 
personal values, organisational 
restrictions; can’t think of one hospice 
Across professional groups DWDA 
barriers/access/organisational issues 
identified 
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team member who would bow out of a 
DWD or not be engaged 
Social Workers – l love it, but conflict 
between professional/personal ethics and 
organisational policy 
Chaplains – I might have done the same 
thing in his circumstance 
Reviewing themes New categories: professional roles and differences 
Nurses, social workers, chaplains – Intimacy of care in home; we 
can spend hours in a home   
Physician – less involved in home visits 
Review of subthemes and relationships 
between them – power identified as 
impacting barriers to access 
Defining and 
naming two of the 
initial themes and 
sub-themes 
Relationship of hospice with medical aid in dying 
Variation among professional groups. Professionals have a 
different sense of power and responsibility with patients 
pursuing medical aid in dying 
Social Justice (cost, access, barriers, 
cultural differences) 
 
Writing up Themes  Final analysis  
 
